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Abstract
Malaria parasites, Plasmodium spp., use the lipoate cofactor in two of its or-
ganelles: the apicoplast and the mitochondion. The apicoplast of the parasite
uses an endogenous, biosynthetic pathway to lipoylate its apicoplast resident
lipoate-dependent protein, the pyruvate dehydrogenase (PDH). Apicoplast
lipoylation and the PDH are dispensible during the blood stage of the parasite,
but have divergent phenotypes outside this stage. Lipoylation in the mito-
chondrion occurs through a scavenging pathway, and initial work suggests
that mitochondrial lipoylation and at least one of the lipoylated substrates are
essential for the blood-stage of the parasite.
In the first chapter, we probed the importance of protein lipoylation by ex-
pressing an exogenous gene from Enterococcus faecalis into various subcellular
compartments in the parasite. This gene, dubbed lipoamidase, hydrolyzes
the amide bond between lipoate and a lipoylated protein, effectively inacti-
vating the substrate protein. This process reverses the reaction catalyzed by
lipoate ligase, and serves as a proxy for knocking down or knocking out the
lipoylation machinery in the parasite. Targeting lipoamidase to the apicoplast
reduced, but did not eliminate, lipoylation in the apicoplast, with no obvious
growth phenotype. This is consistent with multiple published experiments
ii
that suggest apicoplast lipoylation is dispensable in the blood stage of the
parasite. Targeting lipoamidase to the mitochondrion of the parasite resulted
in a severe growth phenotype that was partially rescued by acetate supplemen-
tation. These data strongly suggests that mitochondrial protein lipoylation is
essential for parasite survival.
We sought to expand upon this finding by systematically deleting the
mitochondrial proteins that are lipoylated in malaria parasites. The first
knockout experiments discussed are in the murine model, Plasmodium berghei.
Initial attempts using conventional knockout constructs were unsuccessful, so
we switched to constructs generated by Plasmogem in order to exploit their
higher integration frequency. Knockout experiments resulted in successful
knockout of the mitochondrial KDH E2 subunit with no obvious blood stage
growth defect. The BCDH E2 locus is targetable using the Plasmogem con-
structs, but multiple and exotic techniques to try to single clone a knockout
parasite failed, indicative of a severe growth phenotype. The putative shared
mitochondrial E3 subunit was thought to be indispensible since this protein
should be required for the function of all lipoylated proteins in the parasite
mitochondrion. We found, however, that the E3 locus is targetable, but no
single cloning attempt was made, so it is unclear whether the E3 deletion line
would phenocopy the BCDH E2 knockout and display a severe growth phe-
notype. Finally, pilot lipoamidase experiments were performed in attempts
to replicate the findings in the first chapter by targeting lipoamidase to the
mitochondrion of P. berghei. We obtained genetic evidence of lipoamidase
integration into the genome, and the inactive mutant was successfully cloned
iii
and expressed lipoamidase. Continuation of these experiments in P. berghei
may illuminate lipoylation phenotypes in the murine parasite.
Finally, attempts were made to disrupt the paralog KDH E2 and BCDH
E2 subunits in P. falciparum using a single crossover strategy. The KDH was
disruptible, but multiple attempts to single clone a parasite failed, suggesting
facile plasmid excision at that locus. This may suggest that the KDH E2 knock-
out may have a subtle growth phenotype that prefers having an undisrupted
KDH E2 locus. Multiple attempts to knockout the BCDH E2 locus failed,
with two transfections resulting in what is likely spurious integration into a
distal, dispensable locus. These results indicate that BCDH is essential for
parasite growth. Since BCDH is thought to synthesize acetyl-CoA, the activity
of BCDH may explain the finding that acetate supplementation is required to
bypass the toxicity of lipoamidase.
All told, the sum of these experiments show that the P. falciparum and P.
berghei exercise crucial, mitochondrial, lipoate-dependent biochemistry. This
implicates the lipoate ligases, LipL1 and LipL2, as possible essential genes for
the parasite. Knockout experiments suggest that the KDH is likely dispensible,
but possibly useful, in parasite biochemistry, while the BCDH is important in
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Many aspects of central metabolism hinge on the lipoic acid cofactor. Recent
work in Plasmodium spp. has revealed much regarding central metabolism,
and the reliance on lipoic acid in these pathways. Malaria parasites have both
a biosynthetic and salvaging pathway for lipoic acid, and many phenotypes
have arisen based on production, acquisition and application of this cofactor.
This review seeks to cover not only the complicated mechanisms of lipoylation,
but also their affiliated pathways vis-a-vis the malaria parasite.
1.2 Lipoylation in the apicoplast of P.falciparum
Extensive biochemical work in yeast (Schonauer et al., 2009), bacteria (Ma
et al., 2006; McLaughlin et al., 2016; Morris et al., 1995), Arabidopsis (Ewald et
al., 2014) and mammals (Feng et al., 2009) has shed light on the mechanism
in the ancient and highly difficult chemistry involved in lipoate biosynthesis
(Figure 1). The apicoplast of Plasmodium appears to hold many of the same
1
biochemical players as these other organisms, so the following model of
lipoate synthesis can be built on what has already been discovered.
First, the aliphatic backbone is built through fatty acid synthesis in the
apicoplast. Fatty acids are thought to be built onto the apicoplast resident acyl
carrier protein (ACP). Once the ACP is octanoylated, the octanoyl ligase, LipB,
transfers the octanoyl group from the ACP to a specific lysine residue on the
E2 subunit of the pyruvate dehydrogenase (PDH), resulting in an octanoylated
PDH E2 subunit (Christensen and Cronan, 2010). Finally, LipA acts as a lipoyl
synthase by using iron sulfur clusters generated by the apicoplast resident
iron sulfur biosynthesis machinery to add the sulfurs onto positions C6 and
C8, completing lipoate synthesis onto the PDH E2 subunit (Figure 2).
Work performed in the blood stage of Plasmodium falciparum suggests
that this mechanism may hold true for the parasite. Rescue experiments in
E.coli demonstrate that Pf LipB and Pf LipA can replace their E.coli homologs
(Wrenger and Muller, 2004), suggesting that Pf LipB is an octanoyl transferase
and Pf LipA is a lipoyl synthase. Biochemical work performed by our lab
demonstrates that Pf LipA can indeed acquire iron sulfur clusters and is able to
transfer iron sulfur clusters to substrates. Definitive confirmation of apicoplast
specific expression of these proteins has yet to be performed; bioinformatics
work suggests that Pf LipB is targeted to the apicoplast (Thomsen-Zieger et al.,
2003), while a Pf LipA-leader peptide fused to GFP demonstrated localization
outside of the mitochondrion (Wrenger and Muller, 2004). Though it is likely
that both LipA and LipB are indeed expressed in the apicoplast, no definitive
evidence yet exists to confirm this hypothesis.
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1.3 Deficits in the apicoplast lipoylation model
1.3.1 LipB knockout does not abrogate apicoplast lipoylation
Disruption of LipB should prevent lipoylation of the PDH E2. However, dis-
ruption of Pf LipB results in reduced, and not eliminated, lipoylation signal as
demonstrated through Western blotting against lipoylated proteins. This has
been explained by the potential dual localization of one of the mitochondrial
lipoyl ligases, LipL2, to both the apicoplast and the mitochondrion, resulting
in partial lipoylation of the apicoplast PDH E2 by LipL2 (Gunther et al., 2007).
This hypothesis is somewhat problematic. LipL2 is a functional rescue of
an E. coli LipB knockout as well as knockout of the E.coli lipoyl ligase knockout,
suggesting that LipL2 can function both as an octanoyl transferase and a lipoyl
tranferase (Gunther et al., 2007). However, Pf LipL2 rescue of the E.coli LipB
knockout is quite poor, while rescue of E.coli lipoate ligase knockout is superior
(Allary et al., 2007). Work with recombinant LipL2 protein demonstrates that
LipL2 acts primarily as a lipoyl transferase (Afanador et al., 2017). These data
suggest that though LipL2 may be able to function as an octanoyl transferase,
it may not be sufficiently competent in vivo to perform this function.
Further experimentation is then required to clarify the mechanism of api-
coplast lipoylation. A Pf LipB/LipL2 double knockout may confirm that both
LipB and LipL2 can octanoylate the PDH E2, and confirms that LipL2 can be
functionally localized to the apicoplast. Knockout of LipA and concomitant
disappearance of PDH E2 lipoylation would confirm LipA’s role in sulfura-
tion of the octanoyl-PDH E2. Finally, a good amount of work needs to be
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performed to determine what the source of the octanoate is for apicoplast
lipoylation.
1.3.2 Unknown source of octanoate
The octanoate used to generate the carbon backbone of lipoate is thought
to be built on the acyl carrier protein through fatty acid synthesis, and in
Plasmodium, this pathway should be the apicoplast resident FASII pathway.
However, it is unclear how fatty acid synthesis occurs in the parasite during
the blood stage. Fatty acid synthesis canonically occurs by iterative elongation
of malonyl-CoA generated by the acetyl-CoA carboxylase (ACC) using biotin
as an essential cofactor. Though the ACC is expressed during the blood stage
of the parasite life cycle, it is not biotinylated (Dellibovi-Ragheb et al., 2018),
suggesting that this canonical pathway may not be active during the blood
stage of the parasite life cycle. Metabolomic works appears to confuse this
hypothesis, with parasites demonstrating nominal production of myristate as
the only detectable glucose-derived, synthesized fatty acid (Botte et al., 2013),
and palmitate and stearate synthesized from acetate (Yu et al., 2008). Parasites
without FabI, the enzyme catalyzing the first step of fatty acid synthesis,
appear capable of generating palmitate and stearate from acetate as well,
suggesting a noncanonical fatty acid synthesis mechanism.
As such, it is unclear how the parasite can generate the octanoate needed
to generate lipoate without fatty acid synthesis. The above-mentioned non-
canonical fatty acid synthesis pathway, may be linked to lipoylation, as work
in our lab demonstrates that FabI deficient parasites are still able to lipoylate
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the PDH E2. However, it remains a formal possibility that octanoate is taken
up from the host and ends up attached to the PDH E2. Ultimately, rigorous
determination of how fatty acid metabolism occurs in blood-stage Plasmod-
ium is required to generate hypothesis regarding apicoplast octanoylation of
the PDH E2.
1.4 Lipoate-dependent biochemistry in the apicoplast
of Plasmodium falciparum
1.4.1 Putative generation of acetyl-CoA by the PDH
The only substrate for lipoylation in the apicoplast is the E2 subunit of the
apicoplast resident pyruvate dehydrogenase (PDH). A pyruvate dehydroge-
nase is canonically made up of three subunits: the E1, E2 and E3 subunits, and
all three subunits are required for the conversion of pyruvate to acetyl-CoA.
Biochemical work demonstrates that each subunit of the Pf PDH is catalytically
competent, and all three subunits have been localized to the parasite apicoplast
in the blood stage (Foth et al., 2004; Wrenger and Muller, 2004), suggesting
that the apicoplast is a possible source of pyruvate-derived acetyl-CoA.
Knockouts of the Pf PDH E1 and E3 subunits are tolerated in the blood
stage of the parasite, but result in inconsistent phenotypes. There was no
observed growth phenotype in the E1 knockout. In addition, there appeared
to be no significant change in glucose-derived acetyl-CoA, suggesting that
the PDH may not be a major source of acetyl-CoA for the blood stage of the
parasite (Cobbold et al., 2013). Knockout of the E3 subunit also resulted in no
detriment to growth, but did result in highly synchronous parasite growth
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(Laine et al., 2015).
The PDH E1 knockout is the only lipoate-involved genotype carried past
the blood stage of P.falciparum. This knockout results in the inability to pro-
duce sporozoites from oocysts. This falls in line with the fatty acid synthesis
knockouts. The shared phenotypes between these two pathway knockouts
strongly implicate the need for a fully functional apicoplast PDH to generate
precursors for fatty acid synthesis during the oocyst stage of parasite develop-
ment. It would stand to reason that knockouts of Pf LipB and Pf LipA would
share the same phenotype as those knockouts should inactivate the PDH.
However, these experiments have yet to be performed.
1.4.2 Knowledge of all PDH biochemistry is incomplete
No knockout of the lipoylated PDH E2 subunit has been described in the
literature. It would be interesting to observe the phenotype of the E2 knockout
as it somehow remains lipoylated in the LipB knockout, making the LipB
knockout an insufficient surrogate for the E2 knockout. It may also inform
whether or not the PDH is engaged in canonical PDH activity, or if the different
subunits participate in different biochemistries, especially considering the
PDH E1’s ability to decarboxylate both pyruvate and alpha-ketoglutarate
(Chan, et al. 2013)
The apicoplast has been implicated in generating metabolites that may be
responsible for growth or quorum sensing (Andrabi et al., 2018; Duvalsaint
and Kyle, 2018; Emami et al., 2017). The highly synchronous growth exhibited
by the E3 knockout may implicate the E3 as a member of this this metabolite
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generation. Interestingly, knockout of Pf LipB resulted in faster development
through the intraerythrocytic cycle (Gunther et al., 2007). These data may
suggest that while the PDH may not be important for generation of acetyl-CoA
during the blood stage, it may be using lipoate-dependent biochemistry to
generate signaling molecules to mediate growth.
The ability to "knock out" the apicoplast (Yeh and Derisi, 2011) offers
an intriguing means of further defining the phenotype of parasites without
a complete apicoplast organelle. These lines could be assayed for growth
kinetics and lipoylation to see if the loss of a fully intact organelle phenocopies
the PDH E1 and/or the E3 knockout, and whether or not the PDH E2 can still
be lipoylated. This would key into what biochemical pathways might still be
functional in the degenerate apicoplasts.
1.5 Lipoylation in the mitochondrion of Plasmod-
ium falciparum
Mitochondrial lipoylation occurs through a wholly different mechanism
than the mechanism described in the apicoplast (Figure 2). Fully formed
lipoate is scavenged from the host. Biochemical assays suggest that ery-
throcytes may be enriched for lipoic acid for use as a redox cycling agent
(Constantinescu and Pick, 1995; Constantinescu et al., 1993), suggesting that
red blood cells may be a reservoir of free lipoate for parasites. Parasites can
take up free lipoate from erythrocytes and traffic them to the mitochondrion,
where they can by attached to the three mitochondrial substrates: the E2
subunit of the branched chain alpha-ketoacid dehydrogenase (BCDH), the E2
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subunit of the alpha-ketoglutarate dehydrogenase (KDH), and the H protein
of the glycine cleavage system (GCV) (Allary et al., 2007).
Lipoate attachment occurs in a multi-step, redox gated fashion. First,
lipoate is activated by the mitochondrially localized LipL1 (Wrenger and
Muller, 2004) by consumption of ATP and adenylating free lipoate, forming
lipoyl-AMP (LA-AMP). Under highly reducing conditions, LipL1’s affinity for
LA-AMP drops by around 100-fold, allowing for the previously mentioned
apicoplast and mitochondrially localized lipoyl transferase, LipL2 (Gunther
et al., 2007), to use LA-AMP to attach lipoate to two of the mitochondrial
substrates: the E2 subunit of the BCDH or the E2 subunit of the KDH. Under
less reducing conditions, LipL1 holds onto the activated LA-AMP, and can
attach lipoate to its own substrate, the H protein (Afanador et al., 2014, 2017).
The redox environment of the mitochondrion of the parasite during the
blood stage appears to be quite reductive (Mohring et al., 2017), suggesting
that if this redox gating mechanism is true in vivo, the parasite preferentially
lipoylates the mitochondrial BCDH and KDH E2 subunits over the H protein.
Interestingly, Western blotting appears to show the BCDH and KDH subunits
being lipoylated, while H protein lipoylation occasionally appears difficult to
visualize, and was originally thought to be due to low abundance (Falkard et
al., 2013), but this phenomenon may be at least partly due to this preferential
lipoylation scheme.
Mitochondrial lipoylation is likely essential for the blood stage parasite.
Treating parasites with lipoate analogs reduces mitochondrial lipoylation and
results in inhibited parasite growth (Afanador et al., 2014; Allary et al., 2007).
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A similar phenomenon was observed when an exogenous, bacterial probe,
dubbed lipoamidase, delipoylated the mitochondrial proteins in P.falciparum,
and induced a severe growth phenotype. Finally, LipL1 appears refractory to
knockout (Gunther et al., 2009). Knockout of LipL1 would prevent lipoylation
of all three lipoylated substrates in the mitochondrion, suggesting that at least
one of the mitochondrial substrates is essential for survival in the blood stage
of the parasite.
The importance of mitochondrial lipoylation in the blood stage of the para-
site will likely make normal knockouts experiments difficult, if not impossible,
which would also obviate the ability to interrogate the importance of mito-
chondrial lipoylation outside the blood stage. As such, alternative means to
alter protein expression, such as the auxin induced degron (Kreidenweiss et
al., 2013), Flp/FRT recombination (Lacroix et al., 2011; van Schaijk et al., 2010),
TetR DOZI (Ganesan et al., 2016), or the knock-sideways method (Birnbaum
et al., 2017), may be required to more fully address the question of essentiality
of mitochondrial lipoylation.
1.6 Lipoate-mediated metabolism in the mitochon-
drion of Plasmodium falciparum
1.6.1 Mitochondrially generated acetyl-CoA may be crucial
for blood-stage parasite survival
Expression of active lipoamidase in the mitochondrion of P.falciparum re-
sulted in significant reduction in lipoylation of the mitochondrial substrates,
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along with a significant growth defect. This would suggest that lipoate-
dependent metabolism in the parasite mitochondrion is important for blood
stage survival. This growth defect is partially rescuable by acetate supplemen-
tation. Acetate can be taken up by the parasite and readily converted into
acetyl-CoA by the cytosolic acetyl-CoA synthetase (Cobbold et al., 2016); this
would argue that mitochondrial lipoylation is required for mitochondrially
generated acetyl-CoA generation that is crucial for parasite growth.
The BCDH is one candidate that may be responsible for generating acetyl-
CoA. Like the apicoplast resident PDH, the BCDH is composed of an E1, E2
and E3 subunit. All three subunits have been localized to the mitochondrion
of the parasite (Afanador et al., 2014; Gunther et al., 2005). The E3 subunit, the
dihydrolipoamide dehydrogenase, is likely shared between the three lipoate-
dependent enzyme complexes in the mitochondrion as there appears to be
only one encoded in the parasite genome (Laine et al., 2015). BCDH’s are
canonically associated with the catabolism of branched chain amino acids,
i.e. leucine, isoleucine and valine. However, the parasite does not appear to
code for enzymes upstream of the BCDH that are involved in the catabolism
of branched chain amino acids, nor does the parasite appear to catabolize
branched chain amino acids in culture (Cobbold et al., 2013). The parasite
does appear to have a functional PDH-like enzyme that is not the apicoplast
PDH, as the parasite appears able to convert glucose-derived pyruvate to
acetyl-CoA independent of the apicoplast PDH (Cobbold et al., 2013). If this
is correct, the BCDH may be an essential enzyme that cannot be disrupted.
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The other candidate that may be generating acetyl-CoA in the mitochon-
drion is the KDH. All members of the KDH have been localized to the mito-
chondrion (Afanador et al., 2014; Chan et al., 2013), where it is canonically a
member of the citric acid cycle, converting alpha-ketoglutarate to succinyl-
CoA. Genetic, metabolomics, and biochemical work have confirmed this
canonical activity (Chan et al., 2013; Ke et al., 2015). However, in vitro work
with the E1 subunit of the KDH demonstrated the ability to use both alpha-
ketoglutarate as well as pyruvate as reasonably equivalent rates (Chan et al.,
2013).
If this is the case in vivo, both the BCDH and the KDH may be competent at
converting pyruvate to acetyl-CoA. This has been partially demonstrated by
functional complementation by Pf BCDH E1 of a PbBCDH E1 knockout that
rescues a growth phenotype tied to the generation of acetyl-CoA (Oppenheim
et al., 2014). Biochemical work with the BCDH may help clarify what the most
likely substrate is for the BCDH, while combinatorial knockouts of the BCDH
and KDH may demonstrate if either or both are responsible for acetyl-CoA
generation in P.falciparum. The acetate rescue observed in the lipoamidase
experiments may provide rescue for possible lethality of these knockouts
by exploiting the cytosolic acetyl-CoA- synthetase to provide an alternative
means to generate acetyl-CoA.
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1.6.2 Glutamine metabolism during the blood-stage and be-
yond
Knockout of the KDH E1 subunit results in no significant growth pheno-
type during the blood stage of parasite development, revealing the dispens-
ability of the conversion of alpha-ketoglutarate to succinyl-CoA. This is an
interesting finding, considering the parasite’s auxotrophy for glutamine (Liu
et al., 2006) and preference for glutamine catabolism for fueling the citric acid
cycle (MacRae et al., 2013). This would suggest a robust compensatory mecha-
nism for carbon metabolism (Ke et al., 2015), and the possibility that glutamine
auxotrophy during the blood stage is primarily for protein synthesis. Outside
the blood stage, the KDH E1 knockout does not produce viable oocysts.
It is interesting that disruption of several, closely metabolic pathways,
including the citric acid cycle, apicoplast PDH function (Cobbold et al., 2013),
fatty acid synthesis (van Schaijk et al., 2014), and heme metabolism (Ke et al.,
2014) converge in mosquito stage arrest. This would argue that the mosquito
stage of the parasite is a shift from a more auxotrophic mode in the blood
stage to a more autotrophic mode.
1.7 Lipoylation in the apicoplast and mitochondrion
of Plasmodium berghei
The use of murine models allows for interrogation of the complete malaria
life cycle. However, the panoply of work performed in the interrogation
of lipoylation and lipoate-dependent catalysis reveals significantly different
biochemistry between the different malaria species. Part of this different
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biochemistry appears to be two lipoylation enzymes that appear to have
activity in both the apicoplast and the mitochondrion of the parasite, a finding
different from what is observed in P.falciparum.
1.7.1 LipB
The Plasmodium berghei octanoyl transferase ortholog (LipB) is thought
to be localized to the apicoplast, but this has not been confirmed, nor has
its biochemical activity been confirmed. Knockout of PbLipB in the blood
stage results in reduced lipoylation of the apicoplast resident PDH E2 subunit,
similar to findings in P.falciparum (Falkard et al., 2013). However, the PbLipB
knockout also results in complete abrogation of lipoylation signal of the
mitochondrially residing BCDH E2 subunit, suggesting a role for LipB in
both apicoplast and mitochondrial lipoylation, including the potential for
dual localization of PbLipB, an observation different from the findings of the
P.falciparum homolog, and an interesting parallel to the dual localization of the
Pf LipL2.
The growth phenotype associated with the PbLipB knockout are also dif-
ferent from P.falciparum LipB knockout. While the Pf LipB knockout results in
faster erythrocytic growth (Gunther et al., 2007), the PbLipB knockout results
in slower erythrocytic growth only under serum lipid depleted conditions,
suggesting some involvement of PbLipB in lipid metabolism that may not be
the case in P.falciparum. PbLipB parasites appear more susceptible to lipoate
analog treatment when compared to wild type parasites, but whether or not
this is due to reduced lipoylation of the PDH E2, BCDH E2 or both is unclear.
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The PbLipB knockout is able to progress through mosquito infection and
eventually develop in the liver, where the lipoylation in the apicoplast is
significantly decreased, confirming PbLipB’s role in lipoylation in the api-
coplast (Falkard et al., 2013). FASII knockouts also show minimal lipoylation
of the apicoplast during this stage (Deschermeier et al., 2012), suggesting that
P.berghei, at least in the liver stage, uses synthesized fatty acids to synthesize
lipoate in the apicoplast. Ultimately, parasites deficient in LipB are less infec-
tive, but still able to progress to the blood stage (Nagel et al., 2013), suggesting
that there is sufficient redundancy in lipoate-mediated biochemistry between
the apicoplast and the mitochondrion to progress throughout the life cycle.
1.7.2 LipL1
Initial attempts to knockout LipL1 in P.berghei were sublethal (Gunther
et al., 2009), suggestive of the essential nature of LipL1 for mitochondrial
lipoylation. Using a conditional knockdown system, reduced expression of
LipL1 imparts a growth defect with concomitant reduced lipoylation of the
BCDH and KDH E2 subunits, respectively (Wang et al., 2017). Surprisingly,
LipL1 knockdown also resulted in reduced lipoylation of the apicoplast res-
ident PDH E2 subunit. In another twist, knockdown of LipL1 appears to
result in eventual compensatory upregulation of LipL2 that is concomitant
with restoration of lipoylation of the BCDH, KDH and PDH E2 subunits and
normal parasite growth (Wang et al., 2017).
This data would suggest that both PbLipL1 and PbLipL1 are somehow
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responsible for lipoylating the apicoplast resident PDH E2 and the mitochon-
drion resident BCDH E2, a paradigm that appears distinct from P.falciparum.
Considering the lack of clarity in the P.falciparum model, even more work is
required to clarify the different paradigm in rodent models.
1.8 Lipoate-dependent metabolism in the apicoplast
of murine models of malaria
The PDH E1 and E3 subunits were localized to the apicoplast in Plasmod-
ium yoelii during the blood, sporozoite and intrahepatic stages of parasite
development. Knockouts of either result in no detriment in blood or mosquito
stages, but arrest at the late liver stage (Pei et al., 2010). Liver stage arrest also
occurs in fatty acid synthesis knockouts (Vaughan et al., 2009), implicating the
need for a fully functional FASII pathway that may rely on PDH activity for
generation of acetyl-CoA during the liver stage of P.yoelii.
A slight variation on this theme occurs in P.berghei. The PDH E1 knockout
in P.berghei, has no mentioned blood or mosquito stage phenotype, but a severe
delay to patency in the liver-to-blood transition (Nagel et al., 2013). As in
P.falciparum and P.yoelii, it appears that FASII and apicoplast resident, lipoate-
mediated metabolism converge, as the LipB knockout (Falkard et al., 2013),
FASII knockouts (Yu et al., 2008), PDH E1 knockout (Nagel et al., 2013), and
the biotin ligase knockout (Dellibovi-Ragheb et al., 2018) all result in a severe,
late-liver stage phenotype, but can still progress to blood stage infection.
This demonstrates the importance, but not essentiality, of a fully functional
repertoire of fatty acid synthesis players required for parasite development in
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the liver stage.
It should be noted that the different species of malaria described have fatty
acid synthesis and lipoate-mediated metabolism all converge within a species,
but not between species. As mentioned above, most metabolic pathways seem
to converge in importance in the mosquito stage of P.falciparum, while P.berghei
and P.yoelli demonstrate reliance on similar pathways during the liver stage of
infection. This highlights crucial, metabolic differences between the different
species of malaria that need to be considered when drawing comparisons
between them.
1.9 Lipoate-dependent metabolism in the mitochon-
drion of P.berghei
It is unclear whether or not lipoylation of the BCDH E2 is required for
blood stage growth. As in P.falciparum, the PbBCDH lipoylated E2 subunit
has been localized to the mitochondrion of the blood stage parasite, but un-
like P.falciparum, it is lipoylated both by either LipB (Falkard et al., 2013) or
LipL1/LipL2 (Wang et al., 2017). Genetic work on these enzymes suggest
that lipoylation of the BCDH may not be important to blood stage develop-
ment. However, knockout of the E1 subunit imparts a severe, blood stage
growth phenotype that identifies the PbBCDH E1 as a functional pyruvate
dehydrogenase E1 subunit (Oppenheim et al., 2014).
It is unclear how the PbBCDH complex requires an E1 subunit, but can tol-
erate an unlipoylated BCDH E2 subunit to perform this biochemistry. Knock-
out of the BCDH E2 subunit in Chapter 3 may phenocopy the BCDH E1
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knockout, as multiple attempts to single clone the knockout failed. This
would suggest that the BCDH E1 an E2 subunits are crucial for generation of
acetyl-CoA, but can perform this biochemistry without a lipoyl moiety. More
rigorous interrogation of the BCDH needs to be performed to resolve this
problem.
Knockout of the BCDH E1 subunit results in arrest in the oocyst stage. This
finding is in contrast to the somewhat shared phenotype in P.berghei of liver
stage arrest in FASII, PDH, and biotin ligase knockouts. Knockout of the ATP
synthase in P.berghei appears to impart little effect on male gametocytes, but
inhibits development of female gametes, resulting in arrest prior to oocyst
development (Sturm et al., 2015). These data may suggest that mitochondrial
lipoate-dependent biochemistry is important in mosquito stage development,
while apicoplast lipoate-dependent biochemistry is important in liver stage
development for murine parasites.
Some work has been done on the other mitochondrial lipoate-dependent
proteins in murine models. The PbKDH E2 subunit was knocked out in Chap-
ter 3 with no gross phenotype observed, obviating the KDH as a candidate for
imparting the growth phenotype observed in the PbLipL1 knockdown (Wang
et al., 2017). Attempts to knockout the P.berghei H protein in our lab and by
others have failed (Varadarajan et al., 2014), implicating the H protein as an
essential protein, but for unknown reasons.
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1.10 Potential non-canonic lipoate-dependent bio-
chemistry in Plasmodium spp.
The H protein is in the mitochondrion of P.falciparum (Spalding et al., 2010),
but its role is unclear. H proteins are canonically associated with the multi-
enzyme glycine cleavage complex (GCV) that is involved in the metabolism of
glycine, serine and folate. GCV’s are typically composed of 4 proteins: the P,
T, L and H proteins. P.falciparum and P.berghei appears to code only for a T and
H protein, and neither appear to perform GCV affiliated glycine catabolism
during the blood stage (Varadarajan et al., 2014). It is appealing to consider the
essentiality of the H protein considering the dual lipoylation system at play -
why not just have a single lipoyl ligase, and why have it be redox sensitive?
Redox-dependent activity is not unique to mitochondrial lipoylation in
P.falciparum. The parasite’s essential, cytosolic serine hydroxymethyltrans-
ferase (SHMT) (Pornthanakasem et al., 2012) is also redox sensitive (Chitnum-
sub et al., 2014), with a crucial disulfide bond that needs to be broken in order
to bind its substrate and perform catalysis. In the apicoplast, the acyl carrier
protein also appears redox sensitive, with the ability to form dimers in vitro
with exposed sulfhydrals from its phosphopantotheinate cofactor, but stays as
monomers in vivo (Gallagher and Prigge, 2010). The parasitophorous vacuole
has its own redox sensitive enzyme, SUB1, a serine protease that has a partially
solvent exposed disulfide bridge that can mediate activity (Withers-Martinez
et al., 2014). As such, there has been a redox-switchable enzyme described in
nearly all compartments of the parasite.
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Considering the variety of hosts and their respective oxidative environ-
ments, the parasite may have a redox sensitive program to react to these
different environments. In the case of the mitochondrion, the normal con-
dition of having a highly reductive environment (Mohring et al., 2017) may
push the lipoylation balance to favor lipoylation of the BCDH and KDH to
favor canonical metabolic roles, while oxidative insult results in sacrificing
this metabolism for whatever function is involved in the H protein. Indeed,
it is attractive to think of possible redox-sensitive programs within parasite
organelles, or even cooperatively throughout the entire parasite.
Redox flux mediated through lipoylated proteins has been described else-
where in life. E3 subunits (dihydrolipoamide dehydrogenases) have been
implicated as a redox sink/sensor in bacteria (Bryk et al., 2002; Feeney et
al., 2011; Gonidakis et al., 2010), parasites (Nyvltova et al., 2016) and human
cells (Glasser et al., 2017; McLain et al., 2011), suggesting lipoate-dependent
proteins regularly participate in complex redox flux. These demonstrate that a
protein with a lipoyl domain and a cognate dihydrolipoamide dehydrogenase
can work independently of decarboxylation chemistry to flux redox balance
through lipoate’s reactive thiols. This has demonstrated biochemically, where
E3 subunits from several forms of life, including those of P.falciparum, can
catalyze both the oxidation and reduction of lipoate’s thiols at reasonably com-
parable speeds (Hakansson and Smith, 2007; Laine et al., 2015). It is possible
that in addition to any canonical metabolic roles of the lipoylated proteins in
Plasmodium, they can also act as a redox sinks/sensors in the parasite. This
possibility is underscored by initial screens detecting substantive nitrosylated
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or glutationylated Plasmodium proteins involved in lipoate-mediated catalysis
(Kehr et al., 2011; Wang et al., 2014) .
It has been recently demonstrated that Staphyloccocus aureus can secrete
its lipoylated PDH E2 subunit to suppress TLR-mediated macrophage acti-
vation, allowing for superior survival in mice against mutants that cannot
lipoylate the PDH E2 subunit (Grayczyk et al., 2017). The ability for humans
to immunologically recognize a lipoyl motif has already been demonstrated,
as autoreactive antibodies are generated to the lipoyl domain of the human
PDH E2, indicating a precedence for immune recognition (Pacini et al., 2015).
Moonlighting of canonical proteins, including those involved with lipoate,
as virulence factors and immunological phenomena has been described in
other pathogens (A Ala et al., 1996; Hallstrom et al., 2015; Henderson and
Martin, 2011), but some proximal examples in Plasmodium are beginning to
appear, including surface expressed GAPDH (Cha et al., 2016) and enolase
(Vora et al., 2009), as well as the growing understanding of the parasite ex-
osomal effects on the host (Mantel and Marti, 2014), opening the door to
noncanonical secretion or surface targeting of factors playing a role in parasite
growth or pathogenesis. Considering these observations, the application of
genetic work on the parasite in the mouse and mosquito should be applied in
order to look for non-biochemical phenotypes to highlight immunological or




Lipoylation is an ancient, ubiqtuitous and difficult chemical reaction, in-
extricably tied to central and peripheral metabolism. The role of lipoyla-
tion in the apicoplast of Plasmodium has not been fully determined, since
no means of complete abrogation of apicoplast lipoylation has yet been de-
scribed. However, shared phenotypes with fatty acid synthesis knockouts
within mouse species and human species are suggestive of a general shift
to a more autotrophic mode in the liver and mosquito hosts, respectively.
Mitochondrial lipoylation appears to be a simpler story, with parasite auxotro-
phy for lipoylation demonstrated in the blood stage, and two downstream
enzymes demonstrating essentiality after the blood stage.
Though much work has been performed in investigating Plasmodium lipoy-
lation, it appears that the field has generated more questions than answers.
Knockouts at different points in lipoylation and in different parasite species
result in different, and possibly contradictory, phenotypes. Biochemical infer-
ences have been made for the outcomes of these knockouts, but comparative
genetic and metabolomics work indicate that there are major differences in
the biochemistries between the different Plasmodium species, suggesting that
assumed similarities between the species may be erroneous. This is further
complicated by host difference, such as the existence of reticulocytes in mice
that can provide metabolite rich reservoirs (Srivastava et al., 2015) that may
mask auxotrophy observed in tissue culture of P. falciparum. Noncanonical
roles of these proteins must be considered in evaluating the functions of the
lipoylation machinery and their respective substrates, especially in the context
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of the H protein, which necessitates assay of both the human and murine
species of Plasmodium to consider each models different biochemical and
immunological contexts.
Exploiting the necessity of Plasmodium’s blood-stage lipoate scavenging
indicates that drug intervention in this pathway is feasible. Growth inhibi-
tion in blood-stage parasites by lipoate analogs demonstrates the proof of
principle in in vitro or ex vivo conditions (Afanador et al., 2017; Falkard et
al., 2013). Humans and mice are dependent on endogenous, biosynthetic
lipoylation, with lipoate supplementation unable to rescue genetic defects
abrogating lipoylation (Mayr et al., 2014), indicative of an absent or inefficient
scavenging pathway, suggesting that in vivo intervention may be possible.
Indeed, several lipoate derivatives have been tested to some success in several
disease models (Nakano et al., 2017; Yang et al., 2016; Zhou et al., 2017). One
lipoate derivative, CPI-613, is undergoing multiple clinical trials due to its
ability to dysregulate PDH and KDH activity in several cancer models (Alistar
et al., 2017; Lamar et al., 2016; Pardee et al., 2014). The growing interested
in exploiting lipoate derivatives can be capitalized in Plasmodium research to
both find new means for malaria treatment and to concretize why lipoate is
important to the parasite.
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Table 1.1: Summary of knockouts performed on Plasmodium lipoylation machin-
ery and the substrates. Knockout attempts of the Pb/Pf KDH E2, Pb/Pf BCDH E2 and
PbH protein were performed by our lab.
35
1.14 Figures
Figure 1.1: The canonical mechanism for lipoate biosynthesis and lipoylation of
the pyruvate dehydrogenase (PDH).
This mechanism is also the likely mechanism by which the Plasmodium api-
coplast lipoylation machinery lipoylates the apicoplast PDH.
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Figure 1.2: Lipoylation in the blood stage of Plasmodium. In the apicoplast of
the parasite, LipB transfers the octanoyl group (generated by an unknown source,
but possibly derived from acetate metabolism) from ACP to the E2 subunit of the
apicoplast PDH, followed by sulfuration by LipA. The mitochondrion of the parasite
scavenges exogenous lipoate, and lipoylates the H protein under relatively oxidative
conditions, and works in concert with LipL2 to lipoylate the BCDH and KDH E2




essential in P. falciparum
2.1 Abstract
Lipoate is a redox active cofactor that is covalently bound to key en-
zymes of oxidative metabolism. Plasmodium falciparum is auxotrophic for
lipoate during the intraerythrocytic stages, but it is not known whether lipoate
attachment to protein is required, nor whether lipoate is required in a specific
subcellular compartment of the parasite. To address these questions, we used
an enzyme called lipoamidase (Lpa) as a probe of lipoate metabolism. Lpa was
first described in Enterococcus faecalis, and specifically cleaves protein-bound
lipoate, inactivating enzymes requiring this cofactor. Enzymatically active
Lpa could be expressed in the cytosol of P. falciparum without any effect on
protein lipoylation or parasite growth. Similarly, Lpa could be expressed in
the apicoplast, and although protein lipoylation was reduced, parasite growth
was not inhibited. By contrast, while an inactive mutant of Lpa could be
expressed in the mitochondrion, the active enzyme could not. We designed
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an attenuated mutant of Lpa and found that this enzyme could be expressed
in the parasite mitochondrion, but only in conjunction with a chemical by-
pass system. Our study shows that lipoate attachment to proteins in the
mitochondrion is critical for the survival of malaria parasites.
2.2 Introduction
Lipoic acid (6,8-thiooctanoic acid) is a metabolic cofactor required for the
decarboxylation of alpha-ketoacids and the amino acid glycine in oxidative
and one carbon metabolism (Cronan et al., 2005). Plasmodium spp. have four
metabolic complexes that use the lipoic acid cofactor: pyruvate dehydrogenase
(PDH), which resides in the apicoplast, and the alpha-ketoglutarate dehydro-
genase (KDH), branched-chain alpha-ketoacid dehydrogenase (BCDH), and
the glycine cleavage complex (GCV), all of which reside in the mitochondrion
(Afanador et al., 2014; Allary et al., 2007). These complexes are generally com-
posed of three enzymes named E1, E2, and E3, with the lipoic acid cofactor
covalently bound to one or more conserved lysine residues on the E2 subunit.
The GCV differs from other lipoylated complexes in that its substrate is not
an alpha ketoacid, but instead is the amino acid glycine, and its subunits
are canonically called the T, H, P, and L proteins, of which the H protein is
lipoylated and non-catalytic (Douce et al., 2001). However, there appears to
be no evidence of the L or P proteins in malaria parasites.
The presence of lipoylated proteins in the apicoplast and mitochondrion in-
dicates that both organelles possess functional lipoylation pathways. There are
four enzymes encoded in the P. falciparum genome that are involved in lipoic
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acid acquisition: lipoate synthase (Pf LipA, PF3D7_1344600), lipoate trans-
ferase (Pf LipB, PF3D7_0823600), and two enzymes with homology to lipoate
ligases, designated LipL1 (PF3D7_1314600) and LipL2 (PF3D7_0923600). Pf LipA
and Pf LipB reside in the apicoplast (Wrenger and Müller, 2004) and function-
ally complement their E. coli homologs, showing that P. falciparum possesses
a lipoate synthesis pathway (Allary et al., 2007). LipL1 and LipL2 work in
concert to lipoylate the H protein and the E2 subunits of the BCDH and KDH.
The two ligases also appear to have different subcellular localizations: LipL1
localizes exclusively to the mitochondrion (Wrenger and Müller, 2004); by
contrast, LipL2 appears to partition between the apicoplast and the mito-
chondrion, but its distribution between these organelles is not uniform in
the parasite population (Günther et al., 2007). Uptake and incorporation of
35S-lipoic acid by blood stage parasites shows that despite the potential pres-
ence of LipL2 in the apicoplast, only mitochondrial proteins are lipoylated by
scavenging (Allary et al., 2007). Collectively, these results show that there are
organelle-specific mechanisms of lipoate acquisition in P. falciparum, in which
lipoate scavenging occurs exclusively in the mitochondrion, and lipoylation
in the apicoplast relies on lipoate synthesis.
Although lipoylation in the apicoplast may be dispensable in the blood-
stage of the parasite (Cobbold et al., 2013; Laine et al., 2015), growing evidence
indicates that lipoate scavenging for use in the mitochondrion is likely vital to
the P. falciparum erythrocytic stage parasites. Treatment of parasite cultures
with lipoate analogs 8-bromooctanoate or 6,8-dichlorooctanoate result in de-
creased mitochondrial lipoylation and inhibited parasite growth (Afanador et
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al., 2014; Allary et al., 2007). This appears likely due to ligation of the analog
to the mitochondrial substrates, which can be mitigated by excess lipoate,
indicating that lipoate scavenging and attachment is important for survival.
Consistent with these findings is the report that LipL1 is refractory to deletion
in the murine malaria parasite, P. berghei (Günther et al., 2007; Wang et al.,
2017).
In this study, we exploited the partitioned nature of lipoate metabolism in
P. falciparum to probe the effects of inactivating lipoylated complexes in the
apicoplast and mitochondrion with an enzyme called lipoamidase. Lipoami-
dase (Lpa) is an enzyme first described in Enterococcus faecalis that can cleave
lipoate from lipoylated proteins (Jiang and Cronan, 2005). Our work in E. coli
demonstrated that this can be performed in vivo to induce inactivation of
alpha-keto acid complexes, resulting in a growth defect (Spalding and Prigge,
2009); related observations have been made with a new class of lipoamidases
related to the sirtuin family of proteins that appears to be conserved between
human cells and bacteria (Mathias et al., 2016; Rowland et al., 2017). The
mycobacteriophage integrase system (Spalding et al., 2010) was used to gen-
erate P. falciparum cell lines containing integrated Lpa transgene constructs
targeted to the cytosol, apicoplast, and mitochondrion. Expression of active
Lpa in the cytosol did not affect parasite growth or lipoylation, demonstrat-
ing that no significant lipoate metabolism occurs in the cytosol. Parasites
expressing active Lpa in the apicoplast showed a significant, but not total,
decrease in lipoylated PDH E2 relative to cells expressing catalytically inactive
Lpa, and appeared unaffected by this change. In contrast, we were unable to
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produce parasite lines expressing fully active Lpa in the mitochondrion. We
were able to express a catalytically dead Lpa in this organelle, but a catalyti-
cally attenuated Lpa mutant could only be expressed in the mitochondrion in
conjunction with chemical supplementation of 5 mM acetate in the parasite
growth medium. These results demonstrate that mitochondrial lipoylation is
essential during the blood stages of parasite development, and provide insight
into the essential roles that lipoylated proteins play in the mitochondrion.
2.3 Results
2.3.1 P. falciparum can express the bacterial gene encoding
Lpa.
Lpa has been used in vivo as an inducible probe of alpha-ketoacid dehydro-
genase inactivation in E. coli (Spalding and Prigge, 2009), and the suitability
of Lpa as an in vivo probe hinges on the ability of the organism under study
to express the bacterial enzyme in an active form. To evaluate whether P.
falciparum can express Lpa, we used mycobacteriophage integrase mediated
recombination to generate parasite lines containing an integrated copy of the
gene (Spalding et al., 2010) encoding either active Lpa or Lpa inactivated by
mutations of active site residues K159A and S259A (KSA). Lpa constructs
were tagged at the C-terminus with a hemagglutinin (HA) epitope tag. This
generated the cell lines Lpa and KSA. Plasmid integration at the attB locus
was confirmed by PCR (Fig. 2.1A, B).
Expression of Lpa was determined by SDS-PAGE fractionation of whole
cell lysates, followed by western blot with monoclonal antibodies specific for
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HA. In both cell lines, a single HA-tagged protein of approximately 100 kDa is
present (Fig. 2.1C) at roughly equivalent levels. Untagged Lpa has previously
been reported to migrate at 97 kDa, despite a predicted molecular weight of
79 kDa (Jiang and Cronan, 2005); therefore, the bands identified by anti-HA
western blot are consistent with the empirical size of Lpa. In the absence of
N-terminal leader sequences, Lpa is expected to localize to the cytosol. To
confirm the localization of Lpa, fixed Lpa and KSA parasites were probed
with antibodies specific for HA and co-stained with anti-aldolase antibodies
to delineate the cytosol and DAPI to identify the nucleus. The signal from HA
occupies most of the parasite cell and is coincident with aldolase staining, but
exclusive of the nucleus (Fig. 2.2A). Taken together, these results show that
Lpa and the catalytically dead KSA mutant can be expressed in cytosol of P.
falciparum parasites.
2.3.2 Lpa expressed in the cytosol is active and does not in-
hibit parasite growth
Lipoylated proteins and the enzymes involved in lipoylation have been
localized exclusively to the apicoplast and mitochondrion, so expression of
active lipoamidase in the cytosol was not expected to perturb protein lipoyla-
tion. To test this hypothesis, we compared protein lipoylation in Lpa and KSA
parasites by assaying apicoplast lipoylation using western blotting with an an-
tibody recognizing lipoylated proteins and assaying mitochondrial lipoylation
by using autoradiography with cultures supplemented with 35S-radiolabeled
lipoate. When cell pellets were lysed under denaturing conditions we found
that both parasite lines showed similar levels of lipoylation relative to the
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HSP70 loading control (Fig. 2.2B, left panels), indicating that lipoylation
was not affected by Lpa expression. We then assayed Lpa activity by lysing
identical samples under non-denaturing conditions, followed by incubation
at 30◦C for 15 minutes. Among the Lpa lysates, no detectable lipoylation
remained after incubation. By contrast, protein lipoylation was maintained
in lysates of the catalytically dead KSA mutant (Fig. 2.2B, right panels). This
demonstrates that Lpa is expressed by P. falciparum in an active form and that
Lpa can recognize and cleave lipoate from all four P. falciparum lipoylated
proteins if given access.
We then compared the growth of Lpa and KSA parasite lines to the parental
line to determine whether expression of the active enzyme resulted in a growth
phenotype. Expression of either Lpa or KSA did not result in discernible dif-
ferences in growth when compared to the parental line (Fig. 2.2C). Coupling
this observation to the unchanged lipoylation state of the Lpa expressing
line suggests that there is no lipoylated protein in the cytosol that would be
important for parasite growth, nor is there off-target, deleterious activity by
Lpa in the cysotol.
2.3.3 Reduced lipoylation of the apicoplast pyruvate dehy-
drogenase does not impair parasite growth
In order to determine whether lipoylated PDH is essential for the growth
of blood stage P. falciparum, we sought to expresss Lpa in the apicoplast. To
direct Lpa to the apicoplast, the first 55 amino acids of the acyl carrier protein
(ACP_55), which was previously shown to direct GFP to the apicoplast (Waller
et al., 2000), was appended to the Lpa and KSA constructs. Initial attempts to
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express ACP55Lpa and ACP55KSA using the strong calmodulin promoter were
unsuccessful, perhaps because overexpression of apicoplast proteins by this
promoter is poorly tolerated - a phenomenon that we have observed before
(Gisselberg et al., 2013). Switching to the lower strength RL2 (ribosomal L2
protein) promoter (Nina et al., 2011) allowed us to generate parasite lines for
both constructs. Integration was confirmed by PCR (Fig. 2.3A), and anti-HA
western blot analysis of whole cell lysates from both parasite lines recognized
a doublet characteristic of apicoplast-localized proteins (van Dooren et al.,
2002) in which the lower band corresponds to the expected 100 kDa size of
mature Lpa after import into the apicoplast (Fig. 2.3B). As in the cytosolic
constructs, western blotting suggests relatively equivalent expression of the
two constructs. To determine the subcellular localization of the lipoamidase
proteins, we performed immunofluorescence assay (IFA) on fixed ACP55Lpa
and ACP55KSA parasites. The signal from anti-HA co-localizes with the
apicoplast marker anti-ACP (Fig. 2.4A), demonstrating that both ACP55Lpa
and ACP55KSA localize primarily to the apicoplast.
The effect of ACP55Lpa expression on lipoylation was determined by west-
ern blot and autoradiography. Western blotting revealed that PDH lipoylation
was reduced in ACP55Lpa compared to ACP55KSA parasites, although some
lipoylation persists. Autoradiography of parasites cultured in the presence
of 35S-lipoate shows that mitochondrial lipoylation is largely unaffected (Fig.
2.4B, right panels). We were curious whether low activity of ACP55Lpa (due
to improper protein folding, modification of the N-terminus, or some other
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factors) was responsible for the persistence of some lipoylated PDH. To in-
vestigate this, we analyzed the activity of ACP55Lpa in parasite extracts and
found that ACP55Lpa rapidly reduced lipoylation of all four parasite proteins
to below the limit of detection (Fig. 2.4, left panels). This result shows that
ACP55Lpa is capable of completely delipoylating PDH, but in the apicoplast,
some factors prevent it from doing so efficiently, such as the environmental
conditions or robust lipoylation activity by the lipoate synthesis machinery. Ul-
timately, reduction of lipoylation in the apicoplast appears to have little effect
on the parasite, since expression of Lpa does not impart a growth phenotype
when compared to KSA expression or the parental line (Fig 2.4C).
2.3.4 Lipoamidase is toxic when expressed in the mitochon-
drion
In order to target lipoamidase to the mitochondrion, the cytosolic con-
structs were again modified, this time to contain an N-terminal mitochondrial
targeting motif using the first 33 amino acids from LipL1 (L133). In repeated
transfections, we were able to generate parasite lines expressing mitochon-
drially targeted L133KSA, however, multiple attempts at expressing L133Lpa
failed (Table 2.1). These results are consistent with the hypothesis that one
or more of the lipoylated proteins found in the mitochondrion are essential
for parasite growth. We attempted to demonstrate this phenomenon by us-
ing a conditional destabilization approach and a chemical bypass approach.
In the first approach we used the destabilization domain (DD) developed
by Armstrong and Goldberg (Armstrong and Goldberg, 2007) to generate
parasite lines expressing a destabilized lipoamidase. As shown in Table 2.1,
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we were not able to generate parasites expressing lipoamidase with either
an N-terminal or a C-terminal DD. Acetate and succinate supplementation
has been described as a means of bypassing the essential lipoylated enzymes
(KDH and PDH) in E. coli (Jiang and Cronan, 2005). Even with chemical
supplementation (5 mM acetate) we were still not able to generate parasites
expressing L133Lpa (Table 2.1).
2.3.5 Lipoylated proteins in the mitochondrion are essential
for parasite survival
Cell-free activity assays, such as that shown in Figure 2.2B demonstrate
that lipoamidase can cleave lipoate from all parasite proteins in a surprisingly
short period of time. We hypothesized that Lpa activity may be too high to
effectively control with the conditional tools available for P. falciparum genetics,
all of which have limited dynamic ranges. We considered using low strength
promoters to drive Lpa expression, however, this approach makes it difficult
to identify the expressed protein and confirm its localization. Instead, we
attempted to attenuate the activity of lipoamidase with a series of active site
mutations. We made a homology model of the E. faecalis lipoamidase based on
the structure of a hydrolase (PDB code 3A2Q) (Yasuhira et al., 2010) with 27%
sequence identity and designed active site mutations to attenuate Lpa activity.
Point mutations were designed to interfere with hydrogen bonds orienting
the catalytic lysine K159 (S236A, S236C and S236G), to disrupt stabilization
of the amide carbonyl (A256G, Y375F), and to interfere with the hypothetical
position of the lipoate dithiolan ring (W210F) (Fig. 2.8). Quantification of
lipoamidase activity using an E. coli bioassay identified S236A as the most
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attenuated mutant with a 100-1000 fold decrease in catalytic activity (Table
2.3, Fig. 2.9). This variant was then cloned into the same transfection vector
as L133Lpa and named L133S236A.
The S236A lipoamidase variant was successfully expressed under sup-
plementation with 5mM acetate. As with the other constructs, PCR for attB
integration and western blotting was used to confirm expression (Fig. 2.5A
and 2.5B). Unlike the gene products targeted to the cytosol and the apicoplast,
there was a marked difference in protein levels in the mitochondrion as ob-
served by western blot. The parasite appears to have significantly decreased
levels of the L133S236A construct when compared to L133KSA, even though
they are driven by the same regulatory elements. In addition, there appear to
be some degradation of both gene products, unlike what was demonstrated
for lipoamidase expressed in the cytosol or the apicoplast. Immunofluores-
cence was used to determine mitochondrial localization using MitoTracker
Red. PCC values and PDM images show that lipoamidase is successfully
expressed in the mitochondrion, but there remains some amount of protein
that is outside the mitochondrion (Fig. 2.6A). This holds true for L133KSA
expression as well, suggesting that this finding is likely an artifact of the
overexpression system rather than a specific effect due to lipoamidase activity.
Western blotting reveals that the apicoplast PDH remains lipoylated in
both the L133S236A and L133KSA parasite lines, consistent with these con-
structs having no impact on apicoplast protein lipoylation. By contrast, there
is a significant reduction in lipoylation of all three lipoate-dependent proteins
found in the mitochondrion when compared to either the loading control or
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the apicoplast PDH lipoylation (Fig. 2.6B). These results show that the attenu-
ated S236A lipoamidase mutant is sufficiently active to reduce, but not abolish
the lipoylation of mitochondrial proteins. Parasite growth curves show that
the L133KSA line demonstrates a minor growth defect when compared to the
parental line - a difference that may be due to the overexpression of L133KSA
by the strong calmodulin promoter. Importantly, acetate supplementation
does not affect the growth of either the parental or the L133KSA parasite lines
(Fig. 2.6C). The growth of the L133S236A parasite line, however, is dependent
on acetate supplementation and this line cannot be maintained in the absence
of acetate. Taken together, these results demonstrate that lipoamidase cleaves
lipoate from all three mitochondrial proteins resulting in parasites that cannot
grow without acetate supplementation.
2.4 Experimental Procedures
2.4.1 Generation of the lipoamidase constructs in the pLZ E.
coli expression vector
Primers used for this work are listed in Table 2.2. We generated a series
of lipoamidase constructs in the pLZ expression vector (Allary et al., 2007)
(MalE gene of pMAL_cHT (Muench et al., 2003) replaced with the amino acids
MRGS). The pLZ vector allows us to evaluate the activity of any lipoamidase
construct in E. coli as previously described (Spalding and Prigge, 2009). We
began with pLZ plasmid pMS007, which contains the lipoamidase gene from
Enterococcus faecalis strain V583 (Spalding and Prigge, 2009) and inserted
a hemagglutinin (HA) tag by site-directed mutagenesis using the primers
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HA.F and HA.R, generating plasmid pMS011 encoding the construct Lpa. To
generate Lpa containing a mitochondrial targeting sequence, the nucleotide
sequence encoding the first 33 amino acids of the P. falciparum mitochondrial
protein lipoate ligase 1 (LipL1, PF13_0083) was amplified from P. falciparum
cDNA using the primers L133BamHI.F and L133BamHI.R. This amplicon was
inserted into the BamHI site at the 5’ end of the Lpa gene in plasmid pMS011
to create plasmid pMS030, which encodes the construct L133Lpa. Apicoplast-
targeted lipoamidase, was produced by a similar method, except that the first
55 amino acids of the acyl carrier protein (ACP, PFB0385w) which encode
the signal peptide and apicoplast transit peptide, were amplified from the
plasmid pSP002 (Waters et al., 2002) using the primers ACP55BamHI.F and
ACP55BamHI.R. Ligation of the digested amplicon into pMS011 produced the
plasmid pMS021, containing the construct ACP55Lpa.
Active site double mutants were engineered as controls for the active Lpa,
although a single mutation of any of the catalytic triad residues to alanine
was sufficient to inactivate the enzyme for in vivo studies in E. coli (Spald-
ing and Prigge, 2009). The plasmids pMS011, pMS021, and pMS030 were
mutagenized to contain the K159A/S259A double mutant by consecutive
rounds of site-directed mutagenesis with primer sets K159A.F/K159A.R and
S259A.F/S259A.R. The resulting plasmids: pMS015, pMS023, and pMS033,
contain the double mutant constructs denoted KSA, ACP55KSA, and L133KSA,
respectively. We generated a series of lipoamidase mutants based on the
L133Lpa construct with the goal of attenuating lipoamidase enzymatic activ-
ity. Site directed mutagenesis was performed on pMS030 using primer pairs
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S236A.F/S236A.R, S236C.F/S236C/R, S236G.F/S236G.R, W210.F/W210.R,
A256G.F/A256G.R, and Y375.F/Y375.R to produce plasmids pLZ-LpaS236A,
pLZ-LpaS236C, pLZ-LpaS236G, pLZ-LpaW210F, pLZ-LpaA256G and pLZ-
LpaY375F.
2.4.2 Evaluation of lipoamidase mutants with attenuated ac-
tivity
The pLZ constructs described above, as well as pMS030 and pMS033, were
transformed into lipoylation deficient JEG3 cells (Gisselberg et al., 2013) in
order to reduce background lipoylation signal in cell lysate experiments.
Cells were induced with 0.4 mM isopropyl-beta-D-thiogalactopyranoside
(IPTG) overnight at 20◦C, and lysed in BugBuster (EMD Millipore), 1 mg/mL
lysozyme, 2.5 µg/mL DNAse I for 10 minutes, and used immediately or
frozen at -80◦C. Lysates were analyzed by western blot for the presence of
HA tagged proteins to determine relative expression levels for each construct
using ImageJ quantification. The lysates were then diluted in reaction buffer
described below to normalize protein levels for comparative enzymatic assays.
The H protein from Bacillus subtilis was used as substrate for the lipoami-
dase experiments. The coding region was amplified from genomic DNA using
primers BsHprot.BamHI.F and BsHprot.SalI.R and cloned into the pMAL-cHT
expression plasmid using BamHI and SalI. BL21-Star (DE3) cells (Invitrogen)
were transformed with this plasmid and the pRIL plasmid isolated from BL21-
CodonPlus-RIL cells (Agilent). Cells were induced at midlog phase with 0.4
mM IPTG and harvested after growth at 20◦ C after 10 hours. The H protein
was purified by affinity chromatography and ion exchange using MBPTrap
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and HiTrap Q columns (GE Healthcare).
Lipoamidase activity assays were carried out in 200 mM HEPES and 100
mM NaCl at pH 7.5 with 50 nM purified lipoylated H protein from Bacillus
subtilis serving as the substrate for the reaction. Diluted lysates were added to
each reaction and the reaction mixture was incubated at room temperature for
30 minutes. Reactions were quenched with addition of an equivalent volume
of 6X Laemmli buffer and boiled for four minutes and vortexed for one minute
performed twice for a total of ten minutes. Lipoylated H protein was detected
by western blot probed with 1:5,000 rabbit anti-lipoate antibodies (Afanador
et al., 2017) and 1:5,000 donkey anti-rabbit IgG horseradish peroxidase (HRP)
secondary antibody (GE Healthcare). Quantiation of lipoylation signal was
performed by ImageJ analysis.
2.4.3 Construction of Plasmodium falciparum expression plas-
mids
For expression in P. falciparum, lipoamidase constructs were cloned into
the vector pLN-ENR-GFP (Nkrumah et al., 2006) obtained from the MR4, or a
derivative of this vector, pRL2 in which the strong calmodulin promoter was
replaced with the weaker RL2 promoter (Nina et al., 2011). Lpa constructs
were PCR amplified from the abovementioned plasmid templates using the
reverse primer HAAflII.R, and the following forward primers: LpaAvrII.F
for plasmids pMS011 and pMS015, ACP55AvrII.F for plasmid pMS021, and
L133AvrII.F for plasmids pMS030 and pMS033. The resulting amplicons were
digested with AvrII and AflII followed by ligation into the same endonucle-
ase sites in pLN-ENR-GFP. This produced six plasmids: pMS039 (encoding
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Lpa), pMS040 (encoding KSA), pMS026 (encoding ACP55Lpa), pMS036 (en-
coding L133Lpa), pMS037 (encoding L133KSA) and pLN-L133S236A (encoding
L133S236A). Amplicons from plasmids pMS021 and pMS023 were also in-
serted into digested pRL2 to produce plasmids pMS049 and pMS050 which
encode ACP55Lpa and ACP55KSA driven by the RL2 promoter.
2.4.4 Parasite culture, transfection and harvesting
P. falciparum asexual blood stage cultures were maintained at 2% hematocrit
in complete medium consisting of RPMI 1640 medium with L-glutamine
(USBiological Life Sciences) supplemented with 10% human serum or 5 g/L
AlbuMax II (Thermo Fisher), 20 mM HEPES, 23 mM NaHCO3, and 0.09
mM hypoxanthine. Transfections were performed as described previously
(Spalding et al., 2010); briefly, 400 µL of blood was washed with 5 mL of
CytoMix and resuspended in 400 µL of CytoMix and 100 µg of the pINT
plasmid encoding mycobacteriophage Bxb1 integrase (Nkrumah et al., 2006)
and 100 µg of the appropriate parasite expression vector. Drug selection was
initiated 1-2 days after transfection. Where described, parasites lines were
also supplemented with 5 mM sodium acetate.
For western blot, autoradiography, and genomic DNA extraction, red
blood cells from P. falciparum cultures were pelleted by centrifugation at 500
g for five minutes before lysis of RBCs with 0.2% saponin for three minutes.
The reaction was quenched with ice cold PBS, and the parasites were pelleted
by centrifugation at 3,000 g for ten minutes followed by three washes with ice
cold PBS. The parasite pellets were used immediately or stored at -80◦ C.
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2.4.5 Immunofluorescence microscopy
For mitochondrial staining, parasite culture was treated with 75nM Mi-
toTracker Red CMX-Ros (Invitrogen) for 30 minutes in fresh media prior
to fixation. All cultures were fixed in 4% paraformaldehyde/0.0075% glu-
taraldehyde onto poly-lysine treated slides for thirty minutes. Cells were
permeabilized for 10 minutes in 1% Triton X-100, remaining aldehydes were
reduced with 0.1 mg/mL NaBH4 for 10 minutes and cells were blocked for 2
hours in 3% BSA. Parasite cytosol was stained with 1:2000 mouse anti-aldolase,
the apicoplast was stained with 1:1,000 rabbit anti-ACP (Gallagher and Prigge,
2009) and lipoamidase was stained with 1:500 rat anti-HA mAb 3F10 (Roche)
overnight. After treatment with primary antibodies, slides were washed,
treated with cognate secondary antibodies [1:2,000 rabbit anti-Mouse IgG
Alexa Fluor 594, 1:2,000 goat anti-Rabbit IgG Alexa Fluor 594 or 1:2,000 goat
anti-Rat IgG Alexa Fluor 488 (Invitrogen)], washed and mounted with Prolong
Gold antifade reagent with DAPI (Invitrogen). Microscopy images were taken
with the Zeiss Axio Imager.
2.4.6 In vivo radiolabeling of mitochondrial substrates
35S-labeled lipoate was prepared as previously described (Allary et al.,
2007). Labeling with 0.2 µCi of 35S-radiolabeled lipoate was initiated in 1%
hematocrit cultures with an initial parasitemia of 2%. Cultures were fed
supplemented media and blood films were made to monitor parasites every
day for 48 hours.
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2.4.7 Western blotting and autoradiography
Parasite pellets as described above were resuspended in RIPA buffer to
determine lipoamidase activity in cell lysates, and the reaction was quenched
by addition of Laemmli loading buffer. Otherwise, pellets were resuspended
in NuPAGE LDS sample buffer and boiled and vortexed for 10 minutes.
Proteins were resolved by SDS-PAGE on 4-12% gradient gels and transferred
to nitrocellulose membranes. For autoradiography, membranes were dried
overnight and autoradiography was used to detect 35S lipoate incorporation.
For Western blotting, membranes were blocked and probed with rat anti-HA
primary antibodies (1:5000) to detect lipoamidase, rabbit anti-lipoate (1:5,000)
to detect lipoylation of the apicoplast PDH E2 subunit, and either mouse
anti-HSP70 or mouse anti-aldolase (1:10,000) for loading controls.
2.5 Discussion
2.5.1 Mitochondrial lipoylation generates an essential acetyl-
CoA pool
Lipoic acid is a metabolic cofactor that is acquired in an unusual manner
by the parasite: although it is synthesized in the apicoplast, mitochondrial
proteins are modified with host-derived lipoate. Our experiments demon-
strate a dose-dependency between catalytic ability of lipoamidase in the
parasite mitochondrion and parasite survival: as catalytic ability increases
(from the inactive KSA variant, the attenuated S236A variant, and the wild-
type enzyme), parasite survival decreases, including complete intolerance of
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wild-type lipoamidase expression in the mitochondrion, even with acetate
supplementation. These observations indicate that P. falciparum is auxotrophic
for lipoate in the blood stage of the parasite life cycle. This means that the
some combination of the mitochondrial lipoate ligases and the lipoylated
substrates are essential for the parasite.
The growth inhibition imparted by expression of mitochondrial S236A and
its partial rescue clarifies one, crucial, mitochondrial biochemical pathway.
The current consensus regarding the gene product previously identified as
a mitochondrial branched chain alpha-ketoacid dehydrogenase (BCDH) is
that it is more likely a mitochondrial pyruvate dehydrogenase (PDH), and our
experiments support this claim. Bioinformatic analysis reveals an absence of
enzymes upstream of the putative BCDH, while metabolomic work confirms
the parasite’s inability to catabolize branched chain amino acids (Cobbold
et al., 2013; Oppenheim et al., 2014), calling into question the existence of a
true BCDH. The parasite does have a functional pyruvate dehydrogenase the
bridges glycolysis to the citric acid cycle (MacRae et al., 2013). Knockout of
the apicoplast resident PDH resulted in no severe growth phenotype and no
change in the parasite’s pool of acetyl-CoA (Cobbold et al., 2013; Günther et
al., 2007), making the case that the apicoplast PDH is not the enzyme chiefly
responsible for the conversion of glucose-derived pyruvate to acetyl-CoA.
Knockout of the E1 subunit of the BCDH in P. berghei, however, results in a
severe growth phenotype that is also partially rescued by ex vivo acetate sup-
plementation, where this rescue is likely mediated by the putative acetyl-CoA
synthetase that can convert acetate to acetyl-CoA (Cobbold et al., 2016). Our
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experiments mirror these observations: by drastically reducing mitochondrial
lipoylation with S236A, it appears that mitochondrially derived acetyl-CoA
generation is concomitantly reduced, with acetate supplementation providing
a partial metabolic bypass through the cytosolic acetyl-CoA synthetase (Fig.
2.7). These observations show that the parasite’s chief source of acetyl-CoA is
from the mitochondrion, that the BCDH is likely a mitochondrial PDH that is
responsible for generating acetyl-CoA from pyruvate, and that this source of
acetyl-CoA is necessary for parasite growth.
It is unclear if reducing lipoylation of the KDH contributes to the growth
defect imparted by mitochondrial expression of S236A. KDH biochemistry
may be dispensable and the parasite is able to biochemically compensate for
the absence of this pathway (Ke et al., 2015), suggesting that preventing the
conversion of alpha-ketoglutarate to succinyl-CoA causes no growth phe-
notype to the parasite. However, the KDH E1 subunit is, at least in vitro,
competent in performing PDH biochemistry, decarboxylating both alpha-
ketoglutarate and pyruvate at reasonably comparable rates (Chan et al., 2013).
Therefore, both the BCDH and the KDH may be contributing to the acetyl-CoA
pool under different circumstances. Either way, our experiments demonstrate
that it is reduction of acetyl-CoA generation that is inhibiting parasite growth.
2.5.2 The H protein of the parasite may be essential
It remains unclear why expression of the inactive mutant is not completely
tolerated in the parasite. The fact that acetate supplementation does not ap-
pear to rescue against this growth phenotype suggests that this inhibition is
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independent of acetyl-CoA generation. It is possible that this is merely an
artifact of overexpression of an exogenous gene in the parasite mitochondrion
interfering with normal trafficking or proteostasis in the parasite mitochon-
drion. This phenomenon appeared to be the case for the apicoplast as well
since expression of ACP55KSA was only successful after switching to the
lower strength RL2 promoter. Acetate rescue is insufficient to fully rescue
growth inhibition in parasites expressing mitochondrial S236A, even to the
levels of acetate-supplemented KSA parasite line. This may be explained by
the inability of the cytosolic bypass to sufficiently produce acetyl-CoA.
Another possibility for both the S236A partial rescue phenotype is inhibi-
tion of the H protein. Bioinformatic analysis reveals that the parasite codes
only two of the four proteins required for the glycine cleavage system: the
T and H proteins. Biochemical work (Varadarajan et al., 2014) demonstrated
that the parasite does not appear to perform canonical glycine cleavage, and
both their attempts and our attempts to knock out the gene in P. berghei and
P. falciparum were unsuccessful. These findings suggest that there is a non-
canonical, essential role of the H protein in blood stage malaria parasites.
Whatever its function, it is unlikely that the H protein has any contribution
to the synthesis of acetyl-CoA in the mitochondrion, and thus it is likely that
acetate supplementation will not bypass loss of H protein activity. Presumably,
H protein lipoylation would be crucial for its function, potentially explaining
why acetate supplementation does not fully bypass the activity of the S236A
lipoamidase mutant.
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2.5.3 Complete lipoylation in the apicoplast is dispensible
In many replicate experiments, such as the one shown in Figure 2.4B, right
panels, lipoamidase was not able to completely cleave lipoate from PDH in the
apicoplast. Initially, we thought that this could be a consequence of using the
lower strength RL2 promoter to drive the apicoplast constructs, or that one of
the two lipoylation domains found in PDH might be resistant to lipoamidase
activity. Alternatively, factors associated with apicoplast trafficking such as
the presence of the N-terminal apicoplast targeting peptide or refolding of the
trafficked protein could affect activity. All of these possibilities are discounted
by the experiment shown in Figure 2.4B, left panels, which demonstrates
that the ACP55Lpa construct is able to rapidly cleave lipoate from PDH and
the other lipoylated proteins when the organellar contents are mixed by cell
lysis. This indicates that there is something specific about the apicoplast
that limits lipoamidase activity. One possibility is that the conditions in
the apicoplast, such as the pH and redox potential (Mohring et al., 2017) or
the presence of inhibitory compounds, could limit lipoamidase activity. If
inhibitory compounds or conditions exist, their effects are reversed by cell lysis.
Another possibility is that the LipB/LipA apicoplast lipoylation machinery
simply works faster than lipoamidase activity. This would involve rapid
action of the octanoyl transferase LipB followed by addition of the lipoate
sulfurs by the lipoate synthase LipA. It is hard to imagine rapid catalysis
by LipA since the protein donates sulfur atoms from its iron-sulfur cofactor
to lipoate and must be repaired prior to each round of catalysis. Although
it seems unlikely, apicoplast lipoylation remains a possibility in part due to
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uncertainty about how this pathway functions. Deletion of the LipB protein,
which should be essential for apicoplast lipoylation, results in parasites that
still have some residual PDH lipoylation in both P. falciparum and P. berghei
(Falkard et al., 2013; Günther et al., 2007).
Our experiments demonstrate that reducing apicoplast lipoylation results
in no discernible growth phenotype. This observation falls in line with the
above mentioned knockout experiments of the apicoplast lipoylation ma-
chinery and knockout of several subunits of the apicoplast PDH in several
Plasmodium species (Cobbold et al., 2013; G"unther et al., 2007; Laine et al.,
2015; Pei et al., 2010a). Although PDH activity is essential for liver stage
malaria parasites (Pei et al., 2010b), its activity in blood stage parasites is
puzzling. The apicoplast resident PDH should be fully competent to perform
catalysis based on in vitro experiments (Chan et al., 2013), but it appears that
it may not be performing this reaction at a detectable rate in vivo (Cobbold et
al., 2013). Certainly the substrate pyruvate is available in the apicoplast since
this is also a substrate for the essential isoprenoid biosynthesis pathway. If
PDH activity is not needed for blood stage parasites, then why is it produced
and maintained in a lipoylated state?
2.5.4 Lipoamidase as a tunable tool to probe lipoylation
Lipoamidase has proven to be an effective tool to probe in vivo lipoylation.
The enzyme appears to lack strong substrate specificity, recognizing lipoylated
proteins from E. coli, B. subtilis and P. falciparum, opening the door to the
possibility of using this tool in other organisms. The two mutants generated
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in this project serve as a control for protein expression (WT Lpa vs. KSA)
and a means of probing cells with different levels of lipoamidase activity
(WT Lpa vs. attenuated mutants such as S236A). Adding this to inducible
and knockdown systems available in other organisms offers a wide array of
options to knock down in vivo lipoylation, especially in systems in which
the full array of lipoylation machinery has not yet been discovered. Our
experiments in P. falciparum demonstrate that mitochondrial lipoylation is
essential and implicate the BCDH and H protein as being responsible for this
phenomenon. These results explain why lipoate scavenging is essential for
parasite survival and imply that the lipoate attachment enzymes LipL1 and
LipL2 will also be required for blood stage parasite survival. Overall, these
findings provide new insight into key aspects of mitochondrial metabolism in
malaria parasites.
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2.8 Tables
Table 2.1: Summary of attempted transfection of all lipoamidase constructs in this
paper The only active lipoamidase that was successfully transfected into parasites
was the attenuated S236A variant.
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Table 2.2: Primers used to generate constructs and confirm integration.
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Table 2.3: Coarse assessment of lipoamidase mutants. Using the same assay in
Supplementary Figure 2B, all lipoamidase mutants were tested against WT lipoami-
dase activity. Protein levels were made equivalent by western blotting, and multiple
ten-fold dilutions were made of all lipoamidase variants to approximate relative
catalysis. Mutations at S236 appear to have been the only mutations that imparted a




Figure 2.1: Targeting Lpa and KSA to the parasite cytosol
A. Model of genomic integration of the plasmid expressing lipoamidase into
the dd2attB genome. Co-transfection with the pINT plasmid provides the
integrase that induces attB/attP integration. Primer pairs (red) for retention
of the parental attB locus or the recombined attL and attR loci. B. PCR demon-
strating genomic integration of the Lpa and KSA constructs. Both transgenic
lines demonstrate 5’ (attL) and 3’ (attR) integration and the absence of the
parental attB region. The parental dd2attB line serves as a control. C. Western
blotting to confirm lipoamidase expression. Antibodies specific for the HA
tag were used to demonstrate expression of both the Lpa and KSA constructs
in lysates of the transgenic parasites. Pf HSP70 is used as a loading control.
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Figure 2.2: Lpa and KSA are expressed in the cytosol. A. Lpa and KSA are expressed
in the cytosol. Immunofluorescence analysis of blood stage Lpa (top panels) and KSA
(bottom panels) parasite lines showing co-localization of the lipoamidase constructs,
labeled with an antibody specific for the hemagglutinin tag (anti-HA), with the
cytosolic marker anti-Aldolase. The nuclei are labeled with DAPI. Scale bars = 5
microns. B. Lipoamidase is expressed in an enzymatically active form. In these multi-
panel figures, anti-lipoate (anti-LA) western blot was used to identify lipoylated
apicoplast PDH; autoradiograph of parasites treated with 35S-lipoate (35S-LA) was
used to detect lipoylation of BCDH, KDH and H protein; and anti-Pf Hsp70 was used
as a loading control. The left panels show results for parasites expressing Lpa and KSA
that were lysed in SDS-PAGE loading buffer immediately prior to analysis, showing
comparable protein lipoylation between both parasite lines. Under non-denaturing
conditions (lysis in RIPA buffer followed by a 15 minute incubation at 30◦C), cytosolic
lipoamidase has access to organellar proteins and rapidly cleaves lipoate from all
parasite proteins. C. Expression of either active or inactive lipoamidase imparts
no growth phenotype. The growth of Lpa and KSA parasite lines was monitored
by microscopy at two day intervals to demonstrate that these lines does not differ
significantly from the parental dd2attB parasite line. Error bars represent the SEM of
three biological replicates.
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Figure 2.3: Targeting Lpa and KSA to the apicoplast. A. PCR demonstrates integra-
tion of apicoplast targeted Lpa and LpaKSA, and no evidence of parental attB locus.
B. Western blotting for HA tagged proteins shows both Lpa and KSA as doublets,
indicative of successful apicoplast trafficking.
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Figure 2.4: Lpa and KSA are efficiently trafficked to the apicoplast. A. IFA demon-
strates efficient localization of Lpa constructs to the apicoplast. Fixation results in
the apicoplast collapse. However, PDM and PCC values show strong colocaliza-
tion values indicating both Lpa constructs are successfully expressed in the parasite
apicoplast. B. Apicoplast targeted lipoamidase can only cleave the apicoplast PDH
E2. Autoradiography shows that the mitochondrial lipoylation substrates are intact.
Left panel shows complete cleavage of the PDH E2, suggesting that there is some
in vivo prevention of full delipoylation. C. Expression of either active or inactive
lipoamidase imparts no growth phenotype. Error bars represent the SEM of three
biological replicates.
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Figure 2.5: Targeting S236A and KSA to the mitochondrion. A. PCR shows genomic
integration of both the S236A and KSA constructs targeted to the mitochondrion. B.
S236A expression is strongly attenuated. Unlike the abovementioned constructs, the
active, attenuated form of lipoamidase is somehow expressed at much lower levels
than KSA. Both lanes also show degradation products, suggesting the parasiteâĂŹs
intolerance of both constructs.
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Figure 2.6: Mitochondrial S236A expression in the mitochondrion imparts a
growth defect. A. IFA confirms mitochondrial expression of both lipoamidase vari-
ants. B. Mitochondrial lipoamidase can cleave lipoate from mitochondrial substrates.
Densitometry analysis shows at least an 80% reduction of lipoylation of all the mi-
tochondrial substrates when normalized against the loading control. Apicoplast
PDH E2 lipoylation remains the same between the attenuated and inactive forms of
lipoamidase. C. Mitochondrial expression of lipoamidase imparts a growth pheno-
type. S236A expression imparts the most drastic phenotype, while a modest defect
appears in KSA expressing lines. Dotted lines represent cultures grown in 5mM
sodium acetate. Error bars represent SEM with biological triplicates.
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Figure 2.7: Model of parasite lipoylation and lipoamidase activity. Active lipoami-
dase expression in the mitochondrion imparts a growth phenotype. The ability of
acetate to rescue this phenotype suggests that the generation of acetyl-CoA by a
mitochondrial PDH, likely the gene formerly annotated as a BCDH. It remains a pos-
sibility that some of the growth deficit (and possibly the deficit in the KSA expressing
parasites) is due to abrogation of H protein activity.
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Figure 2.8: Cartoon depiction of lipoamidase mutagenesis rationale. Mutations at
the described positions were made to putatively disrupt lipoamidase’s ability to effi-
ciently bind a lipoylated substrate. These mutations were thought to disrupt carbonyl
stabilization of the lipoamide bond, disrupt hydrogen bonding of the catalytic lysine
(K159), and interfere with hydrophobic interaction at the dithiolan ring. The K159,
S235 and S259 residues make lipoamidase’s catalytic triad.
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Figure 2.9: Attenuation of the S236A lipoamidase mutant. Delipoylation assay
to show S236A is at least 100 times less catalytically efficient when compared to
wild type lipoamidase. Concentration of Lpa variants were normalized based on HA
blotting of cell lysates, and dilutions were made for assay. First lane shows benchmark
lipoylation signal of purified and lipoylated H protein from Bacillus subtilis.
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Chapter 3
Mitochondrial lipoylation may be
essential in Plasmodium berghei
3.1 Abstract
Plasmodium berghei shares P. falciparum’s dual lipoylation strategy - a biosyn-
thetic pathway in the apicoplast and a scavenging pathway in the mitochon-
drion. The apicoplast resident lipoylation machinery and substrates are dis-
pensable in the blood stages of both parasites, while mitochondrial lipoylation
may be essential. There are three mitochondrial proteins that require lipoyla-
tion for function: the BCDH, the KDH and the H protein. These proteins are
also likely to require a shared protein, the mitochondrial dihydrolipoamide
dehydrogenase (E3), in order to recycle lipoate for catalysis. Knockout ex-
periments for all four of these gene products were attempted in P. berghei,
resulting in complete dispensability of the KDH lipoylated subunit (E2) in
the blood stage of the parasite, and BCDH E2 and the E3 recycling subunit.
Multiple attempts to knockout the H protein failed, suggesting an essential,
noncanonical role for this protein.
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3.2 Introduction
Lipoic acid is a small fatty acid with two sulfurs at the end of the aliphatic
chain. It serves as a cofactor in several, crucial biochemical pathways in life,
most extensively described in the pyruvate dehydrogenase reaction, where
pyruvate is used to produce acetyl-CoA, bridging glycolysis to the citric acid
cycle (Perham, 2000). Lipoate-mediated catalysis can be quite complicated,
involving multiple other cofactors and large protein complexes (Introduction
chapter), and the ability to perform lipoate-mediated catalysis appears to
be crucial for most forms of life. Gene deletions in lipoate synthesis and/or
ligation pathways result in severe growth phenotypes or lethality in E. coli
(Cronan et al., 2005), Arabidopsis (Ewald et al., 2014), yeast (Schonauer et al.,
2009), mice (Yi and Maeda, 2005) and humans (Baker et al., 2014; Mayr et al.,
2014; Smith et al., 2012).
Plasmodium harbors a lipoate biosynthetic pathway in its apicoplast in
order to lipoylate the apicoplast resident pyruvate dehydrogenase (PDH).
Knockouts experiments of the apicoplast lipoylation machinery and PDH in
multiple species of Plasmodium result in no defect in blood stage development,
but do demonstrate growth phenotypes outside the blood stage, demonstrat-
ing importance of a lipoylated and fully functional PDH in the mosquito
(Cobbold et al., 2013) or liver stages of parasite development (Falkard et al.,
2013; Pei et al., 2010), but not in the blood stages (Günther et al., 2007; Laine et
al., 2015).
The mitochondrion of the parasite houses two enzymes with homology
to lipoate ligases, LipL1 and LipL2, that use scavenged lipoate to lipoylate
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three mitochondrial substrates (Afanador et al., 2014, 2017; Allary et al., 2007).
These three mitochondrial enzyme complexes are the branched chain alpha-
ketoacid dehydrogenase (BCDH), the alpha-ketoglutarate dehydrogenase
(KDH) and the H protein of the glycine cleavage system (Allary et al., 2007).
The BCDH and KDH complexes are composed of three enzymes that perform
a complicated, three step catalysis (Figure 3.1). The E1 subunit decarboxy-
lates the substrate, the E2 subunit, which is the lipoylated protein, performs
lipoate-dependent ligation of the substrate to coenzyme A, and the shared
mitochondrial dihydrolipoamide dehydrogenase (the E3 subunit) recycles
the lipoate cofactor by reoxidizing lipoate. The glycine cleavage system gen-
erates 5,10-methylenetetrahydrofolate for single carbon chemistry using a
mechanism similar to the BCDH and KDH. The P protein catalyzes the de-
carboxylation of glycine, the T protein and the lipoylated H protein work
together to transfer to alpha-carbon of glycine to tetrahydrofolate and release
ammonia, and the L protein recycles the lipoate cofactor to the oxidized state.
P. berghei scavenges lipoate for mitochondrial lipoylation, and interfer-
ence with lipoylation inhibits parasite growth (Falkard et al., 2013; Wang
et al., 2017), suggesting that mitochondrial lipoylation may be essential to
the murine parasite as it appears to be in P. falciparum (Allary et al., 2007).
Lipoate analogs have demonstrated in vivo activity (Zachar et al., 2011) and
are currently in clinical trials for cancer therapies, raising the possibility that
lipoate metabolism could be targeted in malaria parasites (Alistar et al., 2017;
Dörsam and Fahrer, 2016; Lamar et al., 2016; Pardee et al., 2014; Stuart et al.,
2014; Thomsen-Zieger et al., 2003)
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Work demonstrated in Chapter 2 and in the knockout of the E1 alpha
subunit of the BCDH in P. berghei (Oppenheim et al., 2014) demonstrates
that the BCDH is likely misannotated and really doesn’t have BCDH activity.
This hypothesis is consistent with the apparent lack of many genes in the
genomes of malaria parasites that would be needed downstream of a BCDH
enzyme to further metabolize BCDH products. Instead, the BCDH appears to
be a mitochondrial pyruvate dehydrogenase, forming acetyl-CoA from from
pyruvate. Metabolomics data in P. falciparum points to the BCDH being the
chief source of glucose-derived acetyl-CoA (Cobbold et al., 2013), suggesting
the enzyme complex could be essential in light of the fundamental roles of
acetyl-CoA in cell biology. The KDH E1 subunit has been knocked out in P.
falciparum (Ke et al., 2015), and the lipoylated E2 appears to be disruptible
in the work performed in Chapter 3, making knockout of the entire KDH
dispensable in the blood stage of the parasite. Finally, it is hard to predict
whether the H protein is essential since it is very unlikely to be functioning as
part of a glycine cleavage system do to the lack of appropriate P protein and T
protein candidates in the genomes of malaria parasites. The gene knockout
experiments sought to answer the question of the essentiality of these three
proteins in P. berghei. As an additional approach, two variants of lipoamidase
were targeted to the mitochondrion of the parasite to confirm that lipoylation




3.3.1 Lipoamidase expression is tolerated in P. berghei
Based on of success of lipoamidase expression in P. falciparum described in
Chapter 2, expression in P. berghei was also attempted. The attenuated S236A
and inactive KSA variants of lipoamidase were the first candidates to test
due to their low activity. The mitochondrial targeting sequence of the first
33 amino acids from the P. falciparum LipL1 was retained in this experiment
due to the high sequence similarity to the leader sequence in the P. berghei
ortholog of LipL1. Sequences were cloned into the pL1694-mCherry knockin
expression vector, (Figure 3.2), to insert lipoamidase driven by the PbHsp70
promoter into the dispensable 230p locus for potential interrogation of the
entire lifecycle (Janse et al., 2006). The gene product would be fused to the
mCherry fluorescent protein in order to attempt to use live microscopy for
co-localization assays. Both transfections were successful by PCR (Figure 3.3).
The KSA variant was successfully single cloned (Figure 3.4), and western
blot analysis of parasite lysate confirmed that the KSA-mCherry variant was
expressed (Figure 3.5). Microscopy experiments to confirm mitochondrial ex-
pression were inconclusive and require further experimental troubleshooting
due to poor mCherry fluorescence in live microscopy.
3.3.2 KDH E2 is dispensable in P. berghei
Initial transfections with standard pDEF knockout constructs failed, but
transfection and generation of a clone of the knockout was successful using
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a construct from the PlasmoGem project (Schwach et al., 2015), a library of
highly efficient transfection constructs that employ very large homology arms
for efficient homologous recombination (Figure 3.6A, B, Table 3.4). As there
was no obvious growth phenotype observed in a clone of ∆kdh parasites, the
drug cassette was recycled successfully using 5-fluorocytosine treatment and
successfully single-cloned (Figure 3.6C). This procedure would allow us to
make additional genetic modifications with plasmids containing the hDHFR
drug resistance cassette, including other gene deletions.
3.3.3 BCDH, H protein and the shared E3 subunit may be im-
portant for parasite growth
We attempted to knockout the BCDH E2 protein using the same approach
described above for the KDH E2. We were able to detect successful ∆bcdh
parasites by diagnostic PCR (Figure 3.7), but multiple single cloning attempts
resulted in wild type parasites (Figure 3.8). This suggests that the proportion
of knockout parasites to wild type parasites in the post-transfection population
was low or that wild type parasites have a significant growth advantage
compared to the knockout parasites. An initial attempt at determining the
proportion of wild type to knockout parasites yielded substandard results
(Table 3.5). If the data are correct, the proportion of mutant parasites would
be approximately 1/8th the total parasite population, but extrapolating from
these data strongly suggests that the number of mice needed to obtain at least
one clonal population of the knockout was too high to be feasible. Multiple
attempts were made to increase the proportion of ∆bcdh parasites, including
phenylhydrazine treatment, ex vivo culturing with acetate supplementation
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and high-dose pyrimethamine treatment (Figure 3.9), and constructing a
fluorescent tag for enrichment by flow cytometry (Table 3.1). We were not
able to clone ∆bcdh parasites using these methods and it is likely that this line
has a significant fitness defect compared to wild type parasites.
Attempts to knock out the H protein by both the pDEF and Plasmogem
constructs failed multiple times, but parasites never came up, so it is unclear
if the knockout is not tolerated or if all transfections failed. Knockout out
the mitochondrial E3 subunits resulted in parasites that were positive for the
disrupted locus (Figure 3.10).
3.4 Discussion
3.4.1 Lipoamidase in P. berghei
Further work in exploiting lipoamidase as a metabolic probe in P. berghei
would be informative on interrogating the importance of lipoylation in dif-
ferent life cycle stages of the murine parasite. Current experiments have not
confirmed mitochondrial targeting of the protein - this is partially due to the
constraints of our system. The gene was cloned with an mCherry fusion pro-
tein; however, the intrinsic fluorescence of this line is too low to be useful in
live fluorescence microscopy experiments. Immunofluorescence experiments
are complicated by needing a co-localization marker for the mitochondrion
that is compatible with fixation methods. The only easily available marker
for mitochondrial localization Mitotracker Green, does not work well with
aldehyde based fixation methods. One group appears to have been successful
in fixing blood stage parasites with methanol for Mitotracker Green staining
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(Boysen and Matuschewski, 2011), but this method was not successful as yet
in our experiments. However, the banding pattern observed in anti-mCherry
western blot is similar to the banding pattern observed in the anti-HA blot
used in the successful P. falciparum lipoamidase experiments (Chapter 2).
These similarities are possibly suggestive of mitochondrial targeting, but con-
firmation may require attaching a different tag and/or optimizing microscopy
techniques.
In P. falciparum, acetate supplementation was critical for the success of the
lipoamidase experiments. This technique is difficult to employ with P. berghei
due to the vagaries of mouse metabolism. The growth defect imparted by
mitochondrial lipoamidase expression was rescued by treatment with 5 mM
acetate supplementation, but it is unlikely that this is the lowest amount of
acetate needed to rescue growth appreciably. Running a parallel experiment
in a mouse would be complicated because mouse acetate levels appear to be
tightly regulated round 80 µM, with acetate supplementation clearing serum in
under one hour (Frost et al., 2014). Considering these constraints, attempting
to observe acetate rescue in a parasite line expressing lipoamidase in a mouse
may not be feasible. On the other hand, considering the tightly regulated
acetate concentration in mouse blood and the ability for parasites to infect
metabolically rich reticulocytes (Srivastava et al., 2015), it may be possible to
have a parasite line that can express the attenuated lipoamidase, and another
parasite line that can express the fully active lipoamidase, a phenomenon that
appears impossible in P. falciparum. Performing a radiolabeling experiment as
in Chapter 2 with radiolabeled lipoate to observe reduced lipoylation would
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have to be performed in ex vivo culture in order to prevent loss of the radiolabel
in unrelated tissues. There may also be complications associated with host
cells like white blood cells and immature reticulocytes, which could retain
some lipoylated proteins. Despite these drawbacks, exploring lipoamidase
activity in the murine model system provides an opportunity to observe
parasite growth under in vivo conditions more relevant to the human disease
state. In particular, the murine model makes it possible to interrogate the
significance of protein lipoylation in different malaria lifecycle stages.
3.4.2 Disruption of canonical lipoate-mediated biochemistry
in the parasite mitochondrion
The ease with which the KDH E2 knockout was obtained and cloned in
P. berghei suggests that the enzyme is completely dispensable in the blood
stage of parasite development, even for parasites maintained in vivo. This is
consistent with the observation that the KDH E1 can be deleted in P. falciparum
(Ke et al., 2015). The simplest explanation of these results is that the KDH
proteins are indeed components of a KDH complex and don’t have any other
important roles outside of TCA cycle metabolism. Ke and coworkers showed
that the P. falciparum KDH E1 knockout line could not complete mosquito
stage development and we would assume that our P. berghei E2 knockout
would also fail to thrive during these stages.
Our inability to isolate a BCDH E2 knockout is strongly indicative of a
severe growth phenotype. Knockout of the E1alpha subunit of the BCDH
imparts a severe growth phenotype (Oppenheim et al., 2014) that required
immunocompromised mice for single cloning experiments. Although this
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approach has several drawbacks, it may also be necessary for our BCDH E2
knockout. It is possible that the growth phenotype is so severe that parasites
successfully diluted to one parasite per mouse during cloning experiments
won’t tend to result in infected mice. This scenario would require a different
means of cloning, e.g. loading more than one parasite per mouse in order
to achieve successful infections. Finally, the qPCR experiments are highly
problematic - it was impossible to perform this experiment without getting
signal from non-template controls, so whatever extrapolation that can be made
from the data would be an overestimation of the percentage of knockouts vs.
wild types. It is also likely that over time the wild type population would
continue to expand into a larger and larger proportion of the population, and
continuous passage of this mixed population would result in a vanishing
population of knockouts. All these effects together would make single cloning
using standard methods close to impossible.
Our transfection experiments in P. berghei suggest that the BCDH and H
protein are important for blood stage parasite replication. It is likely that
the BCDH E2 knockout would behave similarly to the BCDH E1 knockout
P. berghei and replicate slowly with the limitation of only being able to use
reticulocytes as host cells (Oppenheim et al., 2014). It is likely that the P.
berghei BCDH complex is actually a pyruvate dehydrogenase (PDH) and not
a branched chain alpha-ketoacid dehydrogenase, an observation made in
Chapter 2 and in metabolomics work (Cobbold et al., 2013; Oppenheim et al.,
2014).
The experiments here help clarify thiamine dependence of blood stage
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parasites. Both blood stage P. falciparum and P. berghei are dependent on
exogenous thiamine (vitamin B1) (Hellgren et al., 2017; Wrenger et al., 2006),
and treatment of both parasites with a toxic analog, oxythiamine, results in
reduced parasite growth. The only identified enzymes in the parasite that
appear to be thiamine dependent are the apicoplast PDH, KDH, the BCDH
and transketolase (Chan et al., 2013). Since the KDH and PDH seem to be
dispensable in the blood stage, the BCDH and transketolase could be the
important thiamine-dependent enzymes inhibited by oxythiamine. This line
of reasoning is consistent with the hypotheses that the parasite’s thiamine
utilization pathway (Wrenger et al., 2006) and pentose phosphate shunt (Hasan
et al., 2015; Preuss et al., 2012) are potential drug targets. Treatment of the
BCDH E1 knockout or a BCDH/KDH double knockout should be able to
confirm this, unless the BCDH/KDH knockout alone is lethal.
3.4.3 Evidence of novel lipoate dependent biochemistry in
the mitochondrion
It is unclear whether the BCDH is the sole producer of acetyl-CoA in the
mitochondrion of malaria parasites. The P. falciparum KDH E1 subunit can
catalyze both pyruvate and alpha-ketoglutarate at sufficiently comparable
rates (Chan et al., 2013), suggesting that the P. falciparum KDH can function as
a backup PDH, and this catalytic setup may be mimicked in P. berghei. As such,
it may be that knockout of the BCDH E1 or E2 subunits survive due to some
functional redundancy with the KDH, and that a double knockout would be
synthetically lethal due to the complete inability to generate acetyl-CoA from
pyruvate in the mitochondrion.
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It has been recently shown that Staphylococcus aureus is able to secrete
its lipoylated PDH, and that this protein can serve to strongly attenuate the
macrophage activation via TLR2-dependent manner, allowing for greater sur-
vival in mice (Grayczyk et al., 2017). It is unclear whether or not Plasmodium
can secrete lipoylated proteins, but this may explain potential differences in
the different permittivity of knockouts between P. falciparum and P. berghei.
It would be interesting to observe the immunological outcomes of P. berghei
knockouts of the lipoylated proteins with "rescue" by IV injected, purified and
lipoylated proteins as performed in S. aureus to see if secretion of lipoylated
proteins is a conserved strategy among pathogens. Ultimately, the potential
metabolic differences and the nature of the mouse model vs. tissue culture
require a good deal of rigorous interrogation to fully flesh out the role of the
BCDH in both species.
It was a surprise to us that the mitochondrial E3 subunit appears to be
disruptible. This protein should be important for the activity of the KDH,
BCDH and the H protein, and deleting it should be equivalent to deleting
all three lipoylated proteins. Since the BCDH and the H proteins appear
independently to be important for parasite growth, it seems unlikely that the
E3 subunit could be deleted. Although the experiments performed here are
inconclusive, the apparent ability to knockout this gene raises the possibility
that alternatives pathways may be at work in the parasite. Either another
protein can catalyze the oxidation of lipoate instead of the E3 subunit, or
conditions in the mitochondrion facilitate this process. This scenario is not
hard to imagine since the glutathione redox potential in the mitochondria
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of blood stage P. falciparum parasites is -328 mV (Mohring et al., 2017), a
value similar to that of lipoate, suggesting potential spontaneous reduction of
oxidized lipoate.
The H protein remains a mystery in parasite biology. The H protein is
part of the glycine cleavage system, which is canonically comprised of four
proteins, including the H protein, but the parasite does not code two of the
four proteins in its genome, and knockout of the only other remaining possible
member of the GCV, the T protein, has no apparent consequence throughout
the parasite life cycle (Varadarajan et al., 2014). In addition, blood stage
parasites also appear unable to perform glycine cleavage (Varadarajan et al.,
2014), so the H protein is probably maintained for some other purpose. One
explanation is that the H protein has a moonlighting function. One such
function is to participate in lipoylation reactions by serving as the source of
lipoate for lipoyl transferases that then lipoylate other proteins (Cao et al.,
2018) . Experiments performed with pure recombinant proteins show that the
P. falciparum H protein does not play this role in conjunction with other lipoate
attachment enzymes (Afanador et al., 2014).
One hypothesis for the role of the H protein involves oxidative defense.
Work in E. coli shows that the shared E3 subunit can act in concert with
lipoylated proteins to mitigate redox damage (Feeney et al., 2011), and work
performed in our lab (Afanador et al., 2014) demonstrates redox sensitivity
by the Plasmodium mitochondrial lipoate ligase, suggesting a possible lipoate-
based redox response in the parasite. Interestingly, we rarely see a band
for lipoylated H protein in anti-lipoate western blots of P. falciparum and P.
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berghei parasites. This might suggest that the H protein is not lipoylated;
however, lipoylated H protein is always detected at levels similar to other
lipoylated proteins in autoradiographs of parasites treated with 35S-lipoate.
This difference in detection might be due to chemical modifications that result
from scavenging reduced oxygen species. Anti-lipoate antibodies do not
recognize lipoate with oxidized sulfur atoms such as sulfenic acid (SOH),
sulfinic acid (SO2H), or sulfonic acid (SO3H). Future studies will tease out
whether this hypothesis has merit. Since the S236A lipoamidase line reduces
H protein lipoylation, these parasites might be more sensitive to different
forms of oxidative stress. Alternatively, new knock down approaches could be
used to specifically reduce H protein levels, changing the sensitivity of these
parasites to oxidative stress in a reversible manner. Ultimately, due the lack of
understanding of how a lipoylated H protein functions outside of the glycine
cleavage system, determining the role of the H protein may remain a mystery
for some time.
3.4.4 Methods Improvement
The difficulty in obtaining single clones of the BCDH KO highlights some
of the problems in dealing with genetic manipulation in P. berghei. The
pyrimethamine/hDHFR selection cassette demonstrates strong repression
of wild type parasites (Janse et al., 2006; Philip et al.), but inconsistent clear-
ance makes post-transfection wild type populations unavoidable. Also en-
compassed here is the issue of transfection efficiency: even with the added
10-fold improvement in transfection efficiency of the PlasmoGem constructs
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against standard plasmids (Pfander et al., 2011), the theoretical maximum effi-
ciency of successful transfectants is only 10%. For genetic modifications that
result in a growth phenotype, that genotype will be seriously outnumbered
by the pyrimethamine-suppressed wild type population waiting to rebound.
Novel methods would be required to successfully isolate parasites with fit-
ness defects resulting in slow growth. Some attempts to enrich knockout
parasites were made in this project without success. Other methods have
been used by other groups, e.g. flow sorting to enrich for modified parasites
(Kenthirapalan et al., 2012) and coupling short-term ex vivo culturing with
mouse-incompatible drugs (Jambou et al., 2011; Soga et al., 2017). It is not
clear whether these methods would work to enrich the ∆bcdh line or other
lines with significant growth defects.
3.5 Future Directions
3.5.1 Lipoamidase in P.berghei
Bringing in both the apicoplast and mitochondrially targeted lipoamidase
variants used in P.falciparum in Chapter 2 would help to resolve the impor-
tance of organelle specific lipoylation in those two compartments due to the
apparent dual organelle activity of the P.berghei lipoylation enzymes (Falkard
et al., 2013; Wang et al., 2017). As in the P.falciparum experiments, localization
experiments, growth curves and Western blotting/autoradiography can be
performed to determine the importance of organelle specific lipoylation. It
would also be interesting to see if any reticulocyte preferences occur as an al-
ternate metabolic phenotype to the growth deficit observed in the P.falciparum
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experiments, as there are no reticulocytes in P.falciparum culture. The mCherry
marker should be swapped for a different tag because of its poor visualization;
one attractive option is a newly described red fluorescent protein (mScarlet)
that is superior to mCherry (Bindels et al., 2017), but is likely still compatible
with mCherry antibodies. This would bring an upgraded tool to the field that
should be compatible with current methods.
Continuing an apicoplast targeted lipoamidase line outside the blood stage
may confirm previously observed phenotypes of apicoplast lipoylation being
important, but not essential, for liver-stage development (Falkard et al., 2013;
Nagel et al., 2013). Continuing a mitochondrially targeted lipoamidase line
outside the blood stage may impart a partial phenotype, potentially bypassing
the pre-oocyst arrest of the BCDH E1 knockout (Oppenheim et al., 2014b).
This may allow us to interrogate the importance of mitochondrial lipoylation
from the oocyst to the liver stage, an observation that has not been done before,
and may not be possible without a lipoamidase. Putting lipoamidase under
a stage specific promoter (Lacroix et al., 2011; De Niz et al., 2015) may also
help fine tune these kinds of experiments. First pass experiments to determine
gross importance would include determining oocyst development, sporozoite
numbers, and looking for delays to prepatency. If any phenotypes emerge,
more granular experiments can be performed, including immunofluorescence
assay for organelle specific lipoylation during sporozoite and intrahepatic
stages, or lipoate analog poisoning during the liver stage to clarify if previous
experiments that could not fully determine if biosynthesis or scavenging was
being poisoned by lipoate analogs.
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Ultimately, repeating the P.falciparum lipoamidase experiments in P.berghei
would help clarify the mystery regarding organelle specific lipoylation, and
would allow exploration of the importance of lipoylation in the non-red blood
cell stages that could not be performed using other methods. This is especially
likely considering the difficulty of the knockout experiments described below.
3.5.2 Knockouts of lipoylation enzymes and lipoylated sub-
strates in P.berghei
Finishing the knockout experiments would likely take the most amount
of time. The easiest to start with is the KDH E2 knockout. This genotype has
already been cloned, and should be ready for growth assays and interroga-
tion of non-blood stage phenotypes as described above. Because this line is
markerless, it should also be ready for further genetic modifications.
The BCDH E2 knockout would likely need to be retried from scratch. The
transfection cassette should be modified in order to accommodate flow sorting
to help enrich for transfectants. Experiments can also try the blasticidin or
puromycin resistance cassette for ex vivo selection (Soga et al., 2017) as they
appear to work faster than pyrimethamine selection and should kill, rather
than inhibit, wild type parasites. Transfection using the most recent AMAXA
nucleofector is likely the best transfection strategy, as it affords an improve-
ment in transfection efficiency compared to the AMAXA that the department
currently has. This should help the starting population of transfectants get
a further head start than the original transfections. Transfection and single
cloning should still be performed in phenylhydrazine pre-treated mice for
optimal conditions for the mutants. Once a clone is obtained, characterization
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as described for the KDH can be performed.
Though an attempt can be made to clone the mitochondrial E3 knockout
obtained, it may phenocopy the BCDH E2 knockout or be worse as it should
have served as a triple knockout of the BCDH E2, KDH E2 and H protein.
The mitochondrial lipoyl ligases can also be attempted as we have those
constructs, though they can be expected to have phenotypes expected of a
double knockout (LipL2) or triple knockout (LipL1).
As discussed previously, metabolic rescue would be difficult in any of these
lines, assuming knowledge of the disrupted pathways. Pre-treatment with
phenylhydrazine may be the best bet in order to improve reticulocyte num-
bers and provide a more nutrient rich environment for the mutant parasites.
Pilot attempts at rescuing with increased glucose in the media in P.falciparum
lipoamidase demonstrates no effect, so putting mice on a high sugar diet may
not improve results. Supplementation may be possible with long term ex vivo
culture (Jambou et al., 2011); this could be coupled to ex vivo drug selection
for a further improved proportion of mutant parasites to wild type parasites.
Ultimately, it would take a good deal of work to fully flesh out the necessity
of mitochondrial lipoylation in P.berghei because of the predicted severe
growth phenotypes and the lack of rigorously tested methods outside of
standard transfection and selection. Pursuing this project would require
validation of these methods, making the ultimate paper an ambitious project.
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156âĂŞ171.
Afanador, G.A., Guerra, A.J., Swift, R.P., Rodriguez, R.E., Bartee, D.,
Matthews, K.A., Schön, A., Freire, E., Freel Meyers, C.L., and Prigge, S.T.
(2017). A novel lipoate attachment enzyme is shared by Plasmodium and
Chlamydia species. Mol. Microbiol. 106, 439-451.
Alistar, A., Morris, B.B., Desnoyer, R., Klepin, H.D., Hosseinzadeh, K.,
Clark, C., Cameron, A., Leyendecker, J., D’Agostino, R., Topaloglu, U., et al.
(2017). Safety and tolerability of the first-in-class agent CPI-613 in combination
with modified FOLFIRINOX in patients with metastatic pancreatic cancer:
a single-centre, open-label, dose-escalation, phase 1 trial. Lancet Oncol. 18,
770-778.
Allary, M., Lu, J.Z., Zhu, L., and Prigge, S.T. (2007). Scavenging of the
cofactor lipoate is essential for the survival of the malaria parasite Plasmodium
falciparum. Mol. Microbiol. 63, 1331-1344.
Baker, P.R., Friederich, M.W., Swanson, M. a, Shaikh, T., Bhattacharya, K.,
98
Scharer, G.H., Aicher, J., Creadon-Swindell, G., Geiger, E., MacLean, K.N., et
al. (2014). Variant non ketotic hyperglycinemia is caused by mutations in
LIAS, BOLA3 and the novel gene GLRX5. Brain 137, 366-379.
Bindels, D.S., Haarbosch, L., van Weeren, L., Postma, M., Wiese, K.E.,
Mastop, M., Aumonier, S., Gotthard, G., Royant, A., Hink, M.A., et al. (2017).
mScarlet: a bright monomeric red fluorescent protein for cellular imaging.
Nat. Methods 14, 53-56.
Boysen, K.E., and Matuschewski, K. (2011). Arrested oocyst maturation in
Plasmodium parasites lacking type II NADH:ubiquinone dehydrogenase. J.
Biol. Chem. 286, 32661âĂŞ32671.
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3.8 Tables
Table 3.1: DNA oligos used to generate constructs for lipoamidase and knockout
experiments.
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Table 3.2: DNA oligos used to generate constructs for lipoamidase and knockout
experiments.
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Table 3.3: DNA oligos used to generate constructs for lipoamidase and knockout
experiments.
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Table 3.4: Summary of P. berghei transfections
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Table 3.5: Mean values of qPCR performed in triplicate on BCDH KO gDNA. Ct
values for 10 ng of gDNA are likely the most valid in the set, suggesting approxi-
mately 1/8th the parasite population bears the knocked out locus. However, repeated
attempts at the experiment resulted in significant Ct values appearing in the nontem-
plate control (NTC), giving values around 26. This would suggest that the Ct value
for the hDHFR loaded with gDNA is likely artificial, and that the true proportion of
mutants is below 1/8th the total population. transfections
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3.9 Figures
Figure 3.1: Canonical lipoate-mediated metabolism in a pyruvate dehydrogenase,
alpha-ketoglutarate dehydrogenase and the glycine cleavage system. Decarboxy-
lation and ligation of the substrate is performed by the E1 subunit (or the P protein).
The E2 subunit (or the H and T proteins) attach the remaining substrate onto a cofactor.
Finally, the E3 (or L protein) consumes NAD+ in order to regenerate the oxidized
lipoyl moiety on the E2 subunit (or H protein).
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Figure 3.2: Knockin construct for lipoamidase into the dispensable 230p locus in P.
berghei. Decarboxylation and ligation of the substrate is performed by the E1 subunit
(or the P protein). The E2 subunit (or the H and T proteins) attach the remaining
substrate onto a cofactor. Finally, the E3 (or L protein) consumes NAD+ in order to
regenerate the oxidized lipoyl moiety on the E2 subunit (or H protein).
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Figure 3.3: Both the KSA and S236A lipoamidase variants can be knocked into
the 230p locus. PCR products of the appropriate size were produced for the KSA
and S236A using genomic DNA from the mixed parasite population. PbANKA-GFP
gDNA was used as a positive control for 5âĂŹ integration since this line was created
using a similar strategy to insert GFP into the 230p locus. PbANKA gDNA was used
at the WT lanes as a negative control.
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Figure 3.4: The P. berghei line expressing the inactive lipoamidase variant (KSA)
was successfully single cloned. 8 out of 20 mice became patently infected during
single cloning, and 7 came up positive for the integrated locus, and 3 were devoid
of the wild type locus. This implies that some mice ended up getting more than one
parasite each during the experiment. The parental line was used as a positive control
for integration PCR, while both PbANKA-GFP and PbANKA were used as negative
controls for PCR for the wild type locus.
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Figure 3.5: Inactive lipoamidase variant (KSA) mCherry fusion protein is well
expressed.. The amino acid sequence suggests that the fusion protein should be seen
at 110kD, but the predominant band appears at the 150kD mark. This is in line with
previous observations that lipoamidase typically runs 30-40kD larger than predicted.
PbANKA GFP lysate serves as a negative control, and PbANKA mCherry lysate and
recombinant mCherry serve as positive controls. It is unclear why the PbANKA
mCherry lysate used as a control does not show any bands.
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Figure 3.6: The KDH locus is disruptible in P. berghei. PCR demonstrates both the
disrupted locus A and the WT locus B, suggesting that the parasite population is
mixed, and that the KDH E2 locus is disruptible. Two gDNA preparations were tested
since the first gDNA preparation was of poor yield. C.The PbKDH E2 KO line was
successfully single cloned, and the markerless line was also generated and single
cloned. Size shift PCR was used to investigate the KDH E2 locus and produce three
possible bands: the wild type locus, integrated (knocked out) locus, and the integrated
locus that excised the hDHFR/yFCU resistance cassette. Three clones that do not
have either the KDH E2 locus or the hDHFR/yFCU cassette were generated. The
next two lanes mark the two single clones generated from the initial single cloning
experiment to isolate clones of the KDH E2 deletion. PbANKA GFP gDNA was used
as a positive control for the wild type locus.
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Figure 3.7: The BCDH locus is disruptible. PCR for the disrupted, integration locus
is positive for the transfected population (left side of the gel), but is also positive for
the wild type population (right side of the gel), suggesting a mixed population of
parasites. The parental PbANKA-GFP gDNA was used as a negative and positive
control, respectively
117
Figure 3.8: The BCDH knockout could not be single cloned.. PCR for the WT locus
was performed (top gel) on parasites that came from five mice that became patently
infected, showing positive signal for the wild type locus. gDNA from the E3 KO and
the parental PbANKA-GFP lines were used as positive controls. PCR for the disrupted
locus (bottom gel) was negative for all five parasite populations. The parental, mixed
population gDNA was used as a positive control, and PbANKA-GFP was used as
a negative control. This is a representative set of gels for three attempts at single
cloning.
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Figure 3.9: Ex vivo culture attempt to enrich for transfectants..Continuous phenyl-
hydrazine treatment was employed in order to enrich for reticulocytes, which are
the preferred host erythrocyte for P. berghei, and possibly more so for this knock-
out. Ex vivo culture was supplemented with 150 nM pyrimethamine (approximately
10X the IC50 in culture) to suppress wild type parasites, and acetate was supplied
to bypass potential toxicity of the knockout. Magnetic purification of schizonts
was then performed to exclude wild type parasites, and continuous passage in
pyrimethamine/phenylhydrazine treated mice was conducted to continue to en-
rich for the mutant parasites.
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Figure 3.10: The shared, mitochondrial E3 subunit may be dispensible in the
blood stage of P. berghei..PCR shows positive signal for both WT locus (left side
of the gel) and the disrupted, integration locus (right side of the gel). PbANKA-GFP
gDNA was used as a positive and negative control, respectively.
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Chapter 4
The KDH, but not the BCDH, is
disruptable in P.falciparum
4.1 Abstract
The lipoamidase experiments in P. falciparum, the results of the P. berghei
knockout attempts, and other experiments demonstrated that mitochondrial
lipoylation is essential for the blood stage of the malaria parasite. However,
these experiments have not yet demonstrated which, or what combination, of
the lipoylated complexes are essential in P. falciparum. Knockout experiments
were performed in P. falciparum targeting the BCDH and the KDH to mixed
results. We were able to disrupt the KDH, demonstrating that this protein is
not essential for blood stage parasites, but we failed to delete the BCDH.
4.2 Introduction
Plasmodium falciparum has three, putative metabolic pathways in the mi-
tochondrion that are lipoate dependent: the branched chain alpha-ketoacid
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dehydrogenase (BCDH), the alpha-ketoglutarate dehydrogenase (KDH) and
the glycine cleavage system. Work in our lab demonstrated that the parasite
scavenges exogenous lipoate and attaches it to these enzyme systems (Allary
et al., 2007). Abrogating these lipoylation pathways by knockdown (Wang
et al., 2017), drug treatment (Afanador et al., 2014) or the lipoamidase exper-
iments described in Chapter 2 demonstrate that lipoylation is essential for
parasite growth, but it is unclear which or what combination of these enzymes
is essential.
Metabolomic experiments demonstrate that both P. falciparum (MacRae
et al., 2013) and P. berghei (Oppenheim et al., 2014) have a typical glycolytic
pathway that is bridged to the mitochondrial citric acid cycle, also known as
the tricarboxylic acid cycle (TCA), which fuels the electron transport chain
(ETC). The parasite’s near-exclusive use of glucose as a carbon-based energy
source and the essentiality of the ETC (Painter et al., 2010) strongly suggest
that a pyruvate dehydrogenase (PDH) exists to connect glycolysis to the TCA.
The genomes of malaria parasites appear to encode two independent PDH
enzyme complexes - one trafficked to the apicoplast and the other trafficked to
the mitochondrion (BCDH). The ability to knockout the apicoplast lipoylation
machinery, which should abrogate any apicoplast PDH activity, demonstrates
that lipoate-dependent PDH catalysis is not essential to the parasite in the
blood stage (Falkard et al., 2013; Günther et al., 2007). This conclusion is
supported by the fact that the apicoplast resident PDH being dispensible in
the blood stage of several species of Plasmodium (Pei et al., 2010). Consistent
with these findings, metabolomic experiments demonstrate that the apicoplast
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PDH is not the primary pathway for acetyl-CoA generation (Cobbold et
al., 2013). The ability of acetate to rescue lipoamidase toxicity described in
Chapter 2, the knockout experiments described in Chapter 3, and the E1 alpha
knockout of the BCDH (Oppenheim et al., 2014) strongly implicate the BCDH
as the chief source of acetyl-CoA for the parasite (and thus a mitochondrial
PDH). These results imply that the lipoylated BCDH E2 subunit should be
essential for blood stage parasite survival.
Available evidence suggests that all of the components of the KDH complex
should be dispensable in blood stage malaria parasites. The E1 subunit of
KDH has been deleted in P. falciparum and metabolomics analysis of this
mutant shows that this step of the TCA pathway is not required for the
survival of blood stage parasites (Ke et al., 2015). It is not clear, however,
whether the lipoylated E2 subunit is required for some other function. Indeed,
some bacteria use lipoylated enzyme complexes such as the PDH or KDH in
oxidative stress pathways in addition to their canonical roles (Spalding and
Prigge, 2010). In order to test whether or not these lipoylated proteins are
essential in P. falciparum, we performed knockout experiments targeting the
BCDH E2 and the KDH E2 proteins.
4.3 Results
4.3.1 The Plasmodium falciparum kdh locus is disruptable
Cloning and implementing a double crossover strategy at the time this
work was done would have required much more time and effort than a
single crossover strategy, so using single crossover was chosen as a pilot
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experiment to see whether the kdh gene is disruptable. The homology arm
used separates the lipoylation domain from the catalytic domain of the KDH
with the expectation that if the disrupted locus still produced mRNA that
could be successfully translated, it would produce a fragmented protein that
could be lipoylated, but unable to perform catalysis (Figure 4.1). The single
crossover was designed in such a way that an HA tag would be appended
to the 3’ end of any truncated protein product. This single KDH homology
arm was cloned into the pCC1s single-crossover plasmid for transfection of P.
falciparum 3D7-GL strain parasites. This line was chosen because it is capable
of producing functional gametocytes, allowing us to study mosquito stage
effects if blood-stage knockouts were viable.
After several weeks of drug-cycling with anti-folate drug WR99210 (Figure
4.2), diagnostic PCR products demonstrated that the kdh locus was success-
fully disrupted (Figure 4.3A,B). Multiple attempts at single cloning a parasite
that harbored only the disrupted locus from the mixed population failed,
resulting in 36 parasite clones with complex genotypes. After expansion from
a single parasite cell, these lines contain both the wild type and disrupted
locus (Figure 4.4). Additionally, there is PCR evidence for episomally main-
tained plasmid in these lines, indicative of spontaneous plasmid excision. This
phenomenon persisted after multiple attempts at drug cycling which should
have favored the growth of parasites with integrated plasmid rather than
episomally maintained plasmid. Presumably, KDH disrupted parasites excise
the transfection plasmid at some rate (through crossover of the homology arm
with its merodiploid copy), allowing us to detect the wild type locus and the
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plasmid over time. Taken together, these results suggests that the kdh gene
can be disrupted, and that the KDH E2 protein is not essential for blood stage
parasite growth; however, we also conclude that we will not be able to obtain
clonal parasite populations based on facile plasmid excision.
4.3.2 The bcdh locus is not disruptable
A 645 nucleotide section of the coding region of the bcdh gene was amplified
using the same design philosophy as the KDH into the pCC1s single crossover
plasmid. Multiple transfection attempts yielded no viable parasites at up to
two months into negative selection. Transfection into alternative parasite lines
(3D7 and NF54) and with acetate supplementation came to little success, with
two successful transfections coming up, but without PCR evidence for the
disrupted locus (Figure 4.6A, B). These parasite lines also did not display evi-
dence of episomal maintenance (Figure 4.7), suggesting spurious integration
into a different part of the parasite genome. Since the transfection plasmid
contains 5’ and 3’ UTR elements cloned from the P. falciparum genome, these
are likely regions for spurious integration (López-Estraño et al., 2007). Based
on multiple failures to target the bcdh locus in multiple parasite strains both
with and without acetate supplementation (Table 4.2) suggests that BCDH E2
protein is essential for blood stage parasite growth.
4.4 Discussion
Although the parasite does appear to tolerate disruption of the kdh gene,
the inability of the parasite to stably maintain the knockout plasmid integrated
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into the genome may suggest plasmid excision is occurring, a phenomenon
previously described in the literature (Jacobs-Lorena et al., 2010; Knuepfer et
al., 2017; Sultan et al., 1997), due to the use of the single-crossover approach.
Because the disruption can occur, but the plasmid appears to be regularly
excised, there may be some slight fitness defect associated with loss of KDH
activity. It should be noted, however, that though multiple and variant meth-
ods to produce single clones were used, it is still a formal possibility that the
clones obtained were simply not single clones.
This does not necessarily contradict the findings of the Pfkdh E1 knockout
(Ke et al., 2015). Analysis of TCA cycle metabolites in the various knockout
lines made by Ke and coworkers showed that nearly every knockout was
accompanied by biochemical compensation feeding into and out of the citric
acid cycle as a result of TCA gene disruption. Although this compensation
may allow the parasites to survive in the absence of a TCA cycle enzyme, the
altered metabolic states may come with some small fitness costs. In the case
of ablating KDH activity, the route of glutamate/glutamine carbon into the
TCA cycle (as alpha-ketoglutarate) is no longer functional. Considering the
importance of glutamine and glutamine as the major carbon input for the
citric acid cycle (MacRae et al., 2013; Srivastava et al., 2016), it is reasonable to
predict that the loss of KDH activity will affect parasite fitness.
The failure to knockout the BCDH in multiple strains of P. falciparum
suggests that the gene is important, and possibly essential, for the parasite.
Based on the hypothesis that BCDH generates acetyl-CoA, this would imply
that acetyl-CoA generated in the mitochondrion is essential for mitochondrial
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and/or cytosolic metabolism. Since the only known role of acetyl-CoA in the
mitochondrion is to act as a carbon source for the dispensable TCA cycle, it
seems likely that acetyl-CoA generated by BCDH is important for cytsosolic
metabolism. We attempted to supplement cytosolic acetyl-CoA production
by providing 5 mM acetate in the parasite medium with the hope that the
cytosolic acetyl-CoA synthetase would supply the required metabolite and
allow us to disrupt the bcdh gene. The inability of acetate supplementation
to bypass loss of BCDH function suggests that cytosolically generated acetyl-
CoA is insufficient in compensating for loss of mitochondrially generated
acetyl-CoA. In addition, although the KDH may moonlight as a PDH, (Chan
et al., 2013; Foth et al., 2004), any potential ability for the KDH to compensate
loss of the BCDH may also be insufficient to rescue the effects of the BCDH
knockout.
Comparisons to the experiments done in P. berghei in the previous chapter
may be informative. The successful single cloning of a stable knockout of the
kdh E2 gene was perhaps possible because the technique of double crossover
homologous recombination with a linearized plasmid was used, eliminating
the possibility of plasmid excision. Since this method permanently deletes
part of the targeted gene, there is no way for the parasite to recover the func-
tion of the knocked out protein, even if there is some fitness defect associated
with its loss. The ability to disrupt the Pbbcdh E2 locus, but not recover a
single clone would suggest that knockout in P. falciparum may be similarly
difficult. The reticulocyte preference characterized in the P. berghei BCDH E1
knockout (Oppenheim et al., 2014) that may be shared with the E2 knockout
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would suggest that the parasite would prefer the more metabolically rich en-
vironment of a reticulocyte (Srivastava et al., 2015) in order to compensate for
loss of BCDH activity. Tissue culture work with blood stage P. falciparum does
not typically include reticulocytes, making it more difficult for the parasite to
tolerate disruption of BCDH activity, even with acetate supplementation.
Although useful comparisons can be made between human and murine
parasite species, some fundamental metabolic pathways differ in significance.
For example, phenotypes differ between knockouts of fatty acid synthesis
genes in different parasite species (van Schaijk et al., 2014; Yu et al., 2008)
and the same is true for coenzyme A synthesis genes (Hart et al., 2016; Saliba
et al., 1998). Similarly, knockout of aconitase, another enzyme of the citric
acid cycle two steps upstream of the KDH, was not described as having a
growth phenotype in P. falciparum (Ke et al., 2015), but has a severe growth
phenotype in P. berghei (Srivastava et al., 2016). In addition, the ability for
P. berghei to invade metabolite enriched reticulocytes (Srivastava et al., 2015)
may mask potential auxotrophies that are more evident in P. falciparum in
tissue culture. Because of these complications, knockout experiments must
be comprehensively performed within a species to fully understand their
respective metabolic requiements.
In addition to spontaneous plasmid excision, parasites appear to be able
hold onto a plasmid at least up to a year after removing drug pressure
(O’Donnell et al., 2001), making drug cycling a possibly fruitless endeavor.
Long term culturing of episomal populations is also problematic, as plasmids
have regulatory elements that may be homologous to dispensable genomic
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regulatory elements, allowing parasites to integrate spuriously at those loci
(López-Estraño et al., 2007). Finally, parasites appear to be able to traffic
plasmids to non-plasmid-bearing parasites via exosome trafficking (Regev-
Rudzki et al., 2013). Both individually and in combination, these confounders
contribute to unwanted uncertainty when attempting to use single-crossover,
especially when targeting genes that may be important for the parasite. This
suggests that a more targeted and robust system, like the recently success-
ful Cas9-mediated genome editing technique (Ghorbal et al., 2014; Wagner
et al., 2014) would be more successful in generating knockouts and clones
of KDH E2 and possibly the BCDH E2 in conjunction with acetate supple-
mentation. This genome editing technique forces a targeted double-strand
break and highly increases the frequency of a double-crossover homologous
recombination event that cannot later be reversed.
No attempt was made to disrupt the H protein in P. falciparum, due to the
small size of the protein’s coding region, and thus, the inability to try a single
crossover deletion. Considering the results observed in the previous chapter
in attempting the parallel knockout in P. berghei, and the apparent essentiality
of PbLipL1 (Wang et al., 2017), the enzyme responsible for lipoylating the H
protein, it would seem that the H protein locus may be refractory to knockout
in P. falciparum as well. As discussed in the previous chapters, why this
particular protein is essential is a matter for speculation.
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4.5 Future Directions
4.5.1 Interrogating canonical lipoate-dependent biochemistry
in Plasmodium falciparum
The hypothesis guiding this project was that lipoylation of at least one of
the mitochondrial substrates was essential for parasite growth. In light of the
experiments performed here, the rest of the thesis, and the current literature,
in order to turn this project into a finished publication, knockout experiments
should be performed for all members of lipoate-dependent biochemistry in
the mitochondrion: the substrates (BCDH E2, KDH E2 and the H protein), the
lipoylation machinery (LipL1 and LipL2) and the recycling subunit (the E3
subunit). Knockouts should be feasible for the BCDH, the KDH, LipL2 and
the mitochondrial E3 subunit. Knockouts should be feasible for the BCDH,
the KDH, LipL2 and the mitochondrial E3 subunit using Cas9 mediated
knockout because of the advantages discussed above. Parasite work should
be continued in a gametocyte competent line as performed above (3D7, 3D7-
GL, NF54) ) in order to preserve the ability to interrogate mosquito stage
phenotypes. Acetate supplementation should be used for these transfections,
considering the acetate dependency observed in the lipoamidase experiments.
It should also be exercised in the KDH knockout attempt as the KDH may
participate in the conversion of pyruvate to acetyl-CoA (Chan et al., 2013).
These particular knockouts should be characterized for growth against
parental lines, with and without acetate supplementation. Considering the
difficulty of getting a KDH knockout clone, it is possible that there may
be a small, but measurable growth phenotype that would provide in vivo
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evidence that the KDH complex can moonlight as a PDH. Because of this
possible phenomenon and the likelihood that the BCDH is the primary system
performing pyruvate-to-acetyl-CoA catalysis, a double knockout should also
be performed because a double knockout may be synthetically lethal, due
to the possibility that both the BCDH and the KDH can convert pyruvate to
acetyl-CoA.
Western blot and/or autogradiography should be used to confirm absence
of lipoylation by knocking out these genes: knockout of the BCDH and KDH
should result in disappearance of the lipoyation band for these respective
proteins, while knockout of the LipL2 should result in disappearance of both
the BCDH and KDH bands. This assay on the BCDH and KDH knockouts
would provide definitive evidence that the lipoylated proteins identified in
previous literature (Allary et al., 2007) are indeed the BCDH and KDH E2
subunits. Performing similar experiments with the LipL2 knockout would
strengthen the model that LipL2 is the enzyme responsible for lipoylating the
BCDH and KDH.
Biochemical work should be performed to confirm the biochemistry sug-
gested in these knockout studies. Plasmid shuffle experiments in yeast may
be the easiest way to demonstrate this, as the yeast knockout library is readily
available, yeast media reagents are available in the lab, and data should be
relatively easily generated; the experiments would only require cloning, trans-
fection of yeast and overnight growth on combinatorially variable agar plates
with various media supplements, such as acetate and branched chain amino
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acids. Yeast rescue experiments using P. falciparum homologs to rescue homol-
ogous yeast knockouts coupled to dilution series experiments can provide a
wealth of data for publication and strengthen the hypotheses regarding the
activities of the BCDH and KDH and the lipoylation enzymes. Purification
of the recombinant BCDH E1 subunit and performing kinetics and binding
assays against branched chain alpha-ketoacids and pyruvate should also be
performed to provide biochemical evidence that the BCDH can catalyze the
PDH reaction in addition to, or instead of, the BCDH reaction.
All these experiments can be performed independently of the success of
the knockouts, allowing for data generation without waiting for knockouts,
which can take weeks to transfect, clone and validate. This basic metabolic
work can be supplemented with mass-spectrometry-based metabolite analysis
in parasites using labeled glucose and glutamine for all knockouts to confirm
the affected biochemical pathways.
All the above experiments should fill in the gaps in our understanding of
mitochondrial lipoate-dependent biochemistry with in vitro confirmation of
the BCDH’s biochemistry, and in vivo evidence to confirm the biochemistry
regarding lipoylation and lipoate-dependent catalysis.
4.5.2 Interrogating non-canonical lipoate-dependent biochem-
istry
The experiments describe above should be sufficient to publish a paper
that looks at canonical lipoate-mediated catalysis. The other genes associated
with this project address what is most likely noncanonical biochemistry, and
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will thusly be exploratory in nature.
It is likely that LipL1 and the H protein will be refractory to knockout
considering the experiments attempted in this thesis in P.berghei and in the
literature. Regarding genetic work, knockdown or a novel inducible knockout
tool would be required to confirm that these genes are essential. Previous
attempts to knockdown the LipL1 using tetR repression (Wang et al., 2017)
resulted in nominal success, meaning that alternative knockdown tools need
to be used, e.g. the auxin induced degron (Kreidenweiss et al., 2013), TetR
DOZI (Ganesan et al., 2016), or the knock-sideways method (Birnbaum et al.,
2017) to more fully determine if these genes are important for parasite survival.
Western blot and autoradiography can be used here as well to observe the
hypothesized reduction in lipoylation.
Fluorescence microscopy can be used to interrogate the hypothesis that
lipoate-mediated biochemistry is important for redox homeostasis. A reporter
line has been generated to use fluorescence to determine the glutathione
redox potential in the parasite mitochondrion (Mohring et al., 2017) - this
can be used as the parental line for any or all of the genetic modifications
described above. This microscopy can be performed on live cells, adding
the possibility of challenging the different parasites knockouts/knockdowns
with various oxidative insults tosee how the loss of lipoate-related proteins
affects the response. Live or immunofluorescence microscopy can be used
with MitoTracker to see if these proteins are important for maintaining the
mitochondrial membrane potential, as demonstrated with microscopy per-
formed against parasites treated with atovaquone and proguanil (Painter et al.,
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2007). Finally, mass spectrometry can be performed on the lipoylated proteins
to see if non-canonical modifications are made on lipoate, e.g. oxidation or
nitrosylation, to see if these molecules are used as redox sinks.
Ultimately, pulldown experiments need to be performed on the H protein
in order to generate other hypotheses for the role of the H protein. This
experiment would demonstrate how much of the H protein is lipoylated,
what covalent modifications occur on the lipoate moiety, and under what
circumstances these may change, e.g. redox insult. It would also be useful to




The disruption constructs for the bcdh and the kdh were made by PCR ampli-
fying homologous regions from gDNA from the 3D7 line of parasites using
primer pairs KDH.KO.F/KDH.KO.R and BCDH.KO.F/BCDH.KO.R, respec-
tively (See Table 4.1 for primer sequences). Homologous sections of about 600
base pairs were designed to begin immediately after the nucleotides coding
for the lipoylated lysine and excluding essential regions at the end of the
catalytic domain. The homology arms also contained an in-frame stop codon
(Table 1 red text) to block translation of the downstream merodiploid copy,
even if it was spuriously transcribed. The PCR products were ligated into
the pCC1s single crossover disruption plasmid using restriction sites BglII
and XhoI, generating plasmids pCC1s-BCDHKO and pCC1s-KDHKO. PCR
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primers were used to verify integration, plasmid retention and presence of
the wild type locus.
4.6.2 Parasite Transfection and Selection
Red blood cells were preloaded with 75 µg of plasmid by electroporation and
added to the 3D7-GL, 3D7 or NF54 line. After one or two days, parasites
were selected by treatment with 5 nM WR99210. In successful transfections,
parasites would appear between 4-6 weeks of selection, at which time they
were PCR confirmed for episomal maintenance of the transfection plasmid.
Parasites were cycled on and off WR99210 (2 weeks on, 2 week off) until
parasite growth kinetics more closely mimicked that of the parental line
(parasitemia increasing by a factor of 8 per two day growth cycle) (Figure
4.2). Once genomic integration was detected by PCR, parasites underwent
single cloning through limiting dilution in 96 well plates, after which clones
were characterized for by PCR to detect the disrupted locus, the wild type
locus, and/or presence of the pCC1s plasmid.
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4.8 Tables
Table 4.1: Primers used for this project. Endonuclease sites are marked in blue text
while translational stop codons are marked in red text.
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Table 4.2: Transfection summary. Transfection success is defined as parasites coming
up before day 40 of transfection.
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4.9 Figures
Figure 4.1: Schematic of single-crossover disruption strategy. Endonuclease sites
are marked in blue text while translational stop codons are marked in red text.
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Figure 4.2: Workflow for gene disruption in P. falciparum. Parasites should be sta-
bly transfected with the single-crossover plasmid, and then selected with WR99210
for several weeks to produce resistant parasites. Parasites are then genotyped for epi-
somal plasmid retention or disruption of the locus, and then drug cycled to eliminate
parasites that lose the plasmid and enrich for parasites with plasmid integration.
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Figure 4.3: The kdh gene is disruptable. A. PCR for 5’ and 3’ integration of the plas-
mid into the KDH locus was performed on the mixed population of parasites, either
as a gDNA preparation or from a 20 µl sample from culture. The gel demonstrates
bands of the appropriate size, demonstrating integration of the entire pCC1s-KDHKO
plasmid into the KDH locus. Genomic DNA of the parental WT line (3D7-GL) and the
plasmid used for integration were used as negative controls. B. Parasite culture was of
mixed genotype. PCR was performed to determine presence of the knockout plasmid
and the WT KDH locus on the same templates used in 1A. The gel demonstrates
bands indicating presence of the plasmid and the undisrupted WT locus, showing
that the population is of mixed genotypes: WT parasites, parasites harboring the
pCC1s-KDHKO plasmid and parasites with the integrated locus as demonstrated
in the previous figure panel. This time, genomic DNA of the parental WT line and
the pCC1s-KDHKO plasmids were used as positive controls for their respective PCR
reactions.
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Figure 4.4: KDH knockout clone could not be isolated. Representative PCR of one
of the KDH KO clones, clone E1. The top half of the gel shows that clone E1 is PCR
positive for the integrated locus. The parental, mixed population was used as a
positive control. The bottom half of the gel shows that parasites are PCR positive for
both the plasmid (pCC1s-KDHKO) as well as the WT locus. This would suggest that
either the clone retrieved was not a single clone, or that the plasmid can be efficiently
excised and/or reintegrated.
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Figure 4.5: BCDH locus is refractory to targeting. A The BCDH locus was retained
in two different transfections. 3D7-GL parasites were transfected with and without
acetate supplementation, and drug cycled until parasite growth more closely resem-
bled wild type kinetics. PCR to identify the BCDH locus demonstrates that the locus
remains undisrupted in all 4 lines. Parental gDNA was used as a positive control. B
There is no PCR evidence of integration of the plasmid into the BCDH locus in any of
the four lines. Both WT gDNA and the transfection plasmid were used as negative
controls; bands that appear are likely spurious products.
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Figure 4.6: Parasite lines did not demonstrate existence of the transfection plas-
mid. A PCR was performed to determine whether parasites were maintaining the
transfection plasmid episomally. No parasite lines demonstrate evidence of harbor-
ing the transfection plasmid. The pCC1s-BCDHKO plasmid was used as a positive
control, and WT gDNA was used as a negative control.
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Chapter 5
Conclusion and Future Directions
5.1 Lipoamidase in Plasmodium
Lipoamidase experiments were used in P. falciparum as a proxy for knock-
down and knockout experiments due to the lack of effective/efficient tools
for genetic manipulation in the parasite. Whether or not this gene would
be tolerated in the parasite was unclear as expression of even the catalyti-
cally inactive mutant in E. coli is quite low and imparts a significant growth
phenotype (Spalding and Prigge, 2009). The experiments performed here
demonstrate in vivo activity and inactivation of Plasmodium proteins, and
have revealed an important role for mitochondrial lipoylation in the parasite.
The demonstrated successful use of lipoamidase in E. coli and in Plasmodium
suggests that it can be used as a tunable tool for probe lipoylation in other
organisms. This idea is strengthened by the fact that lipoamidase appears to
work against both a biosynthetic lipoylation pathway (substrate octanoyla-
tion, followed by sulfuration) and a scavenging pathway (activation of free
lipoate, followed ligation or transfer to the target protein). The experiments
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performed here demonstrate the use of different promoters and active site
mutations to tune this activity. Work in E. coli demonstrated that truncated
variants can also be used to reduce lipoamidase catalytic activity. Advances in
inducible and knockdown technology provide even more granularity to how
much lipoylation to abrogate. Any and all combinations of these methods can
be used to try to attenuate or even completely abolish in vivo lipoylation in
other model organisms, especially in ones where the lipoylation machinery or
chemistry has not been well described.
Lipoamidase expression in the mitochondrion imparts a severe growth
phenotype on blood-stage Plasmodium falciparum. This strongly suggests that
lipoylation of at least one of the mitochondrial proteins is essential for para-
site survival. The fact that acetate supplementation partially rescues parasite
growth suggests that mitochondrially generated acetyl-CoA is important for
parasite growth. There are a number of nonexclusive explanations for why
acetate supplementation does not completely restore parasite growth: con-
version of acetate to acetyl-CoA could be too slow to keep up with demand,
or acetate derived acetyl-CoA inefficiently trafficks to pathways that glucose-
derived acetyl-CoA is used for (Cobbold et al., 2013), or the H protein is
essential for a role that cannot be bypassed by acetate supplementation. Con-
sidering the difference in phenotypes observed in P. falciparum and P. berghei
in the TCA knockouts discussed in Chapter 1, it may be possible that there are
species-specific differences in requirements for the three lipoylated proteins
found in the mitochondrion. Though it has been demonstrated that the P.
falciparum KDH E1 is competent at performing PDH E1 catalysis (Chan et al.,
2013), it is not known whether this is the case in P. berghei. Thus, there may be
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redundancy of function in one parasite species that does not exist in another.
It would be interesting to observe lipoamidase expression in P. berghei.
There has not been experimental evidence to confirm that P. berghei also scav-
enges lipoate for mitochondrial lipoylation, and considering the number of
different phenotypes observed in related pathways (e.g. the LipB knockout
resulting in increased BCDH lipoylation in P. berghei but not P. falciparum
(Falkard et al., 2013; Günther et al., 2007)) it remains a formal possibility that
abrogating lipoylation in the murine parasite may result in different pheno-
types than that observed in P. falciparum. This is also somewhat complicated
by the fact that metabolic flux in a mouse is not identical to that of a flask,
and that includes the steady level of acetate in blood that is not present in
parasite culture media. This then remains an experimentally challenging
task, as specifically radiolabeling parasites in a mouse is a hard target, and so
multiple experiments, such as lipoamidase expression, ex vivo radiolabeling,
and a panoply of knockouts, would be required to determine the importance
of lipoylation in P. berghei, including the possible immunological or other
non-biochemical consequences of ablating lipoylation.
Additionally, experiments in murine models would allow us to interro-
gate the phenotypes of lipoamidase expression during the parasite’s other
stages, e.g. gametocytes, insect stages, etc. The parasite appears to take on
a more auxotrophic mode as it leaves the asexual blood stage, so it would
be curious to see how this affects lipoate-mediated metabolism. It is unclear
whether there is sufficient lipoylated protein to support parasite development
from gametocyte to sporozoites, so the necessity of lipoate salvage for the
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mitochondrial proteins is in question. Some FLP-FRT experiments have been
successfully performed in Plasmodium (Choudhary et al., 2018; Kublin et al.,
2017; Lacroix et al., 2011), so setting up a stage-specific knockout could address
these questions. Fragmentary information suggests that protein lipoylation
is essential for parasite development during the mosquito stages. Failure of
the ∆PDH E1 in P.falciparum to produce sporozoites demonstrates that lipoate
synthesis and apicoplast metabolism are essential for mosquito stage devel-
opment (Cobbold et al., 2013). Similarly, ∆KDH E1 P. falciparum parasites fail
to form viable sporozoites (Ke et al., 2015), suggesting that both apicoplast
and mitochondrial lipoate metabolism (and lipoate scavenging) may also be
required for development during these stages.
5.2 Mitochondrial lipoylation is essential in Plas-
modium
Obviously, knocking out or knocking down the lipoate attachment en-
zymes, LipL1 and LipL2, would strengthen the hypothesis that these are
indeed the machinery responsible for mitochondrial lipoylation. The inher-
ent problem with knock out experiments is that the genetic tools to generate
conditional knockouts don’t yet exist for P. falciparum. Thus, successful knock
out of an essential gene does not result in viable parasites. Knock down
methods exist, however, the limited dynamic range of these methods would
not allow complete elimination of a particular protein target or its activity.
A metabolic bypass was attempted in the lipoamidase experiments, but this
bypass has limited effect, suggesting that complete ablation of mitochondrial
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lipoylation would likely kill the parasite. As such, it would likely be that these
genetic experiments would ideally be coupled to other experiments, such as
the development of LipL1/LipL2 inhibitors to confirm our hypothesis, e.g. a
LipL1 knockdown experiment coupled to 8-bromooctanoate treatment to see
if there is a synergistic effect in inhibiting parasite growth. These experiments
would have the added benefit of validating a potential new drug target for
therapeutic intervention.
It is most likely the case that blood-stage Plasmodium parasites require
mitochondrially-derived acetyl-CoA. Acetyl-CoA is a ubiquitous metabolite,
serving as a metabolic intermediate or precursor for many basic metabolites,
and is also one of the chief means of protein regulation. Acetyl-CoA is typi-
cally derived through the pyruvate dehydrogenase (PDH) pathway, and in
eukaryotes, this activity exists in mitochondria. This is probably also the case
for malaria parasites; however, the best candidate enzyme in the mitochon-
drion was bioinformatically described as a BCDH (branched chain amino
acid dehydrogenase) involved in the metabolism of branched chain amino
acids. The apicoplast resident PDH was thought to be the only bona fide
PDH (Foth et al., 2004) . Work done here and elsewhere (Cobbold et al., 2013;
Oppenheim et al., 2014) suggests that if the apicoplast PDH is generating
acetyl-CoA during the blood stage, it is of little consequence to the parasite as
a whole. Instead, the mitochondrial enzyme annotated as the BCDH appears
to function as a PDH in P. berghei (Oppenheim et al., 2014). If this is also the
case in P. falciparum, it provides an excellent explanation for why inhibition of
this enzyme by lipoamidase is rescued by acetate supplementation.
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It will be very interesting to determine the role of the H protein in the
parasite mitochondrion. Research in our lab and other investigators have so
far failed to knock out the H protein (Varadarajan et al., 2014) and H proteins
are typically described as part of a glycine cleavage system, such as that found
in E. coli. The genomes of malaria parasites do not appear to encode two of the
other enzymes needed for glycine cleavage activity, suggesting that there is a
different role for this protein in malaria parasites. LipL1 only lipoylates the H
protein under relatively oxidizing conditions, suggesting that the role of the
H protein is associated with oxidative conditions. One thought is that the H
protein is involved in an oxidative defense mechanism similar to that recently
observed for the H protein from T. vaginalis (Bryk et al., 2002). Pulldown of
the H protein would be informative not only to see what other proteins may
interact with it, but to also interrogate what modifications may exist on the
lipoate moiety. As mentioned in previous chapters, it is difficult to detect
lipoylated H protein in Western blots, and this could be due to a chemical
modification, such as oxidation of the lipoate sulfur to sulfate or sulfone,
nitrosylation, etc. Performing pulldowns under various conditions, such as
high parasitemia, rings vs. schizonts, under drug pressure, etc., may help to
support the oxidative defense hypothesis.
Ultimately it would also be interesting to understand why protein lipoyla-
tion in the mitochondrion of malaria parasites is gated by redox conditions.
This phenomenon has not been observed in any other organisms and it may
be connected to an overall response to the different redox environments that
malaria parasites encounter during their overall life cycle. As mentioned in
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Chapter 1, the parasite’s serine hydroxymethyltransferase, which is essential
for folate-based single carbon metabolism, appears to have a redox switch
that controls its function. In the apicoplast, the acyl carrier protein appears
to dimerize under oxidative conditions (Gallagher and Prigge, 2009). These
proteins, which are located in different subcellular compartments, may help
malaria parasites to respond to redox conditions by altering various metabolic
pathways. Although this would be a long term project, it would be interesting
to see if parasites have a global metabolic response - one program under an
oxidative environment and another program for a reductive environment. It
would then be interesting to overlay this paradigm against the multiplicity of
host environments the parasite encounters, and what their respective redox
environments contribute.
5.3 Apicoplast lipoylation is dispensable in blood-
stage Plasmodium
It is maddening that no experiment has completely abolished lipoylation
in the parasite apicoplast. In the lipoamidase experiments, it is possible that
this stubbornly persistent signal is crossreactivity against the octanoylated,
and not lipoylated, PDH E2 subunit. However, this does not explain why
the PDH E2 subunit remains somewhat lipoylated in the octanoyl transferase
knockout (∆LipB) experiments (Falkard et al., 2013; Günther et al., 2007). The
possible dual localization of LipL2 (Günther et al., 2009) is an explanation,
although not a satisfactory one, to explain this phenomenon. A combination of
knockouts, e.g. LipB and LipL2, may confirm or refute this analysis, although
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the potential growth defect of the LipL2 knockout would have to be comple-
mented with acetate supplementation. Knockout of the PDH E2 subunit has
not yet been described, but this deletion should remove all lipoylated protein
in the apicoplast; any residual signal in a ∆PDH E2 line would reveal the
presence of a novel lipoylated apicoplast protein. Finally, the question of how
octanoate is derived for apicoplast lipoate synthesis exposes a lack of clarity
regarding parasite fatty acid synthesis. Blood stage parasites don’t seem to
make fatty acids and don’t have a biotinylated ACC (Acetyl-CoA Carboxylase)
to generate the carbon source (malonyl-CoA) for synthesis (Delli Bovi, et al in
press).
There may be some explanation in the other pathway that involves pyru-
vate. Pyruvate in the apicoplast appears to have two fates: either consumption
by the PDH pathway, or consumption into the isoprenoid pathway. As men-
tioned above, it seems that the PDH is not consuming much pyruvate, so
pyruvate is likely primarily consumed in isoprenoid biogenesis. Isoprenoids
are a multifunctional precursor for many products in Plasmodium, with likely
essential roles in farnseylation (Gisselberg et al., 2017a) and geranylation
(Gisselberg et al., 2017b). There is some evidence that apicomplexans may
generate plant like molecules from isoprenoids, such as gibberilic acid, absicic
acid, and isopentenyl adenine (Andrabi et al., 2018), which have been impli-
cated as growth factors in Plasmodium and Toxoplasma. The different growth
phenotypes observed in the P. falciparum LipB, PDH E1 and E3 knockouts
(Cobbold et al., 2013; Günther et al., 2007; Laine et al., 2015) may be a result
of disrupted pyruvate flux in the parasite: with no pyruvate exiting through
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the PDH pathway, more pyruvate is available for the isoprenoid generation
pathway, possibly overloading downstream products. This may then result
in more secretion of these isoprenoid based molecules that affect quorum
sensing in the parasite. Interestingly, some isoprenoid cursors have also been
implicated in inducing increased mosquito attraction (Emami et al., 2017). It
would be interesting to then see the variety of these knockouts in mosquito
feeding assays both in a blood bag and through a mouse to see what contribu-
tion isoprenoid precursors have in mosquito attraction during the blood stage,
and if PDH/LipB knockouts demonstrated increased mosquito feeding.
However, this does not address the function of the PDH in the blood stage
of the parasite. It is still unclear how and why the parasite produces the PDH
complex and activates the E2 subunit with lipoylation during the blood stage.
Although it is possible that this entire arsenal of proteins is completely dis-
pensable in the blood stage of the parasite, the varying phenotypes mentioned
above and the inability to completely ablate E2 lipoylation suggest that these
proteins have some blood stage role, but require more stringent interrogation
outside of gross growth phenotypes.
5.4 Conclusion
Although lipoylation is an uncommon and poorly studied posttranslational
modification, it is an essential basic biochemical in most forms of life. The
work presented in this thesis and the work presented in the field present a
coarse perspective on the role of in the parasite, where its canonical role in
generating acetyl-CoA is likely conserved throughout the parasite’s lifecycle
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through the mitochondrion and occasionally through the apicoplast via their
respective PDH’s, and in generating succinyl-CoA outside of the blood-stage
via the KDH. Secondary, noncanonical roles likely exist for these proteins as
well, most likely in redox balance. Fully delineating these roles would help
understand parasite biology better, potentially provide further drug targets,
and provide greater insight to noncanonical/arcane/ancient biochemistry
that has not yet been observed in other life.
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Chapter 6
Appendix I: Improving yield of 35S
lipoate
6.1 Abstract
Our lab has had previous success in generated radiolabeled lipoate, but
yield of radioactive material per preparation average around 1%. Poor yield
results in long exposure times, and coupling this to the short half-life of sulfur-
35 make radiolabeling experiments cost prohibitive. The experiments in this
project attempted to improve this yield, and ultimately, it was determined
that re-use of spent bacterial media improves yield to approximately twice
as much as before. Experiments are ongoing to see if yield can be improved
further.
6.2 Introduction
Radiolabeled lipoate is particularly useful for demonstrating whether cells
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import lipoate and for visualizing the fate of scavenged lipoate. Lipoylated
proteins can also be observed by western blot with an anti-lipoate antibody,
however, this method cannot discriminate between scavenged and synthe-
sized lipoate. Unfortunately, there are no vendors who sell radiolabeled
lipoate, so methods are required to synthesize it. Chemical synthesis of
75Se-labeled lipoate have been described (Reed et al., 1994) but this method
produces a racemic mixture of R and S lipoate, whereas cells specifically syn-
thesize and use the R stereoisomer. In our method, we harness the ability of E.
coli cells to synthesize R-35S-lipoate.
Work in our lab has established a protocol to generate radiolabeled lipoate
(Figure 1) (Allary et al., 2007). First, we express a recombinant, truncated,
His-tagged E.coli H protein with a C59S mutation that can be lipoylated by the
E.coli lipoylation machinery. These constructs are expressed in the B834(DE3)
strain of E. coli, which are methionine auxotrophs, grown in in minimal media,
with the only sulfur source coming from exogenously supplied methionine in
order to limit sulfur metabolism. Octanoate is provided for facile attachment
by the endogenous EcLipB to octanoylate the H protein, and exogenous iron
and radiolabeled sulfate is provided for the sulfuration of the octanoyl group
to a lipoyl moiety. The bacteria also expresses an exogenous, iron sulfur
cluster biosynthesis operon from A.vinelandii to facilitate iron sulfur cluster
biogenesis to facilitate the sulfuration reaction. The protein is then affinity
purified (Figure 2), TCA precipitated, and then acid hydrolyzed to liberate
the lipoate from the purified protein. The hydrolyslate is then assayed for
radioactivity to determine radioactive yield, which is typically well below 1%
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of the supplemented radioactive sulfur .
Prior attempts made to improve yield include changing protein induction
timing, changing the carbon source or other nutrients, and adjusting the time
of acid hydrolysis. None of these changes improved yields past the average
of 1%. Several other experiments were done to see if yield can be improved,
and the most significant improvement in yield comes from re-using the spent
media.
6.3 Results
6.3.1 Determining maximum theoretical yield
Previous work did not determine whether higher yields of lipoate could
be obtained using this method. In order to determine if >1% yield was even
theoretically possible, E. coli was grown in minimal media and in rich, TB
(terrific broth) medium and protein yields were determined (Table 1). After
acid hydrolysis, hydrolysates were supplemented with a strain of E. coli reliant
on scavenged lipoate for optimal growth to approximate the bioavailable free
lipoate from these preparations. This method was used as a surrogate for
using radiolabeled sulfur due to cost considerations, and previous experi-
ments indicate that comparative yield using radiolabeled sulfur result in a
concentration of 2 nM lipoate.
Protein yields between TB and minimal media were reasonably equivalent,
but the amount of bioavailable lipoate from TB when normalized to protein
yield was at least forty times higher than any other experiment listed in Table
1. These data indicate that under optimal conditions, the recombinant protein
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can be lipoylated significantly more than previously described, but only to 1%
of the total protein.
6.3.2 Testing induction and incubation times and tempera-
tures
The current protocol for purification is a stepwise induction, followed by
treatment with radiolabeled sulfate and shaking at 20◦C for 10 hours, followed
by a 4◦C incubation until the culture can be harvested (typically the next day).
It was thought that this protocol might allow for more facile expression and
lipoylation of the H protein.
Considering the poor lipoate yield, the temperatures and times for induc-
tion and incubation were changed to see if superior yield was possible. In
addition, pseudo-anoxic incubation was also tried because of the sensitivity
of iron sulfur clusters to air. Samples for each condition were taken and run
on Western blots using the anti-lipoate antibody to look for relative lipoylated
protein.
Results in Figure 3 show that protein induction and lipoylation is some-
what nominal under nearly all conditions, as expression under multiple con-
ditions show that exogenous, lipoylated H protein levels are not higher than
the endogenous lipoylated proteins. Bands for the H protein appear relatively
similar in lysates after 4◦C induction, even though Ponceau staining shows
significantly more loaded protein in the lanes with 4◦C induction. This may
mean that a 4◦C incubation after induction may not improve, and may reduce,
the yield of lipoylated protein.
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6.3.3 Reusing spent media allows for two, sequential protein
preps
Multiple runs suggest that E. coli only takes up approximately one-third of
the added radiolabeled sulfur in the media. In order to test if this sulfur was
still available for our use, the spent bacterial media was fully restored with
minimal media components and used again for protein expression. Figure
4 shows that re-use of bacterial media provides comparable uptake and pro-
duction of lipoylated H protein. One attempt was made to reuse this media a
third time, but negligible radioactivity was taken up.
6.4 Discussion
The expense, hassle and quick half-life of producing 35S-labeled protein
necessitates optimizing yield. Reusing the media effectively doubles the
yield of the previous protocols, which is a massive improvement. However,
expression under optimal conditions demonstrates that lipoylation (and not
protein expression or octanoylation) is the true limiting factor in producing
radiolabeled lipoate.
The purified H protein fraction typically shows up as a doublet (Figure 2).
There are three potential products in this fraction: the unmodified H protein,
the octanoylated H protein and the lipoylated H protein. SDS-PAGE might
be able to resolve the charge difference between a the apoprotein with a free
lysine residue, and its octanoylated (or lipoylated) species (Christensen and
Cronan, 2010; Morris et al., 1995). (Christensen and Cronan, 2010; Morris et
al., 1995). Considering the poor sensitivity of Coomassie staining and the poor
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yield of lipoate in our reactions, it is possible that the two bands observed
during purification are the apo-H protein and the octanoylated H protein.
This would suggest that while the protein is readily octanoylated, the severely
limiting step is the sulfuration of the octanoate to lipoate. It should be noted
that it remains a formal possibility that the yield of bioactive lipoate (lipoate
detectable in our bioassay) is lost primarily during the acid hydrolysis step.
However, similar experiments in producing radiolabeled biotin would suggest
that this is not the case (Delli-Bovi et al., 2010).
The lack of significant sulfuration may be due to poor iron or sulfur mobi-
lization by E. coli, insufficient iron sulfur cluster generation by the A. vinelandii
operon, or poor activity of the E. coli sulfuration enzyme, LipA. Experimenta-
tion with time and temperature suggest that these variables have limited effect
on improving lipoylation, so allowing extra time for endogenous processes
like iron/sulfur mobilization or cluster biogenesis does not seem to generate
significantly more product. The data from Figure 3 may suggest that the
4◦C incubation may be reducing yield as signal for the lipoylated, exogenous
protein is not significantly higher, even though the signal for the endogenous
lipoylated proteins is. This could also be explained by increased lipoylation
of the endogenous substrates as a response to the cold, or possible oxidative
damage of the H protein’s lipoyl moiety, reducing the amount of antibody-
recognizable lipoate. In any case, it would seem that yield and time efficiency
favors a 37◦C induction for 4 hours with no post-induction incubation.
Multiple groups have used the A. vinelandii operon to produce sufficient,
iron sulfur cluster using proteins (Delli-Bovi et al., 2010) for assays (Seravalli
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and Ragsdale, 2008) and structural studies (Fenwick et al., 2015), suggesting
that there should be sufficient iron sulfur clusters available. This points to
the sulfuration step being the only likely and actionable step to improve
yield of lipoylated protein. Previous work in our lab has successfully used
the P. falciparum homolog of the E. coli LipA to successfully sulfurate E.coli
substrates in vivo. This would suggest that expressing this homolog in the H
protein expression line should improve lipoylation. Work is currently being
performed to get this underway.
6.5 Methods
6.5.1 General expression protocol
E. coli H protein was expressed and purified as previously described (Allary
et al., 2007). Briefly, methionine auxotroph E.coli B834(DE3) was transformed
with plasmid expressing the truncated, His-tagged E. coli H protein with the
C59S mutation to remove all cysteines from the coding sequence (pLZ003) and
the pDB1292 plasmid expressing the A. vinelandii iron sulfur cluster biogenesis
operon. Cultures were initially shaken at 37◦C in 10 mL minimal media (58
mM K2HPO4, 29.7 mM NH4Cl, 16.7 mM NaH2PO4, 0.83 mM MgCl2, 9.5 mM
citric acid) supplemented with 0.4% (w/v) glucose, 100 µM FeCl3, 500 µM
methionine, 50 µg/ml kanamycin and 100 µg/ml carbenecillin. Exogenous
EcH protein expression was induced with 0.4mM IPTG at OD=0.8, followed
by supplementation to 50 µM sodium octanoate and 0.01% arabinose one hour
later, and finally 2-3mCi of Na 35SO4 one hour after that. The culture was
then transferred to a 20◦C incubator and shaken for 10 hours. Cultures were
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pelleted and lysed in 2 mL BugBuster supplemented with 1 mg/mL lysozyme
and 2.5 µg/mL DNAseI.
6.5.2 Column purification protocol
The following buffers were prepared: Buffer A (20 mM NaH2PO4, 20 mM
K2HPO4, 200 mM NaCl, pH 7.5), Buffer B (20 mM NaH2PO4, 20 mM K2HPO4,
pH 7.5), and Buffer C (20 mM NaH2PO4, 20 mM K2HPO4, pH 5.0).
After BugBuster lysis, the E. coli lysate was centrifuged at 13,000 xg, and
the supernatant was loaded onto a nickel column connected to a benchtop
peristaltic pump (Dynamax RP-1) and the entire purification was run at
0.6mL/minute. The column was then washed with 7.5 mL Buffer A; this
fraction was collected and labeled FT1 (flowthrough 1). The column was
eluted with 5 mL 10 mM imidazole in Buffer A, 2 mL 30 mM imidazole in
Buffer A and 4 mL 50 mM imidazole in Buffer B. This 11 mL fraction was
collected and labeled W1 (wash 1). The Q column was then connected to the
nickel column output, and 5mL of 400 mM imidazole in Buffer B was added,
followed by 5mL of Buffer C to transfer the nickel purified protein onto the Q
column. This fraction was collected and labeled FT2 (flowthrough 2).
The nickel column was then disconnected, and the Q column was attached
directly to the peristaltic pump. The Q column was then eluted into the
following fractions: 3 mL Buffer C, 150 mM NaCl (E1), 1 mL Buffer C, 300
mM NaCl (E2), 1 mL Buffer C, 300 mM NaCl (E3), 1 mL Buffer C, 500 mM
NaCl (E4), 1 mL Buffer C, 500 mM NaCl (E5), and 3 mL Buffer C, 500 mM
NaCl (E6). The purified protein typically eluted in fractions E4 and E5, and
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protein precipitated in these fractions by addition of 111 µL 100% ice-cold
TCA to E4, followed by centrifugation at 4C for 5 minutes. The supernatant
was removed, E5 was added to the tube, along with 111 µL 100% ice-cold TCA,
followed by centrifugation at 4C for 5 minutes. Supernatant was removed,
pellets were resuspended in 200 µl 5 M HCl and incubated at 95C for 4.5 hours.
The hydrolysate was neutralized with 100 µL 1 M K3PO4, 1 µL 0.02% phenol
red was added, and the solution was titrated with 10 M NaOH until phenol
red transitioned from a pale yellow color to red. Samples were taken at each
step for scintillation counting to observe radioactivity yield.
6.5.3 Culture modifications
To determine maximal theoretical yield, 20ml TB media was used instead of
10ml minimal media described above. All other steps remained the same,
except for substitution of radiolabeled sulfate for 40 µM cold sodium sulfate,
which is in large excess compared to 2mCi radiolabeled sulfate. Other at-
tempts as demonstrated in Table 1 include doubling the media volume, later
induction, and substituting glycerol for glucose.
In order to restore spent bacterial media for re-use of radiolabeled sulfur,
spent media was treated as if it were water and supplemented to the minimal
media composition described above, including glucose, FeCl3, methionine,
kanamycin and carbenecillin. Otherwise, these cultures were subsequently
treated identically to freshly prepared cultures for protein purification.
To assay the effect of induction time, temperature and incubation times
on protein lipoylation, multiple identical cultures were transferred to the
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various conditions as described in Figure 3. Pseudo-anoxic conditions were
performed by tightly closing the cap on the culture tube. Samples were taken
at the noted points, pelleted, and lysed by resuspension in 4X NuPAGE buffer,
vortexed for one minute, and boiled for 10 minutes. Samples were resolved
by SDS-PAGE, transferred to a nitrocellulose membrane, and probed with
a rabbit anti-lipoate antibodies followed by an anti-rabbit HRP secondary
antibodies. The blot was treated with ECL reagents, covered with saran wrap
and exposed to film.
6.5.4 Determining bioavailable lipoate
Assaying the bioavailable hydrolysate was performed as previously described
(Allary et al., 2007). E.coli deficient in lipoate biosynthesis (KER176) and reliant
on lipoate scavenging for optimal growth was used to determine the levels of
bioavailable lipoate. Bacteria were grown in various, known concentrations
of lipoate to draw a standard curve of absorbance at 595nm vs. concentration
of lipoate. 10µl and 50µl samples of hydrolysates were used to get an average
approximation of bioavailable lipoate against the standard curve.
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Figure 6.1: Workflow for EcH protein purification The truncated his-tagged H pro-
tein is on a pET28 vector with a C59S mutation to eliminate all sulfur bearing
amino acids except for the first methionine. pDB1282 is the plasmid that hold the
A.vinelandii iron sulfur cluster biogenesis machinery. The B834(DE3) strain of E.coli is
an expression competent strain that is auxotrophic for methionine to mitigate sulfur
consumption for methionine. IPTG induces H protein expression, while arabinose in-
duces the A.vinelandii operon. Cultures are also supplemented with excess octanoate,
iron and sulfur to facilitate lipoylation. Bacteria is then pelleted and lysed, after which
the supernatant is run through a nickel and Q column to purify the his-tagged H
protein. The protein is then TCA precipitated, acid hydrolyzed for 4.5 hours, and
then the hydrolysate is neutralized to prevent further degradation of lipoate.
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Figure 6.2: Representative gel of H protein purification Gel shows fractions from
purification through the nickel and Q columns. The bands in elution fractions E4
and E5 are a doublet, that is likely the unmodified H protein and the octanoylated
H protein. Coomassie staining indicates yield is reasonable, as shown in Table 1. It
is worth noting that bands of similar molecular weight are apparent in the lysate,
further indicating competent expression of the protein.
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Figure 6.3: Temperature and time of induction and incubation do not generally
affect H protein lipoylation Samples taken at different induction points were pro-
cessed for Western blotting. The preinduction lysate demonstrates no evidence of the
truncated, lipoylated, exogenous H protein. Note that amount of lipoylated protein
does not change after 4◦C incubation, even though signal of the endogenous lipoy-
lated proteins is increased. This increase may be commensurate with the increased
protein loaded as demonstrated by the corresponding Ponceau stain of the membrane.
The higher molecular weight bands correspond to the endogenous lipoylated proteins
of E.coli: the PDH E2, the KDH E2 and the H protein, in descending molecular weight
order.
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Figure 6.4: Label incorporation is very poor, but spent media can be reused Nor-
malized graph of Log CPM of samples taken at each step of purifying the 35S radiola-
beled H protein. The difference between elution fractions E4 and E5 are approximately
3 logs lower than the starting radioactivity levels, indicating catastrophic loss of ra-
dioactivity. Data suggests that using spent media provides about the same amount of
product as the first attempt, increasing the total yield by a factor of two. Data for 3
mCi worth of radioactivity shows some higher loss of product during purification,
suggesting 2mCi is sufficient for use.
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6.8 Tables
Table 6.1: Use of TB media shows maximum lipoylation conditions are still very
low Various attempts to improve yield include more media volume, changing media
components and OD at induction. Tests suggest that initial conditions are likely
optimal for minimal media. Insufficient lipoylation in media that provides heavy
excess of nutrients (TB media) suggests the bottleneck for producing lipoylated




7.1 Host Biotin is Required for Liver Stage Devel-
opment in Malaria Parasites
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Acetyl-CoA carboxylase (ACC) is a biotin-dependent enzyme that is
the target of several classes of herbicides. Malaria parasites contain a
plant-like ACC, and this is the only protein predicted to be biotiny-
lated in the parasite. We found that ACC is expressed in the apicoplast
organelle in liver- and blood-stage malaria parasites; however, it is
activated through biotinylation only in the liver stages. Consistent
with this observation, deletion of the biotin ligase responsible for
ACC biotinylation does not impede blood-stage growth, but results in
late liver-stage developmental defects. Biotin depletion increases the
severity of the developmental defects, demonstrating that parasite
and host biotin metabolism are required for normal liver-stage
progression. This finding may link the development of liver-stage
malaria parasites to the nutritional status of the host, as neither the
parasite nor the human host can synthesize biotin.
acetyl-CoA carboxylase | apicoplast | holocarboxylase synthetase |
biotin ligase | Plasmodium
Biotin is an essential metabolite in all known free-living organ-isms. It functions as a CO2 carrier in carboxylation and de-
carboxylation reactions catalyzed by a small family of enzymes, the
biotin carboxylases (1). Biotin carboxylases participate in central
metabolic processes such as gluconeogenesis, lipogenesis, amino
acid metabolism, and energy transduction (2). Bacteria, plants, and
some fungi can synthesize biotin de novo from a pimeloyl-CoA
precursor, but other organisms acquire biotin from their diet or
environment (3). Regardless of how biotin is acquired, a dedicated
ATP-dependent biotin ligase, or holocarboxylase synthetase (HCS),
is required to catalyze the covalent attachment of biotin to a spe-
cific lysine in the target carboxylase (4).
Acetyl-CoA carboxylase (ACC) is the only protein predicted
to be biotinylated in the parasite (5). ACC enzymes, the most
common member of the biotin carboxylase family, are found in
most living organisms and catalyze the first and rate-limiting step
in fatty acid synthesis (FAS) (6). The Plasmodium ACC resem-
bles the homomeric ACC found in the chloroplasts of grasses in
that it contains three functional domains expressed as a single
large polypeptide (7), and localizes to a plastid organelle called
the apicoplast (8). The ACC orthologs that function in the plant
chloroplast are common targets for herbicides (1). Some of these
inhibitors have been tested against blood-stage malaria parasites
(9), but it was shown that any growth inhibition observed with
these compounds is the result of off-target effects, as Plasmo-
dium falciparum ACC can be disrupted (8). ACC has two cata-
lytic domains: a biotin carboxylase (BC) domain that transfers
CO2 from bicarbonate to biotin and a carboxyltransferase (CT)
domain that transfers CO2 from biotin to acetyl-CoA to generate
malonyl-CoA. A third domain, known as biotin carboxyl carrier
protein (BCCP), contains the conserved lysine to which biotin is
attached. Biotin functions as a swinging arm to transfer the CO2
moiety between the active sites of the BC and CT domains (1). The
enzymatic domains of PlasmodiumACC have not yet been studied,
but it has been shown that the BCCP domain of P. falciparum is
biotinylated when expressed in Escherichia coli (10).
Malaria parasites contain a type II FAS (FASII) pathway in
the apicoplast (11) that relies on malonyl-CoA as the two-carbon
subunit for fatty acid elongation (12). Gene KOs of FASII
pathway enzymes in the rodent parasites Plasmodium yoelii and
Plasmodium berghei demonstrated that the FASII pathway is
required for normal liver-stage development, but not for blood-
or mosquito-stage development (13, 14). Thus, ACC and biotin
should be required in the liver stages to provide malonyl-CoA for
downstream FASII pathway enzymes. Consistent with this idea,
pyruvate dehydrogenase, which produces acetyl-CoA, the sub-
strate of ACC, has also been shown to be critical for liver-stage
development in P. yoelii (15).
Biotin metabolism may also be important for other stages of
parasite development. Malaria parasites appear to encode enzymes
comprising a fatty acid elongation (ELO) pathway similar to that
described in the apicomplexan parasite Toxoplasma gondii (16).
As is the case for typical ELO pathways (17), enzymes of the
T. gondii ELO pathway are associated with the ER membrane and
use malonyl-CoA as a substrate (16). P. falciparum parasites lacking
a functional FASII pathway can still elongate fatty acids, possibly
because of the activity of the ELO pathway (14). If malonyl-CoA
can cross the apicoplast membranes, ELO as well as FASII could
depend on ACC activity and biotin metabolism.
Perhaps the most unusual feature of biotin metabolism in
malaria parasites is the presence of two HCS paralogs encoded
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in the genomes of Plasmodium species. Plant cells also contain
two HCS paralogs (18), and HCS activity is partitioned among the
three compartments in which biotin-dependent carboxylases are
found: the mitochondria, chloroplasts, and cytosol (19, 20). In
Arabidopsis thaliana, alternative splicing governs the production of
multiple AtHCS1 isoforms that are targeted to different com-
partments in the cell (21). Multiple isoforms of AtHCS2 are also
produced, but these do not appear to have HCS activity, and
deletion of the AtHCS2 gene has no observable phenotype in A.
thaliana (21). We sought to determine the role of biotin across the
malaria life cycle, including how biotin is acquired, the activity and
localization of the biotin ligases, and the consequence of dis-
rupting biotin metabolism in malaria parasites.
Results
ACC Is Located in the Apicoplast in Liver and Blood Stages but Is Not
Biotinylated During the Blood Stages. ACC is the only predicted
biotin-dependent enzyme in the Plasmodium genome. ACC has
previously been localized to the apicoplast in blood-stage P. falci-
parum (8), but the localization has not been confirmed in the other
stages of the parasite life cycle or in other Plasmodium species. We
localized ACC in liver-stage P. berghei through immunofluores-
cence microscopy of infected HepG2 human liver cells by using
antibodies directed against the BCCP domain of PfACC (10). We
found that BCCP colocalizes with an apicoplast marker, the acyl
carrier protein (ACP), indicating that endogenous PbACC resides
in the apicoplast in liver-stage parasites (Fig. 1A).
ACC enzymes are only active when covalently modified by
biotin. To determine whether PbACC could be biotinylated in
the liver stages, we performed immunofluorescence microscopy
of HepG2 cells infected with P. berghei by using antibodies
against biotin. We observed that biotin colocalizes with the
apicoplast marker ACP, indicating that biotinylated proteins
reside in the apicoplast in liver-stage malaria parasites (Fig. 1B).
We next looked at ACC expression and biotinylation in blood-
stage P. berghei by using immunofluorescence analysis with an-
tibodies specific to BCCP and biotin. We found that PbACC is
expressed in the apicoplast in blood-stage parasites (Fig. 1C), but
we were unable to detect any biotinylated proteins in the blood
stages (Fig. 1D). Thus, ACC is expressed in the apicoplast in
blood- and liver-stage malaria parasites, but appears to be bio-
tinylated only in the liver stages.
To determine whether endogenous ACC is biotinylated in
blood-stage P. falciparum, we performed immunofluorescence
analysis of Dd2attB parasites by using antibodies specific to BCCP
and biotin. We could detect ACC in the apicoplast, and, in some
experiments, ACC protein appeared to be proximal to the apicoplast
as well (Fig. 1E). This phenomenon was also observed in P. berghei
and may reflect slow kinetics of trafficking such a large protein
(∼3,000 aa). We could not detect any biotinylated protein in
P. falciparum because there was no significant signal above the
background autofluorescence observed for uninfected red blood
cells (Fig. 1F). These results indicate that, as in P. berghei, PfACC
is expressed but not biotinylated in the blood stages, and raise the
possibility that ACC activity is regulated through stage-specific
biotinylation.
To investigate the requirements for ACC trafficking to the
apicoplast, we expressed the first 115 residues of PfACC (con-
taining the putative targeting domain) fused to a C-terminal
GFP tag in Dd2attB parasites. We found that ACC-GFP local-
izes to an elongated, branched organelle distinct from the mi-
tochondrion, which is consistent with apicoplast morphology (SI
Appendix, Fig. S1A), and colocalizes with the apicoplast marker
ACP (SI Appendix, Fig. S1B). We also observed that the fusion
protein was processed normally after import into the apicoplast
(SI Appendix, Fig. S1C). Taken together, these results demon-
strate that the ACC leader peptide is sufficient to direct the
protein to the apicoplast in blood-stage P. falciparum.
HCS1 and HCS2 Localize Primarily to the Cytosol. We identified two
biotin ligase paralogs (HCS1 and HCS2) in the Plasmodium
genome. At least one of these enzymes should be responsible for
catalyzing the biotinylation of PbACC; however, neither was
predicted to localize to the apicoplast by targeting algorithms. To
determine the subcellular location of the two biotin ligases in P.
berghei, we tagged both genes with GFP through single cross-over
recombination (SI Appendix, Fig. S2). Immunofluorescence
analysis demonstrated that the GFP-tagged proteins are not
predominantly located in the apicoplast in liver-stage or blood-
stage parasites (SI Appendix, Fig. S3). Because of its size, the
GFP tag may alter protein trafficking and subcellular location.
To address this possibility, we generated HA-tagged parasite
lines through double cross-over recombination (SI Appendix, Fig.
S4). Consistent with the results from the GFP-tagged lines, the
Fig. 1. ACC is expressed in the apicoplast and is biotinylated only in liver-
stage parasites. (A) Immunofluorescence analysis of HepG2 cells at 48 hpi
with P. berghei showing colocalization of PbACC, labeled with antibodies
specific to the BCCP domain of ACC (αBCCP), with the apicoplast marker
αACP. The nuclei are labeled with DAPI. (B) Immunofluorescence analysis
similar to A showing colocalization of biotinylated proteins (αbiotin) with
the apicoplast marker αACP. (C) Immunofluorescence analysis of blood-stage
P. berghei showing colocalization of PbACC (αBCCP) with the apicoplast
marker αACP. (D) Immunofluorescence analysis of blood-stage P. berghei
showing no detectable biotinylated protein (αbiotin). (E) Immunofluores-
cence analysis of blood-stage P. falciparum showing colocalization of PfACC
(αBCCP) with the apicoplast marker αACP. (F) Immunofluorescence analysis
of blood-stage P. falciparum showing no detectable biotinylated protein
(αbiotin) compared with an uninfected control. (Scale bars: 5 μm.)
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HA-tagged proteins do not have obvious apicoplast colocaliza-
tion (Fig. 2). This was true at different time points during liver-
stage development (24, 48, and 56 h) and during blood-stage
development (Fig. 2C).
We also localized the two biotin ligase paralogs in blood-stage
P. falciparum. We overexpressed a second copy of each ligase as
a GFP fusion protein in Dd2attB parasites and characterized
these lines by using fluorescence microscopy of live cells labeled
with DAPI. We found that both fusion proteins primarily localize
to the cytosol (Fig. 3 A and B). We also performed Western blot
analysis on whole-cell lysate from these parasites by using anti-
bodies against GFP and detected a band of the correct mass for
the full-length fusion protein in both biotin ligase overexpression
lines (Fig. 3 C and D). Interestingly, PfHCS2-GFP was more
difficult to detect than PfHCS1-GFP despite the fact that the
expression of both proteins was driven by the same regulatory
elements. This may be a result of a difference in protein stability
between the two ligases. Together, these results demonstrate
that the two biotin ligases are primarily cytosolic in the liver and
blood stages of the parasite life cycle. As biotinylated proteins are
located in the apicoplast of liver-stage parasites, this raises the
question of whether the biotin ligase paralogs are active ligases
and are responsible for protein biotinylation in the parasite.
PfHCS1 and PfHCS2 Are Active Biotin Ligases. To assess biotin ligase
activity for PfHCS1 and PfHCS2, we first tested the activity of the
two ligases in vitro. Recombinant PfHCS1 and PfHCS2 were
expressed in E. coli and purified by affinity chromatography. The
BCCP domain of PfACC was also expressed and purified as a
biotinylation substrate. We found that overexpression of PfBCCP
in E. coli results almost exclusively in apoprotein with less than 1%
of the purified PfBCCP biotinylated. We tested the reactivity of
each ligase toward PfBCCP in vitro and assessed PfBCCP bio-
tinylation through affinity blotting with streptavidin-HRP followed
byWestern blotting with antibodies specific to PfBCCP. We found
that PfHCS1, but not PfHCS2, biotinylated PfBCCP in an ATP-
dependent reaction (Fig. 3E). The very low signal in the absence
Fig. 2. HCS1 and HCS2 localize primarily to the cytosol in P. berghei.
(A) Immunofluorescence analysis of HepG2 cells 24, 48, and 56 hpi with
P. berghei parasites in which PbHCS1 was tagged with an HA tag through
double cross-over recombination. The tagged proteins are labeled with
specific antibodies (αHA), the apicoplast is labeled with αACP, and the nuclei
are labeled with DAPI. (B) Immunofluorescence analysis similar to that
shown for A using P. berghei parasites in which PbHCS2 was tagged with an
HA tag. (C) Immunofluorescence analysis of blood-stage parasites from the
transgenic lines shown in A and B. (Scale bars: 5 μm.)
Fig. 3. PfHCS1 and PfHCS2 are active biotin ligases. (A and B) Epifluor-
escence images of live P. falciparum blood-stage parasites expressing full-
length PfHCS1 fused to GFP (HCS1-GFP) or PfHCS2 fused to GFP (HCS2-GFP).
The parasites were stained with Hoechst to identify nuclei. GFP fluorescence
localizes to the cytosol in trophozoite (Top) and schizont (Bottom) parasites.
(Scale bars: 5 μm.) (C and D) Western blot analysis of lysate from the trans-
genic parasites shown in A and B using antibodies against GFP (αGFP)
showing a dominant band that corresponds to the expected size of the full-
length fusion protein. (E) Recombinant PfHCS1 and PfHCS2 were expressed
in E. coli and purified by affinity chromatography, and their activity was
tested by using an in vitro biotin ligase assay. PfHCS1, but not PfHCS2, bio-
tinylated PfBCCP in vitro in an ATP-dependent reaction. (F) The activities of
PfHCS1 and PfHCS2 were also tested in a cell-free assay. Lysates from para-
sites overexpressing the two ligases (shown in A and B), and a parental
control, were incubated with purified BCCP under reaction conditions similar
to E. PfHCS1 and PfHCS2 exhibit biotin ligase activity in this assay.














of ATP is probably the result of a small amount of biotinyl-AMP
copurified with PfHCS1.
In addition, we performed streptavidin affinity-blot analysis of
whole parasite lysate and observed a dramatic increase in total
protein biotinylation in the PfHCS1 overexpression line (gener-
ated as described here earlier), which was not present in the
PfHCS2 line or a parental control (SI Appendix, Fig. S5). This
indicates that PfHCS1 has unusually lax substrate specificity, likely
because of the release of the biotinyl-AMP conjugate, which re-
acts spontaneously with proteins when it is free in solution.
In a final approach, we performed cell-free assays with parasite
lysate. Whole-cell extract was generated from parasites over-
expressing PfHCS1 or PfHCS2, as well as the parental control, and
the reactivity of these extracts toward recombinant PfBCCP was
tested by using conditions similar to the in vitro biotinylation as-
say. In this assay, both ligases were active against PfBCCP (Fig.
3F), although PfHCS2 activity was slightly, but consistently,
weaker than PfHCS1 in each repetition of this assay. The low level
of biotinylation observed in the parental control is likely a result of
endogenous biotin ligase activity. Taken together, these results
show that malaria parasites express two functional biotin ligases,
which represents an unusual example of an organism that contains
two active biotin ligases. The fact that we observed activity for
PfHCS2 only in the cell-free assay may be because PfHCS2 folds
correctly only when expressed in P. falciparum or because this
enzyme requires a binding partner not present in E. coli.
Robust Biotinylation Activity Can Be Detected in the Cytosol of Blood-
Stage Parasites. To determine whether blood-stage parasites are
capable of biotinylating apicoplast proteins, we used the BCCP
domain of PfACC as a genetic probe for biotinylation activity in
P. falciparum. We expressed PfBCCP with a C-terminal GFP tag
in Dd2attB parasites. In the absence of any targeting sequence,
the BCCP-GFP fusion protein would be expressed in the cytosol.
We also expressed BCCP-GFP with an N-terminal apicoplast-
targeting peptide, the first 55 residues of PfACP. We generated
two constructs for each protein, one in which expression was
driven by the strong calmodulin (CaM) promoter, and one in
which expression was driven by the moderate ribosomal protein
L2 (RL2) promoter (22). We were able to generate transgenic
parasites from three of the constructs: the two cytosolic con-
structs and the apicoplast-localized protein with the RL2 pro-
moter. The final construct failed perhaps because overexpression
of apicoplast proteins by the CaM promoter is poorly tolerated—a
phenomenon we have observed before (23). We first verified that
the GFP fusion proteins were correctly localized in each line by
using live fluorescence microscopy (Fig. 4 A–C) and immunoflu-
orescence analysis (SI Appendix, Fig. S6). We then analyzed
whole-cell lysate from the transgenic parasites by using affinity
blotting with streptavidin-HRP and Western blotting with anti-
bodies specific to GFP. We observed robust biotinylation of
PfBCCP when it was targeted to the cytosol, but could not detect
any biotinylation activity in the apicoplast in blood-stage parasites
(Fig. 4 D–F). The lack of biotinylation activity in the apicoplast
agrees with the biotin ligase localization data, and eliminates the
possibility of a cryptic or noncanonical biotinylation mechanism in
the apicoplast. This also supports the conclusion that ACC is not
biotinylated, and thus inactive, in parasite blood stages.
Biotin Is Not Essential for the Survival of Blood-Stage Parasites. It has
been previously demonstrated that the FASII pathway, which
should be dependent on biotin, is important for the liver stages of
the parasite lifecycle (13, 14). However, it is not known whether
biotin is essential for parasite survival in the blood or mosquito
stages. Geary et al. (24) treated blood-stage parasites with 0.2 mg/mL
avidin and found that it had no effect on parasite growth in cul-
ture, but these experiments were inconclusive because they did not
test whether avidin was able to permeate erythrocytes or measure
the concentration of intraerythrocytic biotin stores. To determine
whether blood-stage P. falciparum is auxotrophic for biotin, we
measured parasite growth in biotin-depleted medium. The me-
dium was prepared from biotin-free RPMI supplemented with the
serum substitute AlbuMAX II. We tested the growth of Dd2attB
parasites as well as the three lines overexpressing the BCCP do-
main of PfACC (generated as described here earlier). To confirm
that we had completely removed biotin from the cultures, we used
PfBCCP as a sentinel protein to detect intracellular biotin. It
should also function as a biotin sink to further sensitize parasites
to biotin deprivation because it would compete with endogenous
substrates for any trace amounts of biotin that remained. We
found that the presence or absence of biotin in the media made no
significant difference in parasite growth (Fig. 5A). On the eighth
Fig. 4. Robust biotinylation activity can be detected in the cytosol but not
the apicoplast of blood-stage P. falciparum. (A) The biotinylation domain
(BCCP) from PfACC was expressed as a GFP fusion protein in the apicoplast of
blood-stage P. falciparum by using the apicoplast targeting domain from
PfACP (ACP-BCCP-GFP) under control of the ribosomal L2 (RL2) promoter.
Localization was verified by epifluorescence microscopy in late ring (Top),
trophozoite (Middle), and schizont (Bottom) parasites. Parasites were
stained with MitoTracker to identify the mitochondrion and DAPI to identify
nuclei. (B) BCCP was expressed as a GFP fusion protein in the cytosol (BCCP-
GFP) under control of the ribosomal L2 (RL2) promoter, and localization was
verified by epifluorescence microscopy as in A. (C) BCCP was expressed as a
GFP fusion protein in the cytosol (BCCP-GFP) under control of the stronger
CaM promoter, and localization was verified by epifluorescence microscopy
as in A. (D–F) Whole-cell lysates from the parasite lines shown in A–C were
analyzed by Western blotting with antibodies against GFP and affinity
blotting with streptavidin-HRP. BCCP is biotinylated in the cytosol but is not
biotinylated when expressed in the apicoplast. (Scale bars: 5 μm.)
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day of the growth assay, parasites were isolated, and whole-cell
extract was analyzed by affinity blotting with streptavidin-HRP
followed by Western blotting with antibodies specific to PfBCCP.
There was no detectable biotinylated PfBCCP in the cultures
grown under biotin-free conditions, indicating that biotin was
completely depleted from the medium (Fig. 5B). We therefore
concluded that biotin is not essential for blood-stage replication in
P. falciparum. In addition, these data show that parasites scavenge
biotin rather than synthesize it, as cytosolic PfBCCP is biotinylated
only when biotin is added to the medium.
It has previously been shown that blood-stage malaria parasites
have the ability to elongate fatty acids taken up from the medium
(25). In addition, it has been demonstrated that parasites lacking a
functional FASII pathway can still incorporate radiolabeled ace-
tate into fatty acid species, most likely because of the activity of
the ELO pathway (14). Based on these results, we tested whether
parasites can survive without biotin under limited fatty acid cul-
ture conditions. We cultured parasites in serum-free medium
supplemented with lipid-free BSA reconstituted with only palmitic
acid (C16:0) and oleic acid (C18:1), which are the minimal re-
quirements for parasite growth (25). Parasites cultured with or
without biotin were maintained in parallel, and biotin made no
difference in the growth rates of the parasites (Fig. 5C). These
results demonstrate that biotin is not required for blood-stage
parasite growth, even under conditions in which the FASII and
ELO pathways would be needed the most.
Biotinylated Proteins Cannot Be Detected in Blood-Stage Parasites.
Thus far, we have been unable to show any biotin-dependent
phenotype in blood-stage parasites. This raises the question of
whether there are any biotinylated proteins in the blood stages.
We were unable to detect any signal above background in im-
munofluorescence analysis of blood-stage P. falciparum (Fig. 1F)
or P. berghei (Fig. 1D) by using antibodies specific to biotin.
Similarly, we were unable to detect biotinylated proteins in the
blood stages by using streptavidin-FITC (SI Appendix, Fig. S7A).
Because these data do not rule out the possibility that there are
biotinylated proteins present at a level below the limit of detection
by microscopy, we used more sensitive techniques to probe this
question further. In radiolabel uptake experiments with blood-
stage P. falciparum, we did not detect incorporation of [3H]biotin
or [35S]biotin into cellular proteins (SI Appendix, Fig. S7B), even
though we have shown that the parasites are capable of scavenging
and incorporating exogenous biotin (Fig. 5B). In a final approach,
we performed affinity-blot analysis of parasite lysate by using
streptavidin-HRP. Although we detected biotinylated proteins in
some of the blots, these bands can often be detected in samples of
uninfected red blood cells (SI Appendix, Fig. S7C). These three
proteins correspond in mass to the human biotin carboxylases
methyl-crotonyl-CoA carboxylase (73.7 kDa), pyruvate carboxylase
(127.2 kDa), and the ACC isoforms (∼268.5 kDa). Although there
are no biotin carboxylases expressed in mature red blood cells, they
are expressed in reticulocytes and leukocytes, which can be present
in small amounts as contaminants in our culture system. Thus, if
blood-stage malaria parasites contain any biotinylated proteins,
these proteins are much less abundant than the trace levels of
human proteins in our culture system.
Biotin- and FASII-Independent Fatty Acid Elongation Activity Is Present
in Blood-Stage P. falciparum. The growth of blood-stage P. falciparum
parasites does not require biotin or ACC (8), leading us to the
hypothesis that the ELO pathway may not rely on malonyl-CoA
produced by ACC. We therefore tested whether ELO activity could
be detected under biotin-free conditions. Synchronized ring-stage
parasites were incubated with [14C]-acetate with or without biotin,
after which free fatty acids were extracted and analyzed by thin-
layer chromatography (TLC). To ensure we were assessing ELO
activity, we compared WT (i.e., Dd2) parasites with FASII-KO
(ΔFabI) parasites (14). We detected radiolabeled C16 and C18
fatty acids in both parasite lines cultured with or without biotin (Fig.
5D). Similar results were obtained in minimal fatty acid culture
medium (Fig. 5D), conditions previously shown to elevate FASII
activity (26). Thus, blood-stage parasites are capable of elongating
fatty acids independent of FASII and biotin.
Neither PbHCS1 Nor PbHCS2 Is Required for Blood-Stage Replication
or Mosquito-Stage Development. To determine which biotin ligase
is responsible for ACC biotinylation, both enzymes were knocked
out in P. berghei ANKA parasites. The KO constructs were
designed by using the pDEF-hDHFR plasmid, which facilitates
double cross-over homologous recombination, resulting in exci-
sion of the entire ORF of the target gene (SI Appendix, Fig. S8 A
and C). Correct integration of the hDHFR cassette and loss of
HCS1 and HCS2 were verified in independent clones by di-
agnostic PCR (SI Appendix, Fig. S8 B and D). The viability of both
KO strains demonstrated that neither gene is essential for survival
in the blood stages. To characterize development through the
mosquito stages, WT and ΔHCS1 or ΔHCS2 gametocytes were fed
to Anopheles stephensi mosquitoes, and infection levels were
measured at different time points. Mosquito midgut oocysts were
visualized 10 d after feeding, midgut sporozoites were counted
12 and 14 d after feeding, and salivary-gland sporozoites were
counted between 16 and 20 d after feeding. Throughout mosquito
stage development, ΔHCS1 and ΔHCS2 parasites exhibited no de-
fects in oocyst formation, sporozoite development, or sporozoite
Fig. 5. Biotin is not essential for survival of blood-stage P. falciparum.
(A) Blood-stage P. falciparum cultures were maintained for 8 d in media with
or without biotin. Four parasite lines were used: the parental control (Dd2),
parasites overexpressing BCCP in the apicoplast under the ribosomal L2 (RL2)
promoter, and parasites overexpressing BCCP in the cytosol under the RL2
promoter or the stronger CaM promoter. Error bars represent SEM of three
biological replicates. (B) On day 8 of the growth assay shown in A, parasites
were harvested and biotinylation levels were assessed by streptavidin-HRP
affinity blotting, followed by Western blotting with αBCCP antibodies.
There was no detectable biotinylated BCCP under biotin-free conditions, in-
dicating that biotin was completely depleted in these cultures. Controls were
parasites cultured in complete medium. (C) Blood-stage parasites (Dd2) were
cultured with or without biotin for 7 d in media containing lipid-free BSA
reconstituted with 30 μM palmitic acid and 30 μM oleic acid. Error bars rep-
resent SEM of three biological replicates. (D) TLC of parasites labeled with
14C-acetate showing incorporation into C16 and C18 fatty acids. This activity
was seen inWT and FASII KO parasites, and was independent of biotin. Similar
results were obtained when this experiment was repeated (Bottom) using the
minimal fatty acid medium described in C. No activity was seen with the
negative control, uninfected red blood cells (RBC).














invasion of the salivary glands compared with WT controls (SI
Appendix, Fig. S9).
Loss of PbHCS1 Affects Early Liver-Stage Development. We next
evaluated in vitro liver-stage growth and morphology of ΔHCS1 and
ΔHCS2 parasites by using immunofluorescence analysis of infected
HepG2 cells at different time points during liver-stage develop-
ment. Early liver-stage morphology was visualized by using mAb
3D11, which recognizes the circumsporozoite protein (CSP) on the
parasite plasma membrane (27), at 24 and 48 h post infection (hpi;
SI Appendix, Fig. S10 A and B). We also used antibodies specific for
a parasitophorous vacuole protein, UIS4 (28), at 48 hpi (SI Ap-
pendix, Fig. S10C). At 24 hpi, ΔHCS1 parasites were an average of
3 μm2 smaller than ΔHCS2 parasites or WT controls (SI Appendix,
Fig. S10D). At 48 hpi, ΔHCS1 parasites were an average of 53 μm2
smaller than WT parasites (SI Appendix, Fig. S10E). Taken to-
gether, these data indicate that parasites lacking either of the biotin
ligases can progress through early liver-stage development, but that
ΔHCS1 parasites display a growth phenotype.
Deletion of PbHCS1, but Not PbHCS2, Results in the Loss of Liver-
Stage Protein Biotinylation. To assess liver stage biotinylation in
the biotin ligase deletion lines, immunofluorescence analysis was
performed on HepG2 cells at 48 hpi with WT, ΔHCS1 , or ΔHCS2
parasites. PbACC expression was visualized by using antibodies
against the BCCP domain of PfACC, verifying that the enzyme is
expressed normally in both deletion lines (Fig. 6A). Although we
did not detect any change in biotinylation in ΔHCS2 parasites, we
observed a complete loss of protein biotinylation in ΔHCS1 par-
asites (Fig. 6 B and C). These data indicate that PbHCS1 is es-
sential for protein biotinylation in liver-stage parasites.
Parasites Lacking PbHCS1 Show Delayed Progression Through Liver
Stages in Vivo. We measured the prepatent period of the biotin
ligase deletion lines by inoculating mice with salivary-gland
sporozoites and measuring the length of time before blood-
stage parasites were detected microscopically. We found that i.v.
injection of 500 sporozoites per mouse did not always result in
blood-stage infection, and that this was particularly true for the
ΔHCS1 sporozoites (SI Appendix, Table S1). Increasing the in-
oculum to 5,000 sporozoites per mouse reproducibly produced a
blood-stage infection and revealed an average delay in patency of
2.1 d for ΔHCS1 parasites compared with WT controls. By
contrast, ΔHCS2 parasites were indistinguishable fromWT in the
number of mice that achieved a patent blood-stage infection and
the prepatent period. Thus, deletion of PbHCS1, but not
PbHCS2, significantly impairs the ability of malaria parasites to
progress from the liver stages to the blood stages.
Deletion of PbHCS1 Affects Late Liver-Stage Development and
Reduces Merosome Production. We visualized merozoite mor-
phology by immunofluorescence microscopy at the late liver-
stage time point of 56 h. By using antibodies specific for MSP1
(merozoite surface protein 1), we generally observed reduced
numbers of merozoites in ΔHCS1 parasites compared with WT
or ΔHCS2 cells (Fig. 7A). Consistent with this observation, the
size of the parasitophorous vacuole (assessed by using antibodies
specific for the parasitophorous vacuole protein UIS4) appeared
to be smaller in ΔHCS1 parasites (Fig. 7B). On average, ΔHCS1
parasites were approximately 73 μm2 smaller at the 56-h time
point, whereas no significant size decrease was observed in
ΔHCS2 cells (Fig. 7C). We next measured the number of mer-
osomes (i.e., membrane-bound clusters of merozoites) released
from HepG2 cells infected with WT or ΔHCS1 parasites at 65 h
post invasion. From independent experiments, each performed
in triplicate, we found that fewer merosomes were produced by
ΔHCS1 parasites compared with WT controls (Table 1). Taken
together, these results show that deletion of PbHCS1 results in
late liver-stage defects, and suggests that biotin metabolism is
important for this stage of development.
Host Biotin Is Required for Normal Liver-Stage Development. We
then tested whether parasites require biotin scavenged from the
host to complete liver-stage development. We cultured HepG2
cells by using media that had been dialyzed against avidin to
remove biotin (which is present in serum) and then supple-
mented with additional avidin. Importantly, this biotin-depletion
medium did not affect hepatocyte morphology or survival over a 6-d
test period (SI Appendix, Fig. S11). Cells were seeded and main-
tained in biotin-depleted media or normal media and infected with
Fig. 6. Deletion of PbHCS1, but not PbHCS2, results in the loss of liver-stage
protein biotinylation. (A) Immunofluorescence analysis of HepG2 cells at 48 hpi
with WT, ΔHCS1, or ΔHCS2 P. berghei showing that PbACC (αBCCP) is expressed
in the apicoplast (αACP) in both deletion lines. (B) Immunofluorescence analysis
similar to A showing that biotinylated protein (αbiotin) can be detected in the
apicoplast (αACP) in WT and ΔHCS2 parasites, but not ΔHCS1 parasites. Regions
of protein biotinylation surrounding the parasite are presumably host mito-
chondria, which are thought to be recruited to the parasitophorous vacuole
(52). (Scale bars: 5 μm.) (C) Biotin signal associated with the apicoplast and
nonapicoplast compartments is expressed as a percentage of the total biotin
signal found in the host cell. Error bars represent SEM from four or more in-
dependent experiments (ΔHCS1, n = 30, n = 6 replicates; ΔHCS2, n = 13, n = 4
replicates; WT, n = 22, n = 6 replicates). ns, not significant; ***P < 0.001.
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WT or ΔHCS1 sporozoites, and merosomes were collected and
counted 65 h post invasion. At least five replicates were used for
each condition. Under normal biotin-replete conditions, we found
that there was an approximately fourfold reduction in the number
of merosomes produced by ΔHCS1 parasites compared with WT
(Table 1); however, the size of the ΔHCS1 merosomes appeared
consistently smaller than those of WT parasites. We therefore
quantified total merozoite numbers by using quantitative PCR and
found that ΔHCS1merosomes contain fewer merozoites. We ob-
served that the number of merozoites per merosome was ∼10-fold
less in the ΔHCS1 parasites, which, when combined with the
lower number of merosomes produced by this mutant, results in
a 40-fold overall decrease in the number of merozoites produced.
This could account for the significant difference in the pre-
patency assays (SI Appendix, Table S1). Under biotin-depleted
conditions, fewer merozoites were produced by WT and ΔHCS1
parasites than were produced by the mutant when grown in the
presence of biotin (Table 1). We assessed the effect of biotin
depletion on infected HepG2 cells with immunofluorescence
analysis and confirmed that host and parasite biotinylation was
significantly reduced (SI Appendix, Fig. S12). Together, these
data indicate that liver-stage parasites rely on biotin scavenged
from the host, and that biotin is required for normal liver-stage
development. These data also suggest that perturbation of biotin
metabolism in the host cell may further impede the development
of liver-stage parasites.
Biotin Is Required for Merosome Infectivity. We assessed the ability
of merosomes produced in vitro to initiate blood-stage infections
in mice. Merosomes were produced as described earlier in HepG2
cells cultured in biotin-depleted media or normal media. Across
three independent experiments, merosomes produced in normal
medium were usually infectious (14 of 14 mice for WT and 9 of
13 mice for ΔHCS1 ) with a delay to patency for ΔHCS1 similar to
that observed in SI Appendix, Table S1. However, WT merosomes
produced under biotin-deficient conditions were infectious in only
1 of 14 mice. Quantification of total merozoites indicates that the
reduced infectivity was not caused by lower numbers of merozo-
ites produced (Table 2). Mutant parasites cultured in biotin-
deficient medium were never infectious. When combined with
the data presented in Table 1, these experiments show that biotin
deficiency affects the infectivity of merozoites as well as reducing
the total number of merosomes produced.
Discussion
We identified one biotinylation substrate (ACC) in malaria
parasites, but two biotin ligases (HCS1 and HCS2). This unusual
arrangement seems to be conserved in all species of malaria para-
sites; however, the organization of biotin metabolism is quite di-
vergent among different apicomplexan genera. The apicomplexan
Cryptosporidium parvum does not contain an apicoplast and en-
codes a cytosolic ACC and cytosolic biotin ligase. By contrast,
Theileria annulata lacks both ACC and biotin ligases. In T. gondii,
two biotinylated proteins (ACC and pyruvate carboxylase) were
Fig. 7. Liver-stage development is abnormal in ΔHCS1 parasites. (A) Immu-
nofluorescence analysis of infected HepG2 cells 56 hpi with WT, ΔHCS1, or
ΔHCS2 P. berghei. The parasite plasma membrane is illuminated with the late
liver-stage marker αMSP1, and the nuclei are labeled with DAPI. (B) Immu-
nofluorescence analysis similar to A at 56 hpi by using antibodies specific for
the parasitophorous vacuole protein UIS4. (C) Quantification of cell area at
56 hpi from three biological replicates with at least 20 measurements per
parasite strain. (Scale bars: 5 μm.) ns, not significant; ****P < 0.0001.
Table 1. Host biotin is required for normal liver stage
development
Expt Line Biotin Mrsm per well (SD) Mzt/Mrsm
Mzt per
well ×103
1 WT + 6,900 (1,924) — —
ΔHCS1 + 1,550 (788) — —
2 WT + 17,390 (5,663) 3,307 58,000
WT − 670 (303) 216 140
ΔHCS1 + 3,270 (434) 304 990
ΔHCS1 − 2,330 (1,492) 60 140
3 WT + 1,500 (418) 4,867 7,300
WT − 313 (314) 319 100
ΔHCS1 + 646 (267) 480 310
ΔHCS1 − 250 (194) 148 37
4 WT + 3,000 (576) 3,667 11,000
WT − 438 (304) 685 300
ΔHCS1 + 958 (359) 501 480
ΔHCS1 − 250 (188) 220 55
Expt, experiment number; Mrsm, merosome; Mzt, merozoite.














identified (29), but there is only one predicted biotin ligase
(TGME49_089760).
The duplication of biotin ligases in malaria parasites is similar
to the situation found in the plant A. thaliana. The two HCS genes
in A. thaliana share 71% sequence identity and likely resulted
from a gene duplication event. Similarly, HCS1 and HCS2 from
P. falciparum share 47% sequence identity and are likely paralogs
created by gene duplication. AtHCS1 is essential for viability,
whereas disruption of the AtHCS2 gene does not lead to any
observable phenotype (21). Similarly, deletion of P. falciparum
HCS1 results in a growth defect whereas deletion of HCS2 does
not (SI Appendix, Table S1). It is possible that HCS2 and AtHCS2
share a common role that has yet to be determined.
Both biotin ligase paralogs are predominantly located in the
cytosol in the blood stages of P. berghei (Fig. 2C) and P. falciparum
(Fig. 3 A and B). It was anticipated that at least one of the ligases
would be located in the apicoplast because this subcellular com-
partment was thought to contain ACC (30, 31). Indeed, ACC is
located in the apicoplast in P. berghei and P. falciparum (Fig. 1 C
and E), consistent with apicoplast localization of ACC in the re-
lated apicomplexan parasite T. gondii (29). Although ACC is
biotinylated in T. gondii (29), it is not biotinylated in blood-stage
malaria parasites (Fig. 1 D and F). We found this result to be
surprising and used a genetic probe to determine whether any
biotin ligase activity is located in the apicoplast. When we expressed
the BCCP domain of ACC in blood-stage P. falciparum parasites, we
found that the probe was biotinylated when expressed in the cytosol,
but that there was no detectable biotinylation when it was expressed
in the apicoplast (Fig. 4). This result is consistent with the cytosolic
localization of both biotin ligases and indicates that the apicoplast of
blood-stage parasites does not contain any enzymes with biotin li-
gase activity. Taken together, these results show that blood-stage
malaria parasites express ACC and two active biotin ligases, but
ACC is not biotinylated because all biotin ligase activity is confined
to the cytosol whereas ACC is exclusively located in the apicoplast.
The fact that ACC is not biotinylated in blood-stage malaria
parasites suggests that biotin is not needed during this stage
of parasite development. We cultured P. falciparum parasites
expressing the BCCP domain in biotin-depleted growth medium.
These parasite lines grew equally well regardless of whether bi-
otin was added back to the medium (Fig. 5A). Subsequent
analysis of parasites expressing BCCP in the cytosol demon-
strated that BCCP was biotinylated only when biotin was added
back to the depleted medium (Fig. 5B). These experiments show
that blood-stage parasites do not synthesize biotin and do not
rely on this vitamin for growth, but can import external biotin
when it is supplied in the medium. Even when parasites were
cultured in growth medium designed to increase the reliance on
fatty acid metabolism, there was still no growth phenotype as-
sociated with biotin depletion (Fig. 5C).
The ability of blood-stage malaria parasites to grow without
biotin has interesting consequences for fatty acid metabolism. All
known FAS and ELO pathways use malonyl-CoA for chain
elongation. ACC is the only predicted source of malonyl-CoA in
malaria parasites, and thus should be required for FASII and
ELO activity. Key enzymes of the FASII pathway, such as FabI,
have been knocked out in human and rodent malaria species,
demonstrating that FASII is dispensable for blood-stage replica-
tion (13, 14). The lack of ACC biotinylation in blood-stage par-
asites further suggests that FASII cannot function during this
stage of parasite development. Fatty acid elongation, however, can
still be observed in ΔFabI parasites, implying that the ELO
pathway is active in the blood stages of P. falciparum and P. berghei
(14). We used the P. falciparum ΔFabI line to show that radiola-
beled acetate is still incorporated into parasite fatty acids regardless
of whether biotin is present in the growth medium, and, further-
more, the incorporation of acetate was the same between ΔFabI
parasites and the parental line (Fig. 5D). Taken together, these data
suggest that FASII is inactive in blood-stage P. falciparum parasites
whereas these parasites have ELO activity that does not depend on
biotin or ACC. The ELO pathway could rely on another source of
malonyl-CoA, such as a malonyl-CoA synthetase (32).
In liver-stage malaria parasites, the arrangement of ACC and
the biotin ligases appears to be the same as it is in blood stages.
The ACC is located in the apicoplast (Fig. 1) whereas the biotin
ligases are predominantly located in the cytosol (Fig. 2 and SI
Appendix, Fig. S3). The obvious difference is that apicoplast
proteins (presumably ACC, although there may be others) are
biotinylated, and this raised the question of which ligase is re-
sponsible for this activity. To answer this question, we deleted
the genes encoding HCS1 and HCS2 in P. berghei and found that
HCS1 is exclusively responsible for protein biotinylation whereas
deletion of HCS2 has no detectable liver-stage phenotype (Fig.
6). This result suggests that HCS1 is partially located in the
apicoplast of liver-stage parasites, albeit at low levels compared
with the majority of HCS1 located in the cytosol (Fig. 2A). There
are examples in other organisms of dual targeting of biotin li-
gases to different cellular compartments, which is regulated by
alternative splicing of a single mRNA or alternative translation
initiation sites. This has been shown in some detail in A. thaliana
(21) and has been suggested in Pisum sativum (20) as well as
humans (33). In addition, there are examples of dual targeting of
proteins to the apicoplast, mitochondrion, and cytosol in malaria
parasites (34–36), although the mechanisms are not well un-
derstood. One suggested mechanism is the use of an ambiguous
targeting sequence that is inefficiently recognized by the protein
sorting machinery, so that a fraction of the total protein is im-
ported into an organelle and the remainder is retained in the
cytosol (37). Regardless of the mechanisms involved, our results
show that biotinylation by HCS1 is stage-specific, occurring in
liver-stage but not blood-stage malaria parasites.
P. berghei parasites lacking HCS1 have a defect in liver-stage
development that begins early in parasite development (SI Ap-
pendix, Fig. S10) and becomes more obvious by 56 h post in-
vasion (Fig. 7). ΔHCS1 parasites produce fewer merosomes than
WT parasites, and these merosomes contain significantly fewer
merozoites (Table 1). In general, late liver-stage developmental
defects and severely curtailed formation of merosomes are hall-
marks of KO parasites with FASII gene deletions (13, 14) or de-
letions of genes required for the FASII pathway (15, 38). Deletion
of FASII-related genes in P. berghei [ΔFabI (14) and ΔLipB (38)]
results in a 4-d delay to patency, with few parasites able to com-
plete liver-stage development and almost no merosome formation.
By contrast, ΔHCS1 parasites display a 2.1-d delay to patency and
Table 2. Biotin is required for merosome infectivity
Expt Line Biotin
Mrsm
injected Mice positive P0, d
Mzt
injected×103
1 WT + 1,000 4/4 3.5 —
WT − 1,000 0/4 * —
ΔHCS1 + 1,000 3/3 5.7 —
ΔHCS1 − 1,000 0/1 * —
2 WT + 2,500 5/5 3.6 27,000
WT − 2,500 0/5 * 520
ΔHCS1 + 2,500 2/5 5.5 170
ΔHCS1 − 2,500 0/5 * 130
3 WT + 2,000 5/5 5.6 6,700
WT − 2,000 1/5 7 350
ΔHCS1 + 2,000 4/5 7.5 320
ΔHCS1 − 2,000 0/5 * 160
Expt, experiment number; Mice positive, fraction of mice infected with
blood stage parasites; Mrsm, merosome; Mzt, merozoite; P0, prepatent
period.
*Parasites were not detected 1 mo after merosome injection.
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quantifiable merosomes. If HCS1 is responsible for activating
ACC to supply malonyl-CoA for FASII, why is the ΔHCS1 phe-
notype different from that of ΔFabI or ΔLipB? One explanation
for the less severe ΔHCS1 phenotype is that the parasites have
another source of malonyl-CoA, allowing them to partially bypass
the need for HCS1. Hepatocyte ACC produces malonyl-CoA, and
it is possible that this metabolite can be scavenged. This expla-
nation is consistent with the observation that WT and ΔHCS1
parasites produce fewer merozoites when cultured in biotin-
depleted medium (Table 1). Presumably, the deletion of HCS1
affects only parasite ACC activity, whereas biotin depletion affects
parasite and host cell ACC activity.
To assess the combined effects of host cell and parasite biotin
deprivation, we conducted merosome infection experiments. We
found that WT and mutant ΔHCS1merosomes produced in vitro
by host cells cultured in complete medium were usually in-
fectious in mice, but were almost never infectious if they were
produced in biotin-deficient conditions (Table 2). The dramatic
decrease in infectivity could result from the merozoites failing to
egress from the membrane-bound merosomes, or it could be that
the merozoites are defective. It is difficult to distinguish between
these possibilities in our experiments; however, the fact that
many merozoites are released during the injection process sug-
gests that the merozoites themselves are less infectious.
These results raise the possibility that biotin is a host nutrient
that could affect parasite development, as has been suggested for
other nutrients (39). In humans, biotin deficiency is almost in-
variably caused by mutations in an essential enzyme called bio-
tinidase, which is required to make use of biotin obtained from
dietary sources (40). More than 165 biotinidase mutations have
been described in humans (41). In some cases, these mutations
are severe enough to cause disease, but it is more common for
these mutations to decrease biotin utilization without causing
disease. Although the data currently available are not sufficient
to implicate biotin deficiency in protection from malaria in-
fection, there is some evidence that biotinidase mutations are
more prevalent in certain African populations (42).
In conclusion, we found that ACC is expressed in the apicoplast
organelle in liver- and blood-stage malaria parasites, but it is
biotinylated only in the liver stages, suggesting that ACC activity is
regulated through stage-specific biotinylation. Because ACC is the
first committed step in FASII pathways, protein biotinylation may
serve as a molecular switch controlling fatty acid biosynthesis in
malaria parasites. Gene deletion experiments showed that the
biotin ligase HCS1 is solely responsible for biotinylation in liver-
stage parasites. Parasites lacking HCS1 show a late liver-stage
defect and produce fewer merosomes with abnormally low num-
bers of merozoites per merosome. Biotin depletion results in more
severe developmental defects, resulting in merozoites that are no
longer capable of blood-stage infection. These results imply that
host and parasite biotin metabolism are required for normal liver-
stage progression and merozoite infectivity. Thus, the develop-
ment of liver-stage malaria parasites may be linked to the nutri-
tional status of the host, as neither the parasite nor the human
host can synthesize biotin.
Materials and Methods
Cells and Antibodies. HepG2 human liver carcinoma cells [HB-8065; Ameri-
canType Culture Collection (ATCC)] were maintained in Dulbecco’s modified
Eagle medium (DMEM) supplemented with 10% FCS, 2 mM glutamine, and
1× penicillin–streptomycin. The following antibodies were used: mouse
monoclonal α-biotin (no. 200–002-211; Jackson) at 1:250 or 1:500 dilution;
rabbit BCCP antiserum (10) (raised against the P. falciparum antigen but
recognizes P. falciparum and P. berghei ACC) at 1:100 (Pf) or 1:250 (Pb) di-
lution; rabbit or rat polyclonal αACP (43, 44) (raised against the P. falciparum
antigen but recognizes P. falciparum and P. berghei ACP) at 1:500 (Pf) or
1:1,000 (Pb) dilution; mouse monoclonal αCSP 3D11 (27) at 1:1,000 dilution;
rabbit αUIS4 (28) at 1:1,000 dilution; P. yoelii MSP1-19 rabbit antiserum
(MRA-23, MR4; ATCC) at 1:1,000 dilution; and mouse monoclonal αGFP
(Roche) at 1:200 (Pf) or 1:1,000 (Pb) dilution. The corresponding secondary
antibodies conjugated to Alexa Fluor-488 or Alexa Fluor-594 (Invitrogen)
were used as indicated.
Immunofluorescence Analysis. To visualize liver-stage parasites, HepG2 cells
were seeded at a density of 105 cells per well on Permanox eight-well chamber
slides coated with collagen (no. 354236; BD Biosciences). P. berghei ANKA
sporozoites were harvested from infected Anopheles stephensi mosquitoes
18–24 d post blood meal, quantified, and centrifuged onto the HepG2 cells at
a density of 2 × 104 sporozoites per well. At the time point indicated, cells were
fixed with 4% paraformaldehyde for 20 min at room temperature, washed
with PBS solution, and permeabilized with methanol overnight at −20 °C.
Slides were blocked and probed in 1% BSA in PBS solution and mounted with
Prolong Gold Antifade Reagent with DAPI (Invitrogen). Average cell area was
quantified by using Volocity software (PerkinElmer). Immunofluorescence
analysis of P. berghei and P. falciparum blood-stage parasites was carried out
as previously described (45) with a few modifications (46). The SI Appendix
provides more details.
P. falciparum Transfections. Parasite transfections were carried out by using
the mycobacteriophage Bxb1 integrase system developed by Nkrumah et al.
(47) and modified by Spalding et al. (48). Vector construction using the
primers listed in SI Appendix, Table S2 is described in the SI Appendix.
Endogenous Tagging and Localization of P. berghei Biotin Ligases. Double
cross-over replacement constructs were made for the P. berghei biotin ligase
genes HCS1 (PBANKA_051100) and HCS2 (PBANKA_132360). P. berghei ANKA
genomic DNA was amplified and cloned into a vector designed to append a
3xHA tag to the 3′ end of the ligase genes. A single cross-over strategy was
used to generate GFP-tagged parasite lines (SI Appendix). Constructs were
linearized and transfected into P. berghei ANKA according to Janse et al.(49).
Biotin Ligase Activity Assays and Affinity/Western Blot Analysis. The biotin li-
gase geneswere subcloned into expression vector pMALcHT (50) for expression
and purification as MBP fusion proteins. The truncated BCCP domain of PfACC
was expressed as a GST fusion protein in BL21-Star(DE3) cells by using a
modified pGEX-4T-3 expression vector (pGEXT) and purified as previously
described (10). The biotin ligase in vitro assay was carried out by using pure
recombinant BCCP and biotin ligase proteins in the presence of ATP and bi-
otin. Biotinylated BCCP was detected by affinity blot using streptavidin cou-
pled to peroxidase (ultrasensitive; Sigma), and the presence of BCCP protein
was confirmed by anti-BCCP Western blot. For the cell-free assay, P. falciparum
parasites were isolated by saponin lysis followed by sonication to release
parasite proteins. BCCP, biotin, and ATP were added to the parasite lysates,
and biotinylation activity was assessed by affinity and Western blot.
Growth Assay and Radiolabel Incorporation. Biotin-depleted medium was
prepared using RPMImedium 1640 modified with L-glutamine without phenol
red and biotin (R9002-01; US Biological), which was supplemented with
25 mM Hepes, 0.375% sodium bicarbonate, 12.5 μg/mL hypoxanthine, 5 g/L
AlbuMAX II, and 25 μg/mL gentamicin. For each parasite line, the cultures and
red blood cells were washed twice in 10 mL biotin-free RPMI to remove biotin
and then divided into parallel cultures for growth assays conducted with or
without biotin supplementation. Lipid-free BSA (Sigma) was reconstituted
with palmitic acid (Sigma) and potassium oleate (Fluka) and used in lieu of
AlbuMAX for growth assays under minimal lipid conditions. For radioactive
biotin incorporation experiments, P. falciparum cultures were maintained
with daily feedings of biotin-free medium. Parasite cultures were labeled for
3 d with 0.48 nmol 3H-biotin (American Radiolabeled Chemicals) or 29.2 nmol
of freshly prepared 35S-biotin (10) each day for 3 d. Label incorporation was
assessed by autoradiography. For acetate incorporation, synchronized ring-
stage parasites were incubated for 24 h with 10 μCi/mL 14C-acetate, after
which parasites were isolated by saponin lysis. Fatty acid methylesters were
extracted and resolved by TLC as described in SI Appendix.
P. berghei Biotin Ligase KOs. To generate the double cross-over KO construct
for PbHCS1 and PbHCS2, homology arms composed of the 5′ and 3′ UTR of
PbHCS1 and PbHCS2 were cloned into the pDEF-hDHFR plasmid (51). Con-
structs were linearized and transfected into P. berghei as described by Janse
et al. (49) with a few modifications (SI Appendix).
P. berghei Liver-Stage Development and Infectivity Assays. For prepatency
assays, salivary gland sporozoites were harvested from infected A. stephensi
mosquitoes and injected into mice i.v. followed by daily monitoring of














parasitemia by blood smear. Merosome production was assessed by col-
lecting the supernatant from HepG2 cells infected with salivary gland spo-
rozoites at 65 hpi. Merosomes were quantified in a hemocytometer, and the
DNA content of the merosome samples was determined with quantitative
real-time PCR. For infectivity assays, harvested merosomes were quantified
and prepared for tail-vein injection into mice. Blood-stage parasitemia was
subsequently monitored by microscopy.
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 Organized and evaluated scientific submissions presentation, and helped facilitate review criteria and review panels 













 Employed peptide/organic/inorganic chemistry to synthesize substrates for enzymatic assay against NCI compound 
libraries 
 Determined product purity using HPLC and mass-spectrometry 
 Assayed activity using radiometry and UV-Vis spectroscopy 
 Purified recombinant protein using affinity chromatography 
 Trained in NMR, gas chromatography and various spectroscopic techniques 
 
Previous Work Experience 
English Teacher, Forest Hills High School (2001-2007) 
 Certified NYC Public School Teacher for English 




 grade), including remedial, ESL, honors and drama classes 
 
Leadership and Service 
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 
 Organized a monthly journal club dedicated to exploring various topics in biology, microbiology and immunology 
 Served as a student representative for external review boards for the Department of Molecular  
Microbiology and Immunology and the Johns Hopkins Malaria Research Institute to provide evaluations for both 
organizations 
 Founder and President of the Lab Science Student Group (2014-2015) designed to improve student relationships 
between lab departments and provide professional development opportunities 
 Facilitated the Tropical Medicine Dinner Club, a semi-monthly meeting and seminar of DC/Baltimore scientist working 
on tropical medicine, as student liaison for logistics and planning 
  
Faculty Member at Forest Hills High School, Forest Hills, NY 
 Established the English Honor Society to support highly performing students with extracurricular activities 
 Co-headed senior thesis committee to establish a rigorous, research-based graduation requirement 
 Served as member of curriculum development committee to review and overhaul the curriculum 
 Volunteered to teach pilot program targeted to poorly performing students with behavioral issues 
 Trained two student teachers in lesson planning, student evaluation and classroom management 
 
Publications, Posters and Presentations 
Jhun, H., Spalding, M., Sinnis, P., Prigge S. “Probing mitochondrial lipoylation in Plasmodium” (preparing for submission) 
 Poster presentations 
- 2018 Delta Omega Poster Competition, Johns Hopkins University, MD 
- 2015 American Society for Biochemistry and Molecular Biology, Boston, MA 
- 2014 Molecular Parasitology Meeting, Woods Hole, MA. 
Oral Presentations   
- 2014 Malaria Research Institute Seminar, Johns Hopkins University, MD 
- 2016 Tropical Medicine Dinner Club, Johns Hopkins University, MD 
 
Jhun, H., Spalding, M.S., Prigge, S.T. “Mitochondrial lipoylation is essential in P. falciparum” mBio (submitted) 
Dellibovi-Ragheb T.A., Jhun H., Goodman, C.D., Walters, M.S., Ragheb, D.R.T., Matthews, K.A., Rajaram, K., Mishra, S., 
McFadden, G.I., Sinnis, P., Prigge, S.T. Host Biotin is Required for Liver Stage Development in Malaria Parasites. PNAS (2018) 
 
Das, T.K., Dana, D., Paroly, S.S., Perumal, S.K., Singh, S., Jhun, H., Pendse, J., Cagan, R.L., Talele, T.T., Kumar, S. Centrosomal 
kinase Nek2 cooperates with oncogenic pathways to promote metastasis.  Oncogenesis. (2013)  
Lamb, H.M., Jhun, H., and Hardwick J.M.   "Bax and Bcl-xL cooperate to alter curvature of cellular membranes" Poster 
presentation at the 2012 Keystone Symposia: Mitochondrial Dynamics and Function, Banff, Canada. 
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